PKCB
Normalized values from positional scanning peptide array
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
S Sites Probabilities
T Sites Probabilities
Log-Odds: S Sites / S Background
Log-Odds: T Sites / T Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| A0A2R8Y4L2 | S95 | Sugiyama | HNRNPA1L3 HNRNPA1P48 | RPHKVDGRVVEPKRAVSREDsQRPDAHLTVKKIFVGGIKED |
| A5A3E0 | S1068 | Sugiyama | POTEF A26C1B | SLSTFQQMWISKQEyDEsGPsIVHRKCL_____________ |
| O00443 | S58 | Sugiyama | PIK3C2A | ALAKLQKDRQVTDNQRGFELsssTRKKAQVyNKQDyDLMVF |
| O14974 | S910 | Sugiyama | PPP1R12A MBS MYPT1 | yETssTsAGDRyDsLLGRsGsysYLEERKPYSSRLEKDDST |
| O15217 | T193 | SIGNOR | GSTA4 | NILSAFPFLQEYTVKLsNIPtIKRFLEPGSKKKPPPDEIYV |
| O15350 | S388 | SIGNOR|PSP | TP73 P73 | LMKLKESLELMELVPQPLVDsYRQQQQLLQRPSHLQPPSYG |
| O15372 | S183 | Sugiyama | EIF3H EIF3S3 | SLKAYRLTPKLMEVCKEKDFsPEALKKANITFEYMFEEVPI |
| O15519 | S193 | SIGNOR|EPSD|PSP | CFLAR CASH CASP8AP1 CLARP MRIT | QSVQGAGTSYRNVLQAAIQKsLKDPSNNFRLHNGRSKEQRL |
| O60220 | S94 | Sugiyama | TIMM8A DDP DDP1 TIM8A | SQFILNRLEQTQKSKPVFSEsLsD_________________ |
| O60488 | T328 | PSP | ACSL4 ACS4 FACL4 LACS4 | GLGPKDTYIGYLPLAHVLELtAEISCFTYGCRIGYssPLTL |
| O60814 | S39 | Sugiyama | H2BC12 H2BFT HIRIP1 HIST1H2BK | VTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| O60841 | S196 | Sugiyama | EIF5B IF2 KIAA0741 | ERsRINssGEsGDEsDEFLQsRKGQKKNQKNKPGPNIEsGN |
| O60841 | S222 | Sugiyama | EIF5B IF2 KIAA0741 | KNQKNKPGPNIEsGNEDDDAsFKIKTVAQKKAEKKERERKK |
| O60927 | T75 | Sugiyama | PPP1R11 HCGV TCTE5 | RRssKCCCIyEKPRAFGEsstEsDEEEEEGCGHtHCVRGHR |
| O75144 | S285 | SIGNOR | ICOSLG B7H2 B7RP1 ICOSL KIAA0653 | LLVVVAVAIGWVCRDRCLQHsYAGAWAVsPETELTGHV___ |
| O75821 | S217 | Sugiyama | EIF3G EIF3S4 | PGELEPVQAtQNKtGKYVPPsLRDGAsRRGESMQPNRRADD |
| O94901 | S113 | SIGNOR | SUN1 KIAA0810 UNC84A | QRRSTNKSAFSINHVSRQVTsSGVSHGGTVSLQDAVTRRPP |
| O95243 | S165 | SIGNOR | MBD4 MED1 | VLSKRGIKSRYKDCSMAALTsHLQNQSNNSNWNLRTRSKCK |
| O95243 | S262 | SIGNOR | MBD4 MED1 | PIKKTKKGCRKsCSGFVQSDsKRESVCNKADAESEPVAQKS |
| O95678 | S162 | Sugiyama | KRT75 K6HF KB18 | IQRVRAEEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWA |
| O95832 | T191 | PSP | CLDN1 CLD1 SEMP1 UNQ481/PRO944 | AASLCLLGGALLCCSCPRKTtSYPTPRPYPKPAPSSGKDyV |
| O96004 | S109 | ELM | HAND1 BHLHA27 EHAND | GGRLGRRKGsGPKKERRRtEsINSAFAELRECIPNVPADTK |
| O96004 | S98 | ELM | HAND1 BHLHA27 EHAND | PGQSPGRLEALGGRLGRRKGsGPKKERRRtEsINSAFAELR |
| O96004 | T107 | ELM | HAND1 BHLHA27 EHAND | ALGGRLGRRKGsGPKKERRRtEsINSAFAELRECIPNVPAD |
| P00338 | S161 | Sugiyama | LDHA PIG19 | DILTYVAWKISGFPKNRVIGsGCNLDsARFRyLMGERLGVH |
| P00338 | S167 | Sugiyama | LDHA PIG19 | AWKISGFPKNRVIGsGCNLDsARFRyLMGERLGVHPLSCHG |
| P00533 | T678 | ELM | EGFR ERBB ERBB1 HER1 | LVVALGIGLFMRRRHIVRKRtLRRLLQERELVEPLtPsGEA |
| P00558 | T168 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | EAFRAsLSKLGDVyVNDAFGtAHRAHssMVGVNLPQKAGGF |
| P01589 | S268 | ELM | IL2RA | FLLISVLLLSGLTWQRRQRKsRRtI________________ |
| P01589 | T271 | ELM | IL2RA | ISVLLLSGLTWQRRQRKsRRtI___________________ |
| P02538 | S176 | Sugiyama | KRT6A K6A KRT6D | IQRVRAEEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWT |
| P02545 | S403 | ELM | LMNA LMN1 | EEERLRLsPsPtsQRsRGRAssHssQtQGGGsVtKKRKLEs |
| P02545 | S404 | ELM | LMNA LMN1 | EERLRLsPsPtsQRsRGRAssHssQtQGGGsVtKKRKLEst |
| P02545 | S5 | ELM | LMNA LMN1 | ________________METPsQRRAtRsGAQAsstPLsPtR |
| P02545 | S625 | ELM | LMNA LMN1 | AQVGGPIssGssAssVtVtRsYRsVGGsGGGsFGDNLVtRS |
| P02545 | T199 | ELM | LMNA LMN1 | AKKQLQDEMLRRVDAENRLQtMKEELDFQKNIysEELREtK |
| P02545 | T416 | ELM | LMNA LMN1 | QRsRGRAssHssQtQGGGsVtKKRKLEstEsRssFsQHARt |
| P02545 | T480 | ELM | LMNA LMN1 | EDQsMGNWQIKRQNGDDPLLtYRFPPKFTLKAGQVVTIWAA |
| P02671 | S576 | ELM | FGA | NtKEsssHHPGIAEFPsRGKsssYSKQFTssTSYNRGDstF |
| P02671 | S577 | ELM | FGA | tKEsssHHPGIAEFPsRGKsssYSKQFTssTSYNRGDstFE |
| P02671 | S578 | ELM | FGA | KEsssHHPGIAEFPsRGKsssYSKQFTssTSYNRGDstFES |
| P02671 | S618 | ELM | FGA | SKSYKMADEAGsEADHEGTHsTKRGHAKSRPVRDCDDVLQT |
| P02786 | S151 | Sugiyama | TFRC | LsEKLDstDFTGtIKLLNENsyVPREAGsQKDENLALyVEN |
| P02786 | S24 | ELM | TFRC | QARsAFsNLFGGEPLsytRFsLARQVDGDNsHVEMKLAVDE |
| P02786 | T143 | Sugiyama | TFRC | yWDDLKRKLsEKLDstDFTGtIKLLNENsyVPREAGsQKDE |
| P04004 | S381 | SIGNOR|iPTMNet|EPSD | VTN | PRPsLAKKQRFRHRNRKGYRsQRGHsRGRNQNsRRPsRAtW |
| P04049 | S497 | SIGNOR | RAF1 RAF | HEGLtVKIGDFGLAtVKsRWsGsQQVEQPTGSVLWMAPEVI |
| P04049 | S499 | ELM | RAF1 RAF | GLtVKIGDFGLAtVKsRWsGsQQVEQPTGSVLWMAPEVIRM |
| P04049 | S619 | SIGNOR | RAF1 RAF | FPQILssIELLQHsLPKINRsAsEPsLHRAAHtEDINACtL |
| P04075 | S336 | Sugiyama | ALDOA ALDA | GKKENLKAAQEEYVKRALANsLACQGKytPsGQAGAAAsEs |
| P04075 | S36 | Sugiyama | ALDOA ALDA | LsDIAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENR |
| P04075 | S39 | Sugiyama | ALDOA ALDA | IAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRRFy |
| P04075 | S46 | Sugiyama | ALDOA ALDA | PGKGILAADEstGsIAKRLQsIGtENtEENRRFyRQLLLtA |
| P04083 | S27 | SIGNOR|ELM | ANXA1 ANX1 LPC1 | FLKQAWFIENEEQEyVQtVKssKGGPGsAVsPyPtFNPssD |
| P04083 | S28 | ELM|EPSD|PSP | ANXA1 ANX1 LPC1 | LKQAWFIENEEQEyVQtVKssKGGPGsAVsPyPtFNPssDV |
| P04083 | T24 | ELM | ANXA1 ANX1 LPC1 | VsEFLKQAWFIENEEQEyVQtVKssKGGPGsAVsPyPtFNP |
| P04259 | S176 | Sugiyama | KRT6B K6B KRTL1 | IQRVRAEEREQIKTLNNKFAsFIDKVRFLEQQNKVLDTKWT |
| P04439 | S359 | ELM | HLA-A HLAA | RKGGsyTQAASSDSAQGSDVsLTACKV______________ |
| P04792 | S82 | Sugiyama | HSPB1 HSP27 HSP28 | AIEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVN |
| P05107 | S745 | GPS6|SIGNOR|ELM|EPSD|PSP | ITGB2 CD18 MFI7 | ALIHLSDLREyRRFEKEKLKsQWNNDNPLFKsAtttVMNPK |
| P05107 | S756 | ELM | ITGB2 CD18 MFI7 | RRFEKEKLKsQWNNDNPLFKsAtttVMNPKFAES_______ |
| P05107 | T758 | GPS6|SIGNOR|ELM|EPSD|PSP | ITGB2 CD18 MFI7 | FEKEKLKsQWNNDNPLFKsAtttVMNPKFAES_________ |
| P05107 | T760 | ELM | ITGB2 CD18 MFI7 | KEKLKsQWNNDNPLFKsAtttVMNPKFAES___________ |
| P05114 | S21 | ELM | HMGN1 HMG14 | MPKRKVssAEGAAKEEPKRRsARLsAKPPAKVEAKPKKAAA |
| P05114 | S25 | ELM | HMGN1 HMG14 | KVssAEGAAKEEPKRRsARLsAKPPAKVEAKPKKAAAKDKS |
| P05129 | T514 | Sugiyama | PRKCG PKCG | IKITDFGMCKENVFPGtTTRtFCGtPDyIAPEIIAyQPYGK |
| P05129 | T518 | Sugiyama | PRKCG PKCG | DFGMCKENVFPGtTTRtFCGtPDyIAPEIIAyQPYGKSVDW |
| P05455 | S325 | Sugiyama | SSB | VLEGEVEKEALKKIIEDQQEsLNKWKSKGRRFKGKGKGNKA |
| P05771 | S16 | SIGNOR|EPSD | PRKCB PKCB PRKCB1 | _____MADPAAGPPPsEGEEstVRFARKGALRQKNVHEVKN |
| P05771 | S311 | Sugiyama | PRKCB PKCB PRKCB1 | PPEGSEANEELRQKFERAKIsQGtKVPEEKTTNTVSKFDNN |
| P05771 | S661 | GPS6|SIGNOR|EPSD | PRKCB PKCB PRKCB1 | LtPtDKLFIMNLDQNEFAGFsyTNPEFVINV__________ |
| P05771 | T17 | SIGNOR|EPSD | PRKCB PKCB PRKCB1 | ____MADPAAGPPPsEGEEstVRFARKGALRQKNVHEVKNH |
| P05771 | T314 | Sugiyama | PRKCB PKCB PRKCB1 | GSEANEELRQKFERAKIsQGtKVPEEKTTNTVSKFDNNGNR |
| P05771 | T500 | Sugiyama | PRKCB PKCB PRKCB1 | IKIADFGMCKENIWDGVttKtFCGtPDyIAPEIIAyQPYGK |
| P05771 | T504 | Sugiyama | PRKCB PKCB PRKCB1 | DFGMCKENIWDGVttKtFCGtPDyIAPEIIAyQPYGKSVDW |
| P05771 | T635 | GPS6|EPSD|Sugiyama | PRKCB PKCB PRKCB1 | PPYKPKARDKRDTSNFDKEFtRQPVELtPtDKLFIMNLDQN |
| P05771 | T642 | SIGNOR|Sugiyama | PRKCB PKCB PRKCB1 | RDKRDTSNFDKEFtRQPVELtPtDKLFIMNLDQNEFAGFsy |
| P05771 | T83 | Sugiyama | PRKCB PKCB PRKCB1 | QGFQCQVCCFVVHKRCHEFVtFsCPGADKGPASDDPRSKHK |
| P05783 | S53 | ELM | KRT18 CYK18 PIG46 | AsVyAGAGGsGsRIsVsRstsFRGGMGsGGLAtGIAGGLAG |
| P05787 | S104 | Sugiyama | KRT8 CYK8 | IQAVRTQEKEQIKTLNNKFAsFIDKVRFLEQQNKMLETKWS |
| P06127 | T434 | SIGNOR|iPTMNet|EPSD | CD5 LEU1 | QRQWIGPTGMNQNMsFHRNHtAtVRsHAENPtASHVDNEys |
| P06127 | T436 | SIGNOR|iPTMNet|EPSD | CD5 LEU1 | QWIGPTGMNQNMsFHRNHtAtVRsHAENPtASHVDNEysQP |
| P06213 | T1375 | ELM | INSR | yEEHIPytHMNGGKKNGRILtLPRSNPS_____________ |
| P06730 | S209 | SIGNOR|iPTMNet|EPSD | EIF4E EIF4EL1 EIF4F | LPPKIVIGyQsHADTAtKsGsttKNRFVV____________ |
| P06748 | S227 | ELM | NPM1 NPM | SNQNGKDsKPsstPRsKGQEsFKKQEKtPKtPKGPssVEDI |
| P06899 | S39 | Sugiyama | H2BC11 H2BFR HIST1H2BJ | VTKAQKKDGKKRKRSRKEsysIyVyKVLKQVHPDTGISSKA |
| P07195 | S162 | Sugiyama | LDHB | DILTYVTWKLSGLPKHRVIGsGCNLDsARFRyLMAEKLGIH |
| P07195 | S168 | Sugiyama | LDHB | TWKLSGLPKHRVIGsGCNLDsARFRyLMAEKLGIHPSSCHG |
| P07195 | S303 | Sugiyama | LDHB | GIENEVFLSLPCILNARGLtsVINQKLKDDEVAQLKKsADt |
| P07205 | T168 | Sugiyama | PGK2 PGKB | EAFRAsLSKLGDVyVNDAFGtAHRAHSSMVGVNLPHKASGF |
| P07307 | S12 | ELM | ASGR2 CLEC4H2 | _________MAKDFQDIQQLsSEENDHPFHQGEGPGTRRLN |
| P07355 | S2 | SIGNOR|EPSD | ANXA2 ANX2 ANX2L4 CAL1H LPC2D | ___________________MstVHEILCKLsLEGDHstPPs |
| P07355 | S26 | ELM|EPSD|PSP | ANXA2 ANX2 ANX2L4 CAL1H LPC2D | EILCKLsLEGDHstPPsAyGsVKAytNFDAERDALNIEtAI |
| P07737 | T65 | Sugiyama | PFN1 | PAEVGVLVGKDRssFyVNGLtLGGQKCsVIRDsLLQDGEFs |
| P07737 | Y60 | Sugiyama | PFN1 | FVNITPAEVGVLVGKDRssFyVNGLtLGGQKCsVIRDsLLQ |
| P07864 | S161 | Sugiyama | LDHC LDH3 LDHX | DILTYIVWKISGLPVTRVIGsGCNLDsARFRYLIGEKLGVH |
| P07864 | S167 | Sugiyama | LDHC LDH3 LDHX | VWKISGLPVTRVIGsGCNLDsARFRYLIGEKLGVHPTSCHG |
| P08034 | S229 | ELM | GJB1 CX32 | VVYLIIRACARRAQRRSNPPsRKGsGFGHRLSPEyKQNEIN |
| P08034 | S233 | ELM | GJB1 CX32 | IIRACARRAQRRSNPPsRKGsGFGHRLSPEyKQNEINKLLS |
| P08183 | S661 | ELM | ABCB1 MDR1 PGY1 | ADESKSEIDALEMssNDsRssLIRKRsTRRsVRGSQAQDRK |
| P08183 | S667 | ELM | ABCB1 MDR1 PGY1 | EIDALEMssNDsRssLIRKRsTRRsVRGSQAQDRKLsTKEA |
| P08183 | S671 | ELM | ABCB1 MDR1 PGY1 | LEMssNDsRssLIRKRsTRRsVRGSQAQDRKLsTKEALDES |
| P08195 | S253 | Sugiyama | SLC3A2 MDU1 | FQGHGAGNLAGLKGRLDyLssLKVKGLVLGPIHKNQKDDVA |
| P08195 | S296 | Sugiyama | SLC3A2 MDU1 | DLLQIDPNFGsKEDFDsLLQsAKKKSIRVILDLTPNYRGEN |
| P08238 | S460 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | GIHEDstNRRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQ |
| P08567 | S113 | ELM | PLEK P47 | VRDIKKAIKCIEGGQKFARKstRRsIRLPEtIDLGALYLsM |
| P08567 | S117 | ELM | PLEK P47 | KKAIKCIEGGQKFARKstRRsIRLPEtIDLGALYLsMKDTE |
| P08567 | T114 | ELM | PLEK P47 | RDIKKAIKCIEGGQKFARKstRRsIRLPEtIDLGALYLsMK |
| P08581 | S985 | ELM | MET | GsELVRYDARVHtPHLDRLVsARsVsPttEMVsNEsVDyRA |
| P08729 | S104 | Sugiyama | KRT7 SCL | LQRVRQEESEQIKTLNNKFAsFIDKVRFLEQQNKLLETKWT |
| P09211 | S185 | SIGNOR | GSTP1 FAEES3 GST3 | VLAPGCLDAFPLLSAYVGRLsARPKLKAFLASPEyVNLPIN |
| P09211 | S43 | SIGNOR | GSTP1 FAEES3 GST3 | ADQGQSWKEEVVTVETWQEGsLKASCLyGQLPKFQDGDLtL |
| P09543 | S9 | ELM | CNP | ____________MNRGFsRKsHTFLPKIFFRKMsSSGAKDK |
| P09651 | S360 | Sugiyama | HNRNPA1 HNRPA1 | PyGGGGQyFAKPRNQGGyGGssssssyGsGRRF________ |
| P09651 | S362 | Sugiyama | HNRNPA1 HNRPA1 | GGGGQyFAKPRNQGGyGGssssssyGsGRRF__________ |
| P09651 | S365 | Sugiyama | HNRNPA1 HNRPA1 | GQyFAKPRNQGGyGGssssssyGsGRRF_____________ |
| P09651 | S95 | Sugiyama | HNRNPA1 HNRPA1 | RPHKVDGRVVEPKRAVsREDsQRPGAHLtVKKIFVGGIKED |
| P09651 | Y366 | Sugiyama | HNRNPA1 HNRPA1 | QyFAKPRNQGGyGGssssssyGsGRRF______________ |
| P09693 | S148 | ELM | CD3G T3G | VLAVGVYFIAGQDGVRQsRAsDKQTLLPNDQLyQPLKDRED |
| P0CG38 | S1068 | Sugiyama | POTEI | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P0CG39 | S1031 | Sugiyama | POTEJ | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P0CG47 | S57 | Sugiyama | UBB | PPDQQRLIFAGKQLEDGRtLsDyNIQKEstLHLVLRLRGGM |
| P0CG48 | S57 | Sugiyama | UBC | PPDQQRLIFAGKQLEDGRtLsDyNIQKEstLHLVLRLRGGM |
| P0DPH7 | T334 | Sugiyama | TUBA3C TUBA2 | ACCMLYRGDVVPKDVNAAIAtIKtKRTIQFVDWCPTGFKVG |
| P11142 | S340 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | ALRDAKLDKsQIHDIVLVGGstRIPKIQKLLQDFFNGKELN |
| P11171 | S578 | EPSD | EPB41 E41P | PtsAPAItQGQVAEGGVLDAsAKKTVVPKAQKETVKAEVKK |
| P11279 | S335 | Sugiyama | LAMP1 | DPAFKAANGSLRALQATVGNsYKCNAEEHVRVTKAFSVNIF |
| P11388 | S29 | SIGNOR|ELM|iPTMNet|EPSD | TOP2A TOP2 | VNENMQVNKIKKNEDAKKRLsVERIYQKKTQLEHILLRPDT |
| P11388 | T1343 | GPS6|ELM|EPSD | TOP2A TOP2 | KTKFTMDLDsDEDFsDFDEKtDDEDFVPsDAsPPKtKTsPK |
| P11473 | S51 | GPS6 | VDR NR1I1 | ATGFHFNAMTCEGCKGFFRRsMKRKALFTCPFNGDCRITKD |
| P12035 | S211 | Sugiyama | KRT3 | IGQVKAQEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWN |
| P13569 | S686 | ELM | CFTR ABCC7 | LHRFsLEGDAPVSWTEtKKQsFKQTGEFGEKRKNsILNPIN |
| P13569 | S790 | ELM | CFTR ABCC7 | LNLMTHSVNQGQNIHRKTTAsTRKVsLAPQANLTELDIYsR |
| P13639 | S23 | Sugiyama | EEF2 EF2 | NFtVDQIRAIMDKKANIRNMsVIAHVDHGKStLtDsLVCKA |
| P13639 | S38 | Sugiyama | EEF2 EF2 | NIRNMsVIAHVDHGKStLtDsLVCKAGIIAsARAGEtRFtD |
| P13639 | S593 | Sugiyama | EEF2 EF2 | SDPVVsyREtVsEEsNVLCLsKsPNKHNRLyMKARPFPDGL |
| P13647 | S181 | Sugiyama | KRT5 | IQRVRTEEREQIKTLNNKFAsFIDKVRFLEQQNKVLDTKWT |
| P13726 | S285 | ELM | F3 | ILVIILAISLHKCRKAGVGQsWKENsPLNVs__________ |
| P13726 | S290 | ELM | F3 | LAISLHKCRKAGVGQsWKENsPLNVs_______________ |
| P13861 | S99 | Sugiyama | PRKAR2A PKR2 PRKAR2 | EsEEDEDLEVPVPsRFNRRVsVCAEtyNPDEEEEDTDPRVI |
| P13987 | T76 | Sugiyama | CD59 MIC11 MIN1 MIN2 MIN3 MSK21 | AGLQVYNKCWKFEHCNFNDVtTRLRENELtyyCCKKDLCNF |
| P14136 | S13 | ELM | GFAP | ________MERRRItsAARRsYVssGEMMVGGLAPGRRLGP |
| P14136 | S17 | ELM | GFAP | ____MERRRItsAARRsYVssGEMMVGGLAPGRRLGPGTRL |
| P14136 | S38 | ELM | GFAP | GEMMVGGLAPGRRLGPGTRLsLARMPPPLPTRVDFSLAGAL |
| P14314 | S126 | Sugiyama | PRKCSH G19P1 | yNsGVICENtCKEKGRKEREsLQQMAEVtREGFRLKKILIE |
| P14598 | S303 | GPS6|SIGNOR|PSP | NCF1 NOXO2 SH3PXD1A | sGQDVsQAQRQIKRGAPPRRssIRNAHsIHQRsRKRLsQDA |
| P14598 | S304 | GPS6|SIGNOR|PSP | NCF1 NOXO2 SH3PXD1A | GQDVsQAQRQIKRGAPPRRssIRNAHsIHQRsRKRLsQDAY |
| P14598 | S315 | GPS6|SIGNOR|EPSD|PSP | NCF1 NOXO2 SH3PXD1A | KRGAPPRRssIRNAHsIHQRsRKRLsQDAYRRNsVRFLQQR |
| P14598 | S320 | GPS6|SIGNOR|PSP | NCF1 NOXO2 SH3PXD1A | PRRssIRNAHsIHQRsRKRLsQDAYRRNsVRFLQQRRRQAR |
| P14598 | S328 | GPS6|SIGNOR|PSP | NCF1 NOXO2 SH3PXD1A | AHsIHQRsRKRLsQDAYRRNsVRFLQQRRRQARPGPQsPGs |
| P14598 | S359 | GPS6|SIGNOR|PSP | NCF1 NOXO2 SH3PXD1A | ARPGPQsPGsPLEEERQtQRsKPQPAVPPRPsADLILNRCs |
| P14598 | S370 | GPS6|SIGNOR|EPSD|PSP | NCF1 NOXO2 SH3PXD1A | LEEERQtQRsKPQPAVPPRPsADLILNRCsESTKRKLASAV |
| P14598 | S379 | GPS6|SIGNOR|PSP | NCF1 NOXO2 SH3PXD1A | sKPQPAVPPRPsADLILNRCsESTKRKLASAV_________ |
| P14618 | S205 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | VKQKGADFLVtEVENGGsLGsKKGVNLPGAAVDLPAVsEKD |
| P14625 | S680 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | RIMKAQAYQtGKDIstNyyAsQKKTFEINPRHPLIRDMLRR |
| P14679 | S523 | SIGNOR|EPSD|PSP | TYR | KRKQLPEEKQPLLMEKEDYHsLYQsHL______________ |
| P14679 | S527 | SIGNOR|EPSD|PSP | TYR | LPEEKQPLLMEKEDYHsLYQsHL__________________ |
| P15172 | T115 | ELM | MYOD1 BHLHC1 MYF3 MYOD | LWACKACKRKTTNADRRKAAtMRERRRLSKVNEAFETLKRC |
| P15336 | S121 | EPSD|PSP | ATF2 CREB2 CREBP1 | EDDIKKMPLDLsPLAtPIIRsKIEEPsVVEttHQDsPLPHP |
| P15336 | S340 | GPS6|EPSD | ATF2 CREB2 CREBP1 | tsttEtPAsPAHttPQtQstsGRRRRAANEDPDEKRRKFLE |
| P15336 | S367 | GPS6|EPSD | ATF2 CREB2 CREBP1 | ANEDPDEKRRKFLERNRAAAsRCRQKRKVWVQSLEKKAEDL |
| P15382 | S102 | PSP | KCNE1 | IESDAWQEKDKAYVQARVLEsYRSCYVVENHLAIEQPNTHL |
| P15880 | S190 | Sugiyama | RPS2 RPS4 | WGNKIGKPHTVPCKVTGRCGsVLVRLIPAPRGtGIVsAPVP |
| P16070 | S291 | ELM | CD44 LHR MDU2 MDU3 MIC4 | TISAGWEPNEENEDERDRHLsFSGSGIDDDEDFISSTISTT |
| P16949 | S25 | SIGNOR|EPSD|PSP | STMN1 C1orf215 LAP18 OP18 | DIQVKELEKRAsGQAFELILsPRsKEsVPEFPLsPPKKKDL |
| P16949 | S38 | SIGNOR|EPSD|PSP | STMN1 C1orf215 LAP18 OP18 | QAFELILsPRsKEsVPEFPLsPPKKKDLsLEEIQKKLEAAE |
| P17252 | T497 | Sugiyama | PRKCA PKCA PRKACA | IKIADFGMCKEHMMDGVttRtFCGtPDyIAPEIIAyQPYGK |
| P17252 | T501 | Sugiyama | PRKCA PKCA PRKACA | DFGMCKEHMMDGVttRtFCGtPDyIAPEIIAyQPYGKSVDW |
| P17252 | T83 | Sugiyama | PRKCA PKCA PRKACA | QGFQCQVCCFVVHKRCHEFVtFsCPGADKGPDTDDPRSKHK |
| P17302 | S368 | SIGNOR|iPTMNet|EPSD | GJA1 GJAL | AAGHELQPLAIVDQRPssRAssRAssRPRPDDLEI______ |
| P17677 | S41 | SIGNOR|iPTMNet|EPSD | GAP43 | EQDGIKPEDKAHKAATKIQAsFRGHITRKKLKGEKKDDVQA |
| P17844 | S557 | ELM | DDX5 G17P1 HELR HLR1 | AANYTNGSFGSNFVSAGIQTsFRTGNPtGTYQNGYDSTQQY |
| P18031 | S378 | ELM | PTPN1 PTP1B | PYGIEsMsQDtEVRSRVVGGsLRGAQAAsPAKGEPsLPEKD |
| P18505 | S434 | ELM | GABRB1 | YGRALDRHGVPSKGRIRRRAsQLKVKIPDLTDVNSIDKWSR |
| P18507 | S366 | ELM | GABRG2 | VFSALVEYGTLHYFVSNRKPsKDKDKKKKNPLLRMFSFKAP |
| P18615 | S131 | Sugiyama | NELFE RD RDBP | QRsIsADDDLQEsSRRPQRKsLyEsFVsssDRLRELGPDGE |
| P18621 | S5 | Sugiyama | RPL17 | ________________MVRysLDPENPtKsCKSRGSNLRVH |
| P18669 | S14 | Sugiyama | PGAM1 PGAMA CDABP0006 | _______MAAYKLVLIRHGEsAWNLENRFsGWyDADLsPAG |
| P19021 | S929 | ELM | PAM | VLGRFRGKGsGGLNLGNFFAsRKGYsRKGFDRLstEGsDQE |
| P19021 | S934 | ELM | PAM | RGKGsGGLNLGNFFAsRKGYsRKGFDRLstEGsDQEKEDDG |
| P19086 | S16 | ELM | GNAZ | _____MGCRQSSEEKEAARRsRRIDRHLRSEsQRQRREIKL |
| P19086 | S27 | ELM | GNAZ | SEEKEAARRsRRIDRHLRSEsQRQRREIKLLLLGTSNSGKS |
| P19338 | S460 | Sugiyama | NCL | ADAEKTFEEKQGtEIDGRsIsLyytGEKGQNQDYRGGKNST |
| P19429 | S42 | SIGNOR | TNNI3 TNNC1 | RssNyRAYAtEPHAKKKsKIsAsRKLQLKtLLLQIAKQELE |
| P19429 | S44 | SIGNOR | TNNI3 TNNC1 | sNyRAYAtEPHAKKKsKIsAsRKLQLKtLLLQIAKQELERE |
| P19429 | T143 | SIGNOR | TNNI3 TNNC1 | TEIADLtQKIFDLRGKFKRPtLRRVRIsADAMMQALLGARA |
| P19484 | S466 | SIGNOR | TFEB BHLHE35 | ASDPLLstMsPEAsKAssRRssFsMEEGDVL__________ |
| P19484 | S467 | SIGNOR | TFEB BHLHE35 | SDPLLstMsPEAsKAssRRssFsMEEGDVL___________ |
| P20618 | S157 | Sugiyama | PSMB1 PSC5 | IIGGLDEEGKGAVysFDPVGsyQRDsFKAGGSASAMLQPLL |
| P20618 | S162 | Sugiyama | PSMB1 PSC5 | DEEGKGAVysFDPVGsyQRDsFKAGGSASAMLQPLLDNQVG |
| P20700 | S395 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | LMNB1 LMN2 LMNB | sAYRKLLEGEEERLKLsPsPssRVtVsRAsssRsVRTTRGK |
| P20700 | S396 | ELM | LMNB1 LMN2 LMNB | AYRKLLEGEEERLKLsPsPssRVtVsRAsssRsVRTTRGKR |
| P20700 | S405 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | LMNB1 LMN2 LMNB | EERLKLsPsPssRVtVsRAsssRsVRTTRGKRKRVDVEESE |
| P20700 | S406 | ELM | LMNB1 LMN2 LMNB | ERLKLsPsPssRVtVsRAsssRsVRTTRGKRKRVDVEESEA |
| P21730 | S334 | SIGNOR|EPSD|PSP | C5AR1 C5AR C5R1 | sLPsLLRNVLTEEsVVREsKsFTRsTVDTMAQKTQAV____ |
| P22059 | S190 | Sugiyama | OSBP OSBP1 | QRWVTALELAKAKAVKMLAEsDEsGDEEsVsQtDKTELQNT |
| P22059 | S193 | Sugiyama | OSBP OSBP1 | VTALELAKAKAVKMLAEsDEsGDEEsVsQtDKTELQNTLRT |
| P23246 | S283 | Sugiyama | SFPQ PSF | GPGGRsEEKIsDsEGFKANLsLLRRPGEKTyTQRCRLFVGN |
| P23396 | T220 | Sugiyama | RPS3 OK/SW-cl.26 | PKKPLPDHVsIVEPKDEILPttPIsEQKGGKPEPPAMPQPV |
| P23396 | T221 | Sugiyama | RPS3 OK/SW-cl.26 | KKPLPDHVsIVEPKDEILPttPIsEQKGGKPEPPAMPQPVP |
| P23527 | S39 | Sugiyama | H2BC17 H2BFH H2BFN HIST1H2BO | VTKAQKKDGKKRKRSRKEsysIyVyKVLKQVHPDTGISSKA |
| P23677 | T311 | ELM | ITPKA | KMLAVDPEAPTEEEHAQRAVtKPRYMQWREGISSSTTLGFR |
| P24941 | T160 | Sugiyama | CDK2 CDKN2 | AIKLADFGLARAFGVPVRtytHEVVtLWyRAPEILLGCKYY |
| P25789 | T10 | Sugiyama | PSMA4 HC9 PSC9 | ___________MSRRyDsRttIFsPEGRLYQVEYAMEAIGH |
| P25789 | Y5 | Sugiyama | PSMA4 HC9 PSC9 | ________________MSRRyDsRttIFsPEGRLYQVEYAM |
| P26010 | T783 | SIGNOR|iPTMNet|EPSD | ITGB7 | KEQQQLNWKQDsNPLYKSAItttINPRFQEADSPTL_____ |
| P26373 | S181 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | YKKEKARVItEEEKNFKAFAsLRMARANARLFGIRAKRAKE |
| P26373 | S77 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PIVRCPTVRYHTKVRAGRGFsLEELRVAGIHKKVARTIGIs |
| P27348 | S63 | Sugiyama | YWHAQ | LLsVAyKNVVGGRRSAWRVIsSIEQKTDTSDKKLQLIKDYR |
| P27797 | S52 | Sugiyama | CALR CRTC | GWtsRWIEsKHKSDFGKFVLssGKFyGDEEKDKGLQTSQDA |
| P27797 | T34 | Sugiyama | CALR CRTC | LAVAEPAVYFKEQFLDGDGWtsRWIEsKHKSDFGKFVLssG |
| P27824 | S583 | ELM|Sugiyama | CANX | VsQEEEDRKPKAEEDEILNRsPRNRKPRRE___________ |
| P28329 | S464 | SIGNOR|EPSD | CHAT | PFDGIVLVQCTEHLLKHVTQssRKLIRADsVSELPAPRRLR |
| P28329 | S465 | SIGNOR|EPSD | CHAT | FDGIVLVQCTEHLLKHVTQssRKLIRADsVSELPAPRRLRW |
| P28329 | S558 | SIGNOR|EPSD | CHAT | ALQLAFYRLHRRLVPTYESAsIRRFQEGRVDNIRSAtPEAL |
| P28329 | S594 | SIGNOR|EPSD | CHAT | tPEALAFVRAVTDHKAAVPAsEKLLLLKDAIRAQTAYTVMA |
| P28329 | T373 | SIGNOR|EPSD | CHAT | LTSDGRSEWAEARTVLVKDStNRDSLDMIERCICLVCLDAP |
| P28799 | S81 | EPSD|PSP | GRN | CQVDAHCSAGHSCIFTVSGTsSCCPFPEAVACGDGHHCCPR |
| P29317 | S892 | PSP | EPHA2 ECK | DKLIRAPDSLKTLADFDPRVsIRLPstsGsEGVPFRTVsEW |
| P29353 | S139 | EPSD|PSP | SHC1 SHC SHCA | GRRTRVEGGQLGGEEWTRHGsFVNKPTRGWLHPNDKVMGPG |
| P29353 | S213 | EPSD|PSP | SHC1 SHC SHCA | SLVCEAVPGAKGAtRRRKPCsRPLSSILGRSNLKFAGMPIT |
| P29353 | T206 | EPSD|PSP | SHC1 SHC SHCA | QVTREAISLVCEAVPGAKGAtRRRKPCsRPLSSILGRSNLK |
| P29474 | T495 | SIGNOR | NOS3 | YQPDPWKGSAAKGTGITRKKtFKEVANAVKISASLMGTVMA |
| P29966 | S159 | SIGNOR|ELM|iPTMNet|EPSD|PSP | MARCKS MACS PRKCSL | EDGAtPsPsNEtPKKKKKRFsFKKsFKLsGFsFKKNKKEAG |
| P29966 | S163 | SIGNOR|ELM|iPTMNet|EPSD|PSP | MARCKS MACS PRKCSL | tPsPsNEtPKKKKKRFsFKKsFKLsGFsFKKNKKEAGEGGE |
| P29966 | S167 | ELM | MARCKS MACS PRKCSL | sNEtPKKKKKRFsFKKsFKLsGFsFKKNKKEAGEGGEAEAP |
| P29966 | S170 | SIGNOR|ELM|iPTMNet|EPSD | MARCKS MACS PRKCSL | tPKKKKKRFsFKKsFKLsGFsFKKNKKEAGEGGEAEAPAAE |
| P29972 | T157 | ELM | AQP1 CHIP28 | QGLGIEIIGTLQLVLCVLATtDRRRRDLGGSAPLAIGLSVA |
| P29972 | T239 | ELM | AQP1 CHIP28 | GGALAVLIYDFILAPRSSDLtDRVKVWtsGQVEEyDLDADD |
| P30086 | S153 | iPTMNet|EPSD | PEBP1 PBP PEBP | CDEPILsNRsGDHRGKFKVAsFRKKyELRAPVAGtCyQAEW |
| P30101 | T485 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | KKyEGGRELsDFIsyLQREAtNPPVIQEEKPKKKKKAQEDL |
| P30273 | S69 | EPSD|PSP | FCER1G | QVRKAAITSyEKsDGVytGLsTRNQEtyEtLKHEKPPQ___ |
| P30411 | S373 | ELM | BDKRB2 BKR2 | KGGCRSEPIQMENsMGTLRTsIsVERQIHKLQDWAGSRQ__ |
| P30622 | S204 | Sugiyama | CLIP1 CYLN1 RSN | PISNLTKtAsEsIsNLsEAGsIKKGERELKIGDRVLVGGTK |
| P30679 | S336 | ELM | GNA15 GNA16 | YTRMYTGCVDGPEGsKKGARsRRLFSHYTCATDTQNIRKVF |
| P31749 | S473 | EPSD|PSP | AKT1 PKB RAC | DQDDSMECVDSERRPHFPQFsysAsGtA_____________ |
| P31749 | T308 | EPSD|PSP | AKT1 PKB RAC | IKITDFGLCKEGIKDGAtMKtFCGtPEyLAPEVLEDNDyGR |
| P31946 | S65 | Sugiyama | YWHAB | LLsVAyKNVVGARRSsWRVIsSIEQKTERNEKKQQMGKEYR |
| P32119 | T142 | Sugiyama | PRDX2 NKEFB TDPX1 | EGIAYRGLFIIDGKGVLRQItVNDLPVGRsVDEALRLVQAF |
| P33176 | S57 | Sugiyama | KIF5B KNS KNS1 | DTVVIASKPYAFDRVFQSsTsQEQVyNDCAKKIVKDVLEGy |
| P33778 | S39 | Sugiyama | H2BC3 H2BFF HIST1H2BB | ITKAQKKDGKKRKRsRKEsysIyVyKVLKQVHPDTGISSKA |
| P34741 | S187 | SIGNOR|ELM|iPTMNet|EPSD | SDC2 HSPG1 | LVYRMRKKDEGsyDLGERKPssAAYQKAPTKEFYA______ |
| P34741 | S188 | SIGNOR|ELM|iPTMNet|EPSD | SDC2 HSPG1 | VYRMRKKDEGsyDLGERKPssAAYQKAPTKEFYA_______ |
| P35221 | S641 | Sugiyama | CTNNA1 | GIRDIRKAVLMIRtPEELDDsDFEtEDFDVRsRtsVQtEDD |
| P35221 | T634 | Sugiyama | CTNNA1 | ASRLVyDGIRDIRKAVLMIRtPEELDDsDFEtEDFDVRsRt |
| P35408 | S259 | ELM | PTGER4 PTGER2 | RGHPAAsPALPRLSDFRRRRsFRRIAGAEIQMVILLIATSL |
| P35408 | S354 | ELM | PTGER4 PTGER2 | KTVLSKAIEKIKCLFCRIGGsRRERSGQHCSDSQRTSSAMs |
| P35408 | S430 | ELM | PTGER4 PTGER2 | GGRNLLPGVPGMGLAQEDttsLRtLRISETSDSSQGQDSES |
| P35408 | S460 | ELM | PTGER4 PTGER2 | SDSSQGQDSESVLLVDEAGGsGRAGPAPKGSSLQVTFPSET |
| P35408 | S484 | ELM | PTGER4 PTGER2 | GPAPKGSSLQVTFPSETLNLsEKCI________________ |
| P35408 | T433 | ELM | PTGER4 PTGER2 | NLLPGVPGMGLAQEDttsLRtLRISETSDSSQGQDSESVLL |
| P35548 | T135 | EPSD|PSP | MSX2 HOX8 | WMQEPGRYsPPPRHMSPTTCtLRKHKtNRKPRTPFTTSQLL |
| P35548 | T141 | EPSD|PSP | MSX2 HOX8 | RYsPPPRHMSPTTCtLRKHKtNRKPRTPFTTSQLLALERKF |
| P35568 | S323 | EPSD|PSP | IRS1 | sRtEsItAtsPAsMVGGKPGsFRVRAssDGEGtMsRPAsVD |
| P35568 | S441 | EPSD|PSP | IRS1 | SDGGFISSDEYGSSPCDFRSsFRsVtPDsLGHtPPARGEEE |
| P35579 | S1916 | GPS6|ELM|PSP | MYH9 | LQRELEDAtEtADAMNREVssLKNKLRRGDLPFVVPRRMAR |
| P35612 | S713 | ELM | ADD2 ADDB | sPEGsPsKsPsKKKKKFRTPsFLKKSKKKEKVEs_______ |
| P35612 | S726 | ELM | ADD2 ADDB | KKKFRTPsFLKKSKKKEKVEs____________________ |
| P35637 | S257 | GPS6|ELM|EPSD|PSP | FUS TLS | GGYEPRGRGGGRGGRGGMGGsDRGGFNKFGGPRDQGsRHDs |
| P35908 | S191 | Sugiyama | KRT2 KRT2A KRT2E | IQNVKAQEREQIKTLNNKFAsFIDKVRFLEQQNQVLQTKWE |
| P37108 | S25 | Sugiyama | SRP14 | EsEQFLtELTRLFQKCRTSGsVyItLKKYDGRTKPIPKKGt |
| P37802 | S163 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | LFsGDPNWFPKKSKENPRNFsDNQLQEGKNVIGLQMGtNRG |
| P37802 | S185 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | NQLQEGKNVIGLQMGtNRGAsQAGMtGyGMPRQIL______ |
| P37802 | T180 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | RNFsDNQLQEGKNVIGLQMGtNRGAsQAGMtGyGMPRQIL_ |
| P38646 | T120 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | LVGMPAKRQAVtNPNNtFyAtKRLIGRRYDDPEVQKDIKNV |
| P38646 | Y118 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | ERLVGMPAKRQAVtNPNNtFyAtKRLIGRRYDDPEVQKDIK |
| P39023 | S13 | Sugiyama | RPL3 OK/SW-cl.32 | ________MSHRKFSAPRHGsLGFLPRKRSSRHRGKVKSFP |
| P39023 | S265 | Sugiyama | RPL3 OK/SW-cl.32 | HRGLRKVACIGAWHPARVAFsVARAGQKGYHHRTEINKKIY |
| P40818 | S719 | Sugiyama | USP8 KIAA0055 UBPY | KPQIPAERDREPSKLKRsyssPDItQAIQEEEKRKPTVtPT |
| P41143 | S344 | ELM | OPRD1 OPRD | NFKRCFRQLCRKPCGRPDPSsFSRAREATARERVtACtPsD |
| P41180 | T888 | SIGNOR|ELM|iPTMNet|EPSD | CASR GPRC2A PCAR1 | TIEEVRCsTAAHAFKVAARAtLRRsNVsRKRsssLGGSTGS |
| P41594 | S840 | SIGNOR|iPTMNet|EPSD | GRM5 GPRC1E MGLUR5 | PKVYIILAKPERNVRSAFTTstVVRMHVGDGKSSSAASRSS |
| P41594 | T841 | SIGNOR | GRM5 GPRC1E MGLUR5 | KVYIILAKPERNVRSAFTTstVVRMHVGDGKSSSAASRSSS |
| P42261 | S849 | ELM | GRIA1 GLUA1 GLUH1 GLUR1 | CYKsRsEsKRMKGFCLIPQQsINEAIRTStLPRNsGAGASS |
| P42677 | S11 | Sugiyama | RPS27 MPS1 | __________MPLAKDLLHPsPEEEKRKHKKKRLVQsPNsy |
| P42677 | S78 | Sugiyama | RPS27 MPS1 | GCSTVLCQPTGGKARLtEGCsFRRKQH______________ |
| P43243 | S188 | Sugiyama | MATR3 KIAA0723 | EPPyRVPRDDWEEKRHFRRDsFDDRGPsLNPVLDyDHGsRs |
| P43487 | S60 | Sugiyama | RANBP1 | TLEEDEEELFKMRAKLFRFAsENDLPEWKERGTGDVKLLKH |
| P43629 | S415 | SIGNOR|PSP | KIR3DL1 CD158E NKAT3 NKB1 | EVTYAQLDHCVFTQRKITRPsQRPKtPPTDTILYTELPNAK |
| P46776 | S68 | Sugiyama | RPL27A | yHPGyFGKVGMKHYHLKRNQsFCPtVNLDKLWtLVsEQtRV |
| P46777 | S176 | Sugiyama | RPL5 MSTP030 | GNKVFGALKGAVDGGLsIPHstKRFPGyDsEsKEFNAEVHR |
| P46777 | S224 | Sugiyama | RPL5 MSTP030 | VADyMRyLMEEDEDAyKKQFsQyIKNsVtPDMMEEMyKKAH |
| P46777 | T177 | Sugiyama | RPL5 MSTP030 | NKVFGALKGAVDGGLsIPHstKRFPGyDsEsKEFNAEVHRK |
| P46779 | S115 | Sugiyama | RPL28 | HMIRKNKYRPDLRMAAIRRAsAILRSQKPVMVKRKRTRPTK |
| P46783 | S146 | Sugiyama | RPS10 | TYRRSAVPPGADKKAEAGAGsAtEFQFRGGFGRGRGQPPQ_ |
| P46937 | S109 | Sugiyama | YAP1 YAP65 | RKLPDsFFKPPEPKsHsRQAstDAGtAGALtPQHVRAHssP |
| P47712 | S727 | Sugiyama | PLA2G4A CPLA2 PLA2G4 | VIKEAMVESIEyRRQNPsRCsVsLsNVEARRFFNKEFLSKP |
| P47756 | S192 | Sugiyama | CAPZB | TVMLWLQTNKSGsGtMNLGGsLtRQMEKDEtVsDCsPHIAN |
| P48048 | S201 | SIGNOR | KCNJ1 ROMK1 | KIsRPKKRAKtItFSKNAVIsKRGGKLCLLIRVANLRKsLL |
| P48048 | S4 | SIGNOR | KCNJ1 ROMK1 | _________________MNAsSRNVFDTLIRVLTESMFKHL |
| P48058 | S862 | ELM | GRIA4 GluA4 GLUR4 | AEAKRMKLtFSEAIRNKARLsITGSVGENGRVLTPDCPKAV |
| P48058 | T850 | ELM | GRIA4 GluA4 GLUR4 | LVALIEFCYKSRAEAKRMKLtFSEAIRNKARLsITGSVGEN |
| P48668 | S176 | Sugiyama | KRT6C KRT6E | IQRVRAEEREQIKTLNNKFAsFIDKVRFLEQQNKVLDTKWT |
| P48736 | S582 | SIGNOR|EPSD|PSP | PIK3CG | DPLNPLTAEDKELLWHFRYEsLKHPKAYPKLFSSVKWGQQE |
| P49327 | S207 | Sugiyama | FASN FAS | GINVLLKPNTSVQFLRLGMLsPEGtCKAFDtAGNGYCRSEG |
| P49768 | S346 | SIGNOR | PSEN1 AD3 PS1 PSNL1 | DtVAENDDGGFsEEWEAQRDsHLGPHRstPEsRAAVQELss |
| P49795 | T201 | ELM | RGS19 GAIP GNAI3IP | QLQIYTLMHRDSYPRFLSSPtYRALLLQGPSQsssEA____ |
| P49840 | S21 | SIGNOR|ELM|iPTMNet|EPSD|PSP | GSK3A | MsGGGPsGGGPGGsGRARtssFAEPGGGGGGGGGGPGGsAs |
| P49841 | S9 | EPSD|PSP | GSK3B | ____________MSGRPRttsFAEsCKPVQQPsAFGsMKVS |
| P51116 | S601 | Sugiyama | FXR2 FMR1L2 | RPQRRNRSRRRRNRGNRtDGsIsGDRQPVtVADyIsRAEsQ |
| P51811 | S63 | ELM | XK XKR1 XRG1 | FSLLPCALVQLTLLFVHRDLsRDRPLVLLLHLLQLGPLFRC |
| P51991 | S375 | Sugiyama | HNRNPA3 HNRPA3 | ssGsPyGGGyGsGGGsGGyGsRRF_________________ |
| P53396 | S455 | Sugiyama | ACLY | ANFLLNAsGststPAPsRtAsFsEsRADEVAPAKKAKPAMP |
| P55042 | S214 | SIGNOR|iPTMNet|EPSD | RRAD RAD | DDVPIILVGNKSDLVRSREVsVDEGRACAVVFDCKFIETSA |
| P55042 | S257 | SIGNOR|iPTMNet|EPSD | RRAD RAD | HHNVQALFEGVVRQIRLRRDsKEANARRQAGTRRREsLGKK |
| P55042 | S273 | SIGNOR | RRAD RAD | LRRDsKEANARRQAGTRRREsLGKKAKRFLGRIVARNsRKM |
| P55042 | S290 | SIGNOR|iPTMNet|EPSD | RRAD RAD | RREsLGKKAKRFLGRIVARNsRKMAFRAKsKsCHDLSVL__ |
| P55042 | S299 | SIGNOR|iPTMNet|EPSD | RRAD RAD | KRFLGRIVARNsRKMAFRAKsKsCHDLSVL___________ |
| P55087 | S180 | SIGNOR | AQP4 | LLVELIITFQLVFTIFASCDsKRTDVTGSIALAIGFSVAIG |
| P55209 | T269 | Sugiyama | NAP1L1 NRP | GPEIMGCTGCQIDWKKGKNVtLKtIKKKQKHKGRGTVRTVT |
| P55209 | T272 | Sugiyama | NAP1L1 NRP | IMGCTGCQIDWKKGKNVtLKtIKKKQKHKGRGTVRTVTKTV |
| P56537 | S235 | SIGNOR|PSP | EIF6 EIF3A ITGB4BP OK/SW-cl.27 | LSVVESVFKLNEAQPstIAtsMRDsLIDsLt__________ |
| P56537 | T234 | EPSD | EIF6 EIF3A ITGB4BP OK/SW-cl.27 | ELSVVESVFKLNEAQPstIAtsMRDsLIDsLt_________ |
| P57053 | S39 | Sugiyama | H2BC12L H2BFS H2BS1 | VTKAQKKDGRKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| P58876 | S39 | Sugiyama | H2BC5 H2BFB HIRIP2 HIST1H2BD | VTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| P60174 | S212 | Sugiyama | TPI1 TPI | WLKsNVsDAVAQstRIIyGGsVtGAtCKELASQPDVDGFLV |
| P60174 | T217 | Sugiyama | TPI1 TPI | VsDAVAQstRIIyGGsVtGAtCKELASQPDVDGFLVGGAsL |
| P60709 | S199 | Sugiyama | ACTB | DLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyV |
| P60709 | S323 | Sugiyama | ACTB | ttMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGG |
| P60709 | S368 | Sugiyama | ACTB | sLstFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P60709 | S52 | Sugiyama | ACTB | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIE |
| P60709 | S60 | Sugiyama | ACTB | HQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEHGIVTNWD |
| P60709 | T324 | Sugiyama | ACTB | tMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGGs |
| P60709 | Y53 | Sugiyama | ACTB | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEH |
| P61081 | S175 | Sugiyama | UBE2M UBC12 | NNRRLFEQNVQRSMRGGyIGstyFERCLK____________ |
| P61247 | S236 | Sugiyama | RPS3A FTE1 MFTL | KMLKKPKFELGKLMELHGEGsssGKAtGDEtGAKVERADGy |
| P61254 | S9 | Sugiyama | RPL26 | ____________MKFNPFVtsDRsKNRKRHFNAPsHIRRKI |
| P61313 | S100 | Sugiyama | RPL15 EC45 TCBAP0781 | tyGKPVHHGVNQLKFARsLQsVAEERAGRHCGALRVLNsyW |
| P61764 | S306 | SIGNOR|iPTMNet|EPSD | STXBP1 UNC18A | DLWIALRHKHIAEVSQEVTRsLKDFSSsKRMNTGEKTTMRD |
| P61764 | S313 | SIGNOR|iPTMNet|EPSD | STXBP1 UNC18A | HKHIAEVSQEVTRsLKDFSSsKRMNTGEKTTMRDLSQMLKK |
| P61978 | S401 | Sugiyama | HNRNPK HNRPK | GDLGGPIIttQVtIPKDLAGsIIGKGGQRIKQIRHEsGAsI |
| P61978 | S417 | Sugiyama | HNRNPK HNRPK | DLAGsIIGKGGQRIKQIRHEsGAsIKIDEPLEGsEDRIITI |
| P61978 | S75 | Sugiyama | HNRNPK HNRPK | GAVIGKGGKNIKALRtDyNAsVsVPDssGPERILsISADIE |
| P61981 | S64 | Sugiyama | YWHAG | LLsVAyKNVVGARRSsWRVIsSIEQKtsADGNEKKIEMVRA |
| P62249 | S9 | Sugiyama | RPS16 | ____________MPsKGPLQsVQVFGRKKTATAVAHCKRGN |
| P62263 | S139 | Sugiyama | RPS14 PRO2640 | LARSGMKIGRIEDVtPIPsDstRRKGGRRGRRL________ |
| P62277 | S12 | Sugiyama | RPS13 | _________MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDD |
| P62277 | S14 | Sugiyama | RPS13 | _______MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDDVK |
| P62280 | T15 | Sugiyama | RPS11 | ______MADIQTERAyQKQPtIFQNKKRVLLGEtGKEKLPR |
| P62280 | T54 | Sugiyama | RPS11 | PRYYKNIGLGFKtPKEAIEGtyIDKKCPFTGNVsIRGRILs |
| P62304 | S89 | Sugiyama | SNRPE | KSRKQLGRIMLKGDNITLLQsVsN_________________ |
| P62491 | S177 | SIGNOR|PSP | RAB11A RAB11 | DSTNVEAAFQTILTEIYRIVsQKQMSDRRENDMsPsNNVVP |
| P62701 | T247 | Sugiyama | RPS4X CCG2 RPS4 SCAR | VIGKGNKPWIsLPRGKGIRLtIAEERDKRLAAKQSSG____ |
| P62736 | S325 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P62736 | S54 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P62736 | S62 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | HQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEHGIItNWD |
| P62736 | T326 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P62736 | Y55 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P62807 | S39 | Sugiyama | H2BC4 H2BFL HIST1H2BC; H2BC6 H2BFH HIST1H2BE; H2BC7 H2BFG HIST1H2BF; H2BC8 H2BFA HIST1H2BG; H2BC10 H2BFK HIST1H2BI | VTKAQKKDGKKRKRsRKEsysVyVyKVLKQVHPDTGIssKA |
| P62857 | S41 | Sugiyama | RPS28 | tGsQGQCtQVRVEFMDDtsRsIIRNVKGPVREGDVLtLLEs |
| P62899 | T119 | Sugiyama | RPL31 | PNKLytLVtyVPVttFKNLQtVNVDEN______________ |
| P62899 | T26 | Sugiyama | RPL31 | KGGEKKKGRsAINEVVtREytINIHKRIHGVGFKKRAPRAL |
| P62906 | T9 | Sugiyama | RPL10A NEDD6 | ____________MSSKVsRDtLyEAVREVLHGNQRKRRKFL |
| P62917 | S130 | Sugiyama | RPL8 | GTIVCCLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKL |
| P62917 | S14 | Sugiyama | RPL8 | _______MGRVIRGQRKGAGsVFRAHVKHRKGAARLRAVDF |
| P62917 | Y133 | Sugiyama | RPL8 | VCCLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKLPSG |
| P62979 | S57 | Sugiyama | RPS27A UBA80 UBCEP1 | PPDQQRLIFAGKQLEDGRtLsDyNIQKEstLHLVLRLRGGA |
| P62987 | S57 | Sugiyama | UBA52 UBCEP2 | PPDQQRLIFAGKQLEDGRtLsDyNIQKEstLHLVLRLRGGI |
| P63173 | T14 | Sugiyama | RPL38 | _______MPRKIEEIKDFLLtARRKDAKSVKIKKNKDNVKF |
| P63220 | S31 | Sugiyama | RPS21 | LYVPRKCSASNRIIGAKDHAsIQMNVAEVDKVTGRFNGQFK |
| P63261 | S199 | Sugiyama | ACTG1 ACTG | DLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyV |
| P63261 | S323 | Sugiyama | ACTG1 ACTG | ttMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGG |
| P63261 | S368 | Sugiyama | ACTG1 ACTG | sLstFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P63261 | S52 | Sugiyama | ACTG1 ACTG | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIE |
| P63261 | S60 | Sugiyama | ACTG1 ACTG | HQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEHGIVTNWD |
| P63261 | T324 | Sugiyama | ACTG1 ACTG | tMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGGs |
| P63261 | Y53 | Sugiyama | ACTG1 ACTG | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEH |
| P63267 | S324 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P63267 | S53 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P63267 | S61 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | HQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEHGIItNWD |
| P63267 | T325 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P63267 | Y54 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P67809 | S136 | Sugiyama | YBX1 NSEP1 YB1 | GEKGAEAANVtGPGGVPVQGsKYAADRNHYRRYPRRRGPPR |
| P68032 | S325 | Sugiyama | ACTC1 ACTC | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P68032 | S54 | Sugiyama | ACTC1 ACTC | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P68032 | S62 | Sugiyama | ACTC1 ACTC | HQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEHGIItNWD |
| P68032 | T326 | Sugiyama | ACTC1 ACTC | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P68032 | Y55 | Sugiyama | ACTC1 ACTC | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P68104 | S53 | SIGNOR | EEF1A1 EEF1A EF1A LENG7 | GIDKRTIEKFEKEAAEMGKGsFKYAWVLDKLKAERERGITI |
| P68104 | T432 | ELM|Sugiyama | EEF1A1 EEF1A EF1A LENG7 | VEsFSDyPPLGRFAVRDMRQtVAVGVIKAVDKKAAGAGKVT |
| P68133 | S325 | Sugiyama | ACTA1 ACTA | TTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P68133 | S54 | Sugiyama | ACTA1 ACTA | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P68133 | S62 | Sugiyama | ACTA1 ACTA | HQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEHGIItNWD |
| P68133 | T326 | Sugiyama | ACTA1 ACTA | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P68133 | Y55 | Sugiyama | ACTA1 ACTA | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P68363 | T334 | Sugiyama | TUBA1B | ACCLLyRGDVVPKDVNAAIAtIKtKRsIQFVDWCPTGFKVG |
| P68431 | T7 | EPSD | H3C1 H3FA HIST1H3A; H3C2 H3FL HIST1H3B; H3C3 H3FC HIST1H3C; H3C4 H3FB HIST1H3D; H3C6 H3FD HIST1H3E; H3C7 H3FI HIST1H3F; H3C8 H3FH HIST1H3G; H3C10 H3FK HIST1H3H; H3C11 H3FF HIST1H3I; H3C12 H3FJ HIST1H3J | ______________MARtKQtARKstGGKAPRKQLATKAAR |
| P78417 | S23 | Sugiyama | GSTO1 GSTTLP28 | GESARsLGKGsAPPGPVPEGsIRIySMRFCPFAERTRLVLK |
| P83731 | S7 | Sugiyama | RPL24 | ______________MKVELCsFsGyKIYPGHGRRYARTDGK |
| P83731 | S86 | Sugiyama | RPL24 | EIQKKRTRRAVKFQRAItGAsLADIMAKRNQKPEVRKAQRE |
| P83731 | T83 | Sugiyama | RPL24 | QsEEIQKKRTRRAVKFQRAItGAsLADIMAKRNQKPEVRKA |
| P98082 | S24 | SIGNOR|ELM|iPTMNet|EPSD|PSP | DAB2 DOC2 | EVEtSATNGQPDQQAAPKAPsKKEKKKGPEKTDEyLLARFK |
| Q00341 | S904 | Sugiyama | HDLBP HBP VGL | FHRSVMGPKGSRIQQITRDFsVQIKFPDREENAVHSTEPVV |
| Q00526 | T160 | Sugiyama | CDK3 CDKN3 | AIKLADFGLARAFGVPLRtYtHEVVTLWYRAPEILLGSKFY |
| Q00610 | S146 | Sugiyama | CLTC CLH17 CLTCL2 KIAA0034 | AVYHWSMEGESQPVKMFDRHssLAGCQIINYRTDAKQKWLL |
| Q01546 | S196 | Sugiyama | KRT76 KRT2B KRT2P | IGQVKAQEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWE |
| Q01844 | S266 | SIGNOR|ELM | EWSR1 EWS | SYSQAPSQYSQQSSSYGQQSsFRQDHPssMGVyGQESGGFS |
| Q01970 | S1105 | GPS6 | PLCB3 | EMNEREKKELQKILDRKRHNsIsEAKMRDKHKKEAELTEIN |
| Q01995 | S181 | ELM | TAGLN SM22 WS3-10 | REFtEsQLQEGKHVIGLQMGsNRGAsQAGMTGYGRPRQIIS |
| Q02543 | S123 | Sugiyama | RPL18A | AGAVtQCyRDMGARHRARAHsIQIMKVEEIAASKCRRPAVK |
| Q02790 | T42 | Sugiyama | FKBP4 FKBP52 | GVDIsPKQDEGVLKVIKREGtGTEMPMIGDRVFVHYTGWLL |
| Q03721 | S15 | GPS6|SIGNOR|ELM|EPSD|PSP | KCNC4 C1orf30 | ______MISSVCVssYRGRKsGNKPPsKTCLKEEMAKGEAS |
| Q03721 | S21 | GPS6|SIGNOR|ELM|EPSD|PSP | KCNC4 C1orf30 | MISSVCVssYRGRKsGNKPPsKTCLKEEMAKGEASEKIIIN |
| Q03721 | S8 | GPS6|ELM|EPSD|PSP | KCNC4 C1orf30 | _____________MISSVCVssYRGRKsGNKPPsKTCLKEE |
| Q03721 | S9 | GPS6|ELM|EPSD|PSP | KCNC4 C1orf30 | ____________MISSVCVssYRGRKsGNKPPsKTCLKEEM |
| Q04917 | S64 | Sugiyama | YWHAH YWHA1 | LLsVAyKNVVGARRSsWRVIsSIEQKTMADGNEKKLEKVKA |
| Q05209 | S39 | ELM | PTPN12 | sPDHNGEDNFARDFMRLRRLsTKYRTEKIyPTATGEKEENV |
| Q05209 | S435 | ELM | PTPN12 | LPGKNESTIEQIDKKLERNLsFEIKKVPLQEGPKsFDGNtL |
| Q05586 | S889 | ELM | GRIN1 NMDAR1 | RAEPDPKKKATFRAITSTLAssFKRRRssKDTSTGGGRGAL |
| Q05586 | S890 | ELM | GRIN1 NMDAR1 | AEPDPKKKATFRAITSTLAssFKRRRssKDTSTGGGRGALQ |
| Q05586 | S896 | ELM | GRIN1 NMDAR1 | KKATFRAITSTLAssFKRRRssKDTSTGGGRGALQNQKDTV |
| Q05586 | S897 | ELM | GRIN1 NMDAR1 | KATFRAITSTLAssFKRRRssKDTSTGGGRGALQNQKDTVL |
| Q05639 | S53 | SIGNOR | EEF1A2 EEF1AL STN | GIDKRTIEKFEKEAAEMGKGsFKYAWVLDKLKAERERGITI |
| Q05639 | T432 | Sugiyama | EEF1A2 EEF1AL STN | VESFSQYPPLGRFAVRDMRQtVAVGVIKNVEKKSGGAGKVT |
| Q06124 | S576 | SIGNOR|PSP | PTPN11 PTP2C SHPTP2 | DQSPLPPCTPTPPCAEMREDsARVyENVGLMQQQKsFR___ |
| Q06124 | S591 | PSP | PTPN11 PTP2C SHPTP2 | EMREDsARVyENVGLMQQQKsFR__________________ |
| Q06187 | S180 | GPS6|SIGNOR|iPTMNet|EPSD | BTK AGMX1 ATK BPK | KNAMGCQILENRNGSLKPGSsHRKtKKPLPPtPEEDQILKK |
| Q06210 | S261 | Sugiyama | GFPT1 GFAT GFPT | GsQGERGKDKKGSCNLsRVDsttCLFPVEEKAVEyyFASDA |
| Q06481 | T723 | ELM | APLP2 APPL2 | VAIATVIVISLVMLRKRQYGtISHGIVEVDPMLtPEERHLN |
| Q06830 | T143 | Sugiyama | PRDX1 PAGA PAGB TDPX2 | EGIsFRGLFIIDDKGILRQItVNDLPVGRsVDEtLRLVQAF |
| Q07020 | T136 | Sugiyama | RPL18 | AGGKILtFDQLALDsPKGCGtVLLsGPRKGREVYRHFGKAP |
| Q07020 | T85 | Sugiyama | RPL18 | RMIRKMKLPGRENKtAVVVGtItDDVRVQEVPKLKVCALRV |
| Q07869 | S179 | GPS6|PSP | PPARA NR1C1 PPAR | HKCLSVGMSHNAIRFGRMPRsEKAKLKAEILTCEHDIEDSE |
| Q07869 | S230 | GPS6|PSP | PPARA NR1C1 PPAR | IYEAYLKNFNMNKVKARVILsGKASNNPPFVIHDMETLCMA |
| Q12906 | S647 | SIGNOR|EPSD|PSP | ILF3 DRBF MPHOSPH4 NF90 | GPMHNEVPPPPNLRGRGRGGsIRGRGRGRGFGGANHGGYMN |
| Q13131 | S496 | SIGNOR|EPSD|PSP | PRKAA1 AMPK1 | sIDDEItEAKsGtAtPQRsGsVsNYRSCQRsDsDAEAQGKs |
| Q13224 | S1303 | SIGNOR|iPTMNet|EPSD | GRIN2B NMDAR2B | QSPTNSKAQKKNRNKLRRQHsYDTFVDLQKEEAALAPRSVs |
| Q13224 | S1323 | SIGNOR|iPTMNet|EPSD | GRIN2B NMDAR2B | sYDTFVDLQKEEAALAPRSVsLKDKGRFMDGSPyAHMFEMS |
| Q13255 | T695 | ELM | GRM1 GPRC1A MGLUR1 | LVTKTNRIARILAGSKKKICtRKPRFMSAWAQVIIASILIS |
| Q13887 | S153 | ELM | KLF5 BTEB2 CKLF IKLF | SINMNVFLPDITHLRTGLYKsQRPCVTHIKTEPVAIFSHQS |
| Q14004 | S389 | Sugiyama | CDK13 CDC2L CDC2L5 CHED KIAA1791 | SYSRHSSYERGGDVsPsPyssSsWRRsRsPysPVLRRSGKS |
| Q14152 | S1364 | PSP | EIF3A EIF3S10 KIAA0139 | DREREGEKEKASWRAEKDREsLRRTKNEtDEDGWttVRR__ |
| Q14152 | S988 | Sugiyama | EIF3A EIF3S10 KIAA0139 | PRRGPEEDRFsRRGADDDRPsWRNTDDDRPPRRIADEDRGN |
| Q14152 | T1379 | Sugiyama | EIF3A EIF3S10 KIAA0139 | EKDREsLRRTKNEtDEDGWttVRR_________________ |
| Q14155 | S518 | Sugiyama | ARHGEF7 COOL1 KIAA0142 P85SPR PAK3BP PIXB Nbla10314 | ERYLLLFPNVLLMLSASPRMsGFIyQGKLPtTGMTITKLED |
| Q14244 | S282 | Sugiyama | MAP7 | AAHSRNsMDRPKLFVtPPEGssRRRIIHGTAsYKKEREREN |
| Q14469 | S37 | ELM | HES1 BHLHB39 HL HRY | tPAsVNttPDKPKTASEHRKssKPIMEKRRRARINESLSQL |
| Q14469 | S38 | ELM | HES1 BHLHB39 HL HRY | PAsVNttPDKPKTASEHRKssKPIMEKRRRARINESLSQLK |
| Q14847 | S146 | SIGNOR | LASP1 MLN50 | FEKSRMGPsGGEGMEPERRDsQDGssyRRPLEQQQPHHIPt |
| Q14CN4 | S138 | Sugiyama | KRT72 K6IRS2 KB35 KRT6 KRT6IRS2 | IQRVRAQEREQIKALNNKFAsFIDKVRFLEQQNQVLETKWN |
| Q15021 | S1310 | Sugiyama | NCAPD2 CAPD2 CNAP1 KIAA0159 | RACHTRGLDGIKELEIGQAGsQRAPsAKKPSTGSRyQPLAs |
| Q15052 | S488 | Sugiyama | ARHGEF6 COOL2 KIAA0006 PIXA | ERYLMLFSNVLIMLSASPRMsGFIYQGKIPIAGTVVTRLDE |
| Q15052 | S640 | SIGNOR | ARHGEF6 COOL2 KIAA0006 PIXA | sKsPKTMKKFLHKRKTERKPsEEEyVIRKstAALEEDAQIL |
| Q15052 | S684 | SIGNOR | ARHGEF6 COOL2 KIAA0006 PIXA | EAYCTSANFQQGHGsstRKDsIPQVLLPEEEKLIIEETRsN |
| Q15080 | T154 | ELM | NCF4 SH3PXD4 | YQSPYDSEQVPQALRRLRPRtRKVKsVsPQGNsVDRMAAPR |
| Q15121 | S104 | ELM | PEA15 | TRVLKIsEEDELDtKLtRIPsAKKYKDIIRQPsEEEIIKLA |
| Q15139 | S249 | ELM | PRKD1 PKD PKD1 PRKCM | EPLLQKsPsEsFIGREKRsNsQsyIGRPIHLDKILMSKVKV |
| Q15185 | S113 | Sugiyama | PTGES3 P23 TEBP | RAKLNWLsVDFNNWKDWEDDsDEDMsNFDRFSEMMNNMGGD |
| Q15438 | S394 | ELM | CYTH1 D17S811E PSCD1 | AAISRDPFYEMLAARKKKVSstKRH________________ |
| Q15438 | T395 | ELM | CYTH1 D17S811E PSCD1 | AISRDPFYEMLAARKKKVSstKRH_________________ |
| Q15906 | S132 | ELM | VPS72 TCFL1 YL1 | REEKALLPLELQDDGsDsRKsMRQStAEHTRQTFLRVQERQ |
| Q16236 | S40 | SIGNOR|ELM | NFE2L2 NRF2 | IDILWRQDIDLGVSREVFDFsQRRKEYELEKQKKLEKERQE |
| Q16625 | S340 | SIGNOR|ELM|iPTMNet|EPSD | OCLN | DsPMAYSsNGKVNDKRFYPEssyKstPVPEVVQELPLtsPV |
| Q16625 | S490 | EPSD|PSP | OCLN | EsEEyMAAADEYNRLKQVKGsADYKSKKNHCKQLKSKLSHI |
| Q16658 | S39 | ELM | FSCN1 FAN1 HSN SNL | CGNKyLTAEAFGFKVNASAssLKKKQIWTLEQPPDEAGSAA |
| Q16778 | S39 | Sugiyama | H2BC21 H2BFQ HIST2H2BE | VTKAQKKDGKKRKRSRKEsysIyVyKVLKQVHPDTGIssKA |
| Q16820 | S687 | SIGNOR|ELM | MEP1B | MLIITLVSVYCTRKKYRERMsSNRPNLTPQNQHAF______ |
| Q16831 | S61 | Sugiyama | UPP1 UP | TSRHNFPALFGDVKFVCVGGsPsRMKAFIRCVGAELGLDCP |
| Q32P51 | S95 | Sugiyama | HNRNPA1L2 HNRNPA1L | TPHKVDGRVVEPKRAVsREDsQRPGAHLtVKKIFVGGIKED |
| Q3SY84 | S143 | Sugiyama | KRT71 K6IRS1 KB34 KRT6IRS1 | IQKVRAQEREQIKALNNKFAsFIDKVRFLEQQNQVLETKWE |
| Q3ZCM7 | S75 | Sugiyama | TUBB8 | SGGRYVPRAVLVDLEPGtMDsVRSGPFGQVFRPDNFIFGQC |
| Q5JVS0 | T354 | SIGNOR|iPTMNet|EPSD | HABP4 | MVKDDYEDDSHVFRKPANDItSQLEINFGNLPRPGRGARGG |
| Q5JVS0 | T375 | SIGNOR|iPTMNet|EPSD | HABP4 | SQLEINFGNLPRPGRGARGGtRGGRGRIRRAENYGPRAEVV |
| Q5QNW6 | S39 | Sugiyama | H2BC18 HIST2H2BF | VTKVQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| Q5T7P8 | T283 | SIGNOR|PSP | SYT6 | GSSDPYVKIYLLPDRKCKLQtRVHRKTLNPTFDENFHFPVP |
| Q5T7P8 | T417 | SIGNOR|PSP | SYT6 | SDPYVKVSLLCDGRRLKKKKttIKKNTLNPVYNEAIIFDIP |
| Q5T7P8 | T418 | SIGNOR|PSP | SYT6 | DPYVKVSLLCDGRRLKKKKttIKKNTLNPVYNEAIIFDIPP |
| Q5VTE0 | T432 | Sugiyama | EEF1A1P5 EEF1AL3 | VEsFSDyPPLGRFAVRDMRQtVAVGVIKAVDKKAAGAGKVT |
| Q5XKE5 | S155 | Sugiyama | KRT79 K6L KB38 KRT6L | IQRVRTQEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWA |
| Q68EM7 | S702 | SIGNOR | ARHGAP17 RICH1 MSTP066 MSTP110 | tGQPPGQPSAPSQLSAPRRysssLsPIQAPNHPPPQPPTQA |
| Q6DN03 | S39 | Sugiyama | H2BC20P HIST2H2BC | VTKAQKKDGKKRKRSRKEsysIyVyKVLKRVHPDTGIWCKA |
| Q6DRA6 | S39 | Sugiyama | H2BC19P HIST2H2BD | VTKAQKKDGKKRKRSRKEsysIyVyKVLKRVHPDTGIWCKA |
| Q6PCE3 | S175 | Sugiyama | PGM2L1 BM32A | PFVPYAVQKLKAVAGVMItAsHNRKEDNGYKVYWETGAQIT |
| Q6PEY2 | T334 | Sugiyama | TUBA3E | ACCMLYRGDVVPKDVNAAIAtIKtKRTIQFVDWCPTGFKVG |
| Q6PKG0 | S627 | Sugiyama | LARP1 KIAA0731 LARP | FLFDEEMEQMDGRKNtFtAWsDEEsDyEIDDRDVNKILIVt |
| Q6S8J3 | S1068 | Sugiyama | POTEE A26C1A POTE2 | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| Q6ZMR3 | S161 | Sugiyama | LDHAL6A LDHL2 | DILTYVAWKLSGFPKNRVIGsGCNLDsARFRYFIGQRLGIH |
| Q6ZMR3 | S167 | Sugiyama | LDHAL6A LDHL2 | AWKLSGFPKNRVIGsGCNLDsARFRYFIGQRLGIHSESCHG |
| Q6ZN17 | S243 | PSP | LIN28B CSDD2 | QEASSTKSSIAPEEQSKKGPsVQKRKKT_____________ |
| Q71U36 | T334 | Sugiyama | TUBA1A TUBA3 | ACCLLyRGDVVPKDVNAAIAtIKtKRTIQFVDWCPTGFKVG |
| Q71UM5 | S78 | Sugiyama | RPS27L | GCSTVLCQPTGGKARLtEGCsFRRKQH______________ |
| Q7RTS7 | S153 | Sugiyama | KRT74 K6IRS4 KB37 KRT5C KRT6IRS4 | IQKVRAQEREQIKVLNDKFAsFIDKVRFLEQQNQVLETKWE |
| Q7Z2W7 | S1040 | PSP | TRPM8 LTRPC6 TRPP8 | YFYMVVKKCFKCCCKEKNMEssVCCFKNEDNETLAWEGVMK |
| Q7Z2W7 | S1041 | PSP | TRPM8 LTRPC6 TRPP8 | FYMVVKKCFKCCCKEKNMEssVCCFKNEDNETLAWEGVMKE |
| Q7Z417 | S652 | Sugiyama | NUFIP2 KIAA1321 PIG1 | NtLLGsAKEQRYQRGLERNDsWGsFDLRAAIVYHTKEMEsI |
| Q7Z794 | S177 | Sugiyama | KRT77 KRT1B | IQRIKTQEREQIMVLNNKFAsFIDKVRFLEQQNQVLQTKWE |
| Q86VQ1 | S223 | Sugiyama | GLCCI1 | QTPsCWAEEGAEKRSHQRsAsWGsADQLKEQIAKLRQQLQR |
| Q86Y46 | S145 | Sugiyama | KRT73 K6IRS3 KB36 KRT6IRS3 | IQKVRAQEREQIKVLNNKFAsFIDKVRFLEQQNQVLETKWE |
| Q8IWA4 | S284 | PSP | MFN1 | LVEELKVVNALEAQNRIFFVsAKEVLsARKQKAQGMPESGV |
| Q8IWA4 | S290 | PSP | MFN1 | VVNALEAQNRIFFVsAKEVLsARKQKAQGMPESGVALAEGF |
| Q8IWA4 | S86 | SIGNOR|PSP | MFN1 | IIGEVLSRRHMKVAFFGRTSsGKSSVINAMLWDKVLPSGIG |
| Q8IWX8 | S904 | Sugiyama | CHERP DAN26 SCAF6 | KGVGVALDDPyENyRRNKsysFIARMKARDECK________ |
| Q8N257 | S39 | Sugiyama | H2BC26 H2BU1 HIST3H2BB | VTKAQKKDGKKRKRGRKEsysIyVyKVLKQVHPDTGIssKA |
| Q8NE86 | S92 | PSP | MCU C10orf42 CCDC109A | SDDVTVVYQNGLPVISVRLPsRRERCQFTLKPISDSVGVFL |
| Q8NER1 | T705 | SIGNOR|PSP | TRPV1 VR1 | ETVNKIAQESKNIWKLQRAItILDTEKSFLKCMRKAFRSGK |
| Q8NFA2 | S159 | SIGNOR | NOXO1 P41NOX SH3PXD5 | SRVILPTPEEQPLSRAAGRLsIHsLEAQSLRCLQPFCTQDT |
| Q8TD47 | T247 | Sugiyama | RPS4Y2 RPS4Y2P | VIGNGNKPWISLPRGKGIRLtIAEERDKRLAAKQSSG____ |
| Q8WVK2 | S132 | Sugiyama | SNRNP27 | FDSTKGKKVDGsVNAyAINVsQKRKYRQYMNRKGGFNRPLD |
| Q92686 | S36 | SIGNOR|ELM|iPTMNet|EPSD | NRGN | ILDIPLDDPGANAAAAKIQAsFRGHMARKKIKSGERGRKGP |
| Q92793 | S437 | ELM | CREBBP CBP | SHWKNCTRHDCPVCLPLKNAsDKRNQQTILGSPASGIQNTI |
| Q92890 | S299 | Sugiyama | UFD1 UFD1L | KKVEEDEAGGRFVAFsGEGQsLRKKGRKP____________ |
| Q93079 | S39 | Sugiyama | H2BC9 H2BFJ HIST1H2BH | VTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| Q96C90 | T57 | SIGNOR | PPP1R14B PLCB3N PNG | AGEGPGGADDEGPVRRQGKVtVKYDRKELRKRLNLEEWILE |
| Q96D31 | S27 | SIGNOR|EPSD|PSP | ORAI1 CRACM1 TMEM142A | PPPsRssPELPPSGGSTTSGsRRsRRRsGDGEPPGAPPPPP |
| Q96D31 | S30 | SIGNOR|EPSD|PSP | ORAI1 CRACM1 TMEM142A | sRssPELPPSGGSTTSGsRRsRRRsGDGEPPGAPPPPPSAV |
| Q96G46 | T273 | Sugiyama | DUS3L | GAPRQENCGAQQVPAGPGtstPPssPVRtCGPLtDEDVVRL |
| Q96PX8 | S695 | SIGNOR | SLITRK1 KIAA1910 LRRC12 UNQ233/PRO266 | NGPYNADGAHRVYDCGSHSLsD___________________ |
| Q99418 | S392 | SIGNOR|ELM|EPSD | CYTH2 ARNO PSCD2 PSCD2L | QAAVSVDPFYEMLAARKKRIsVKKKQEQP____________ |
| Q99848 | S270 | Sugiyama | EBNA1BP2 EBP2 | FGGKKKGSKWNtREsyDDVssFRAKTAHGRGLKRPGKKGSN |
| Q99877 | S39 | Sugiyama | H2BC15 H2BFD HIST1H2BN | VTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| Q99879 | S39 | Sugiyama | H2BC14 H2BFE HIST1H2BM | INKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| Q99880 | S39 | Sugiyama | H2BC13 H2BFC HIST1H2BL | VTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| Q9BQE3 | T334 | Sugiyama | TUBA1C TUBA6 | ACCLLyRGDVVPKDVNAAIAtIKtKRTIQFVDWCPTGFKVG |
| Q9BRS2 | S507 | Sugiyama | RIOK1 RIO1 | ENQVEERtCsDsEDIGssECsDtDSEEQGDHARPKKHTTDP |
| Q9BRS2 | T509 | Sugiyama | RIOK1 RIO1 | QVEERtCsDsEDIGssECsDtDSEEQGDHARPKKHTTDPDI |
| Q9BYX7 | S368 | Sugiyama | POTEKP ACTBL3 FKSG30 | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| Q9H1D0 | S184 | SIGNOR|PSP | TRPV6 ECAC2 | AVVNQNMNLVRALLARRASVsARATGTAFRRSPCNLIYFGE |
| Q9H1D0 | T728 | SIGNOR|PSP | TRPV6 ECAC2 | ELGCPFSPHLSLPMPSVSRStSRssANWERLRQGtLRRDLR |
| Q9H788 | S235 | Sugiyama | SH2D4A PPP1R38 SH2A | EEERTKQICKSWKEDSEWQAsLRKSKAADEKRRSLAKQARE |
| Q9H7D7 | S121 | Sugiyama | WDR26 CDW2 MIP2 PRO0852 | ASSSLATPELGSSLKKKKRLsQsDEDVIRLIGQHLNGLGLN |
| Q9HBA0 | S162 | SIGNOR | TRPV4 VRL2 VROAC | PPPILKVFNRPILFDIVSRGsTADLDGLLPFLLtHKKRLTD |
| Q9HBA0 | S189 | SIGNOR | TRPV4 VRL2 VROAC | LLPFLLtHKKRLTDEEFREPsTGKTCLPKALLNLSNGRNDT |
| Q9HBA0 | T175 | SIGNOR | TRPV4 VRL2 VROAC | FDIVSRGsTADLDGLLPFLLtHKKRLTDEEFREPsTGKTCL |
| Q9NPC2 | T341 | SIGNOR | KCNK9 TASK3 | KLAPHYFHSISYKIEEISPStLKNSLFPSPISSISPGLHSF |
| Q9NPQ8 | T441 | Sugiyama | RIC8A | AARGLMAGGRPEGQysEDEDtDtDEyKEAKAsINPVTGRVE |
| Q9NQ39 | S157 | Sugiyama | RPS10P5 RPS10L | TYRRCSVPPGADKKAEAGAGsAtEFQFRGRCGRGRGQPPQ_ |
| Q9NQ66 | S887 | ELM | PLCB1 KIAA0581 | TTTLTPKPPSQALHSQPAPGsVKAPAKTEDLIQSVLTEVEA |
| Q9NR19 | S30 | Sugiyama | ACSS2 ACAS2 | sGsGSRGQEEAGAGGRARsWsPPPEVsRSAHVPSLQRYREL |
| Q9NSB2 | S178 | Sugiyama | KRT84 KRTHB4 | AQRVKKDEKEQIKTLNNKFAsFIDKVRFLEQQNKLLETKWS |
| Q9P2D0 | S1200 | SIGNOR|EPSD|PSP | IBTK BTKI KIAA1417 | FtPSKAPKPVNAWASsLHsVsSKsFRDFLLEEKKSVTSHSS |
| Q9P2D0 | S1203 | SIGNOR|EPSD|PSP | IBTK BTKI KIAA1417 | SKAPKPVNAWASsLHsVsSKsFRDFLLEEKKSVTSHSSGDH |
| Q9UBR2 | S78 | Sugiyama | CTSZ | SPADLPKSWDWRNVDGVNyAsItRNQHIPQYCGSCWAHAST |
| Q9UBS0 | S473 | GPS6|SIGNOR|ELM|EPSD|PSP | RPS6KB2 STK14B | PPPPSTTAPLPIRPPSGTKKsKRGRGRPGR___________ |
| Q9UBU3 | S41 | EPSD|PSP | GHRL MTLRP UNQ524/PRO1066 | AMAGSSFLSPEHQRVQQRKEsKKPPAKLQPRALAGWLRPED |
| Q9UEY8 | S693 | ELM | ADD3 ADDL | sPEGsPsKsPsKKKKKFRTPsFLKKNKKKEKVEA_______ |
| Q9UH77 | S433 | SIGNOR|PSP | KLHL3 KIAA1129 | AYSYKTNEWFFVAPMNTRRSsVGVGVVEGKLYAVGGYDGAS |
| Q9UI15 | S185 | Sugiyama | TAGLN3 NP25 | EQLRQGQNVIGLQMGSNKGAsQAGMtGyGMPRQIM______ |
| Q9UII2 | S39 | Sugiyama | ATP5IF1 ATPI ATPIF1 | TMQARGFGsDQSENVDRGAGsIREAGGAFGKREQAEEERyF |
| Q9UJY1 | S14 | ELM | HSPB8 CRYAC E2IG1 HSP22 PP1629 | _______MADGQMPFSCHYPsRLRRDPFRDsPLsSRLLDDG |
| Q9UJY1 | T63 | ELM | HSPB8 CRYAC E2IG1 HSP22 PP1629 | DLTASWPDWALPRLsSAWPGtLRSGMVPRGPTATARFGVPA |
| Q9UKV3 | S388 | Sugiyama | ACIN1 ACINUS KIAA0670 | EEEEREIKssQGLKEKsKsPsPPRLtEDRKKAsLVALPEQt |
| Q9ULW6 | T342 | Sugiyama | NAP1L2 BPX | GTAIEYSTGCEIDWNEGKNVtLKtIKKKQKHRIWGTIRTVT |
| Q9ULW6 | T345 | Sugiyama | NAP1L2 BPX | IEYSTGCEIDWNEGKNVtLKtIKKKQKHRIWGTIRTVTEDF |
| Q9ULX6 | T267 | Sugiyama | AKAP8L NAKAP NAKAP95 HRIHFB2018 | RFGFGFGNGMKQMRRTWKTWtTADFRTKKKKRKQGGsPDEP |
| Q9UNX3 | S9 | Sugiyama | RPL26L1 RPL26P1 | ____________MKFNPFVtsDRsKNRKRHFNAPSHVRRKI |
| Q9UPR0 | T584 | Sugiyama | PLCL2 KIAA1092 PLCE2 | KILIKAKKLsSNCSGVEGDVtDEDEGAEMSQRMGKENMEQP |
| Q9UQ80 | S363 | SIGNOR|iPTMNet|EPSD | PA2G4 EBP1 | yKsEMEVQDAELKALLQssAsRKtQKKKKKKAsKtAENAts |
| Q9UQ80 | T366 | SIGNOR|iPTMNet|EPSD | PA2G4 EBP1 | EMEVQDAELKALLQssAsRKtQKKKKKKAsKtAENAtsGEt |
| Q9Y2B0 | S55 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | VDELEWEIAQVDPKKTIQMGsFRINPDGsQsVVEVPyARsE |
| Q9Y5S8 | T430 | SIGNOR | NOX1 MOX1 NOH1 | FASILKSIWYKFQCADHNLKtKKIYFYWICRETGAFSWFNN |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Cell Cycle | R-HSA-1640170 | 1.480194e-11 | 10.830 | 1 | 0 |
| Cellular Senescence | R-HSA-2559583 | 2.366266e-09 | 8.626 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 3.036937e-09 | 8.518 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 7.050980e-09 | 8.152 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 1.017261e-08 | 7.993 | 1 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 2.158370e-08 | 7.666 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 2.676639e-08 | 7.572 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 6.344170e-08 | 7.198 | 1 | 0 |
| M Phase | R-HSA-68886 | 8.824223e-08 | 7.054 | 1 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 9.643610e-08 | 7.016 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 3.471054e-07 | 6.460 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 2.667226e-06 | 5.574 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 2.809223e-06 | 5.551 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 3.151075e-06 | 5.502 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 3.317881e-06 | 5.479 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 3.764335e-06 | 5.424 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 5.122307e-06 | 5.291 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 7.434135e-06 | 5.129 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 8.643911e-06 | 5.063 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 9.015653e-06 | 5.045 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 1.017724e-05 | 4.992 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 1.487332e-05 | 4.828 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 1.867474e-05 | 4.729 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 1.867474e-05 | 4.729 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 2.108551e-05 | 4.676 | 1 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 2.470366e-05 | 4.607 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 2.477743e-05 | 4.606 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 2.942083e-05 | 4.531 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 2.969507e-05 | 4.527 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 3.802049e-05 | 4.420 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 4.142000e-05 | 4.383 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 4.989246e-05 | 4.302 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 5.345798e-05 | 4.272 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 5.627733e-05 | 4.250 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 5.916448e-05 | 4.228 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 6.838856e-05 | 4.165 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 7.287911e-05 | 4.137 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 7.636521e-05 | 4.117 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 7.804847e-05 | 4.108 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 9.042477e-05 | 4.044 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 9.157656e-05 | 4.038 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 9.900494e-05 | 4.004 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 1.056728e-04 | 3.976 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 1.058509e-04 | 3.975 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 1.095974e-04 | 3.960 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 1.459964e-04 | 3.836 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 1.459964e-04 | 3.836 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 2.018892e-04 | 3.695 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 2.055435e-04 | 3.687 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 2.056902e-04 | 3.687 | 1 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 2.296210e-04 | 3.639 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 2.507174e-04 | 3.601 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 2.737397e-04 | 3.563 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 2.806595e-04 | 3.552 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 2.817721e-04 | 3.550 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 3.452235e-04 | 3.462 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 3.676544e-04 | 3.435 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 3.976459e-04 | 3.401 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 4.155075e-04 | 3.381 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 4.815955e-04 | 3.317 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 4.774829e-04 | 3.321 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 4.774829e-04 | 3.321 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 5.571502e-04 | 3.254 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 5.608656e-04 | 3.251 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 5.775274e-04 | 3.238 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 6.327476e-04 | 3.199 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 6.573879e-04 | 3.182 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 6.405238e-04 | 3.193 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 6.804465e-04 | 3.167 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 6.879014e-04 | 3.162 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 7.339909e-04 | 3.134 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 7.085051e-04 | 3.150 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 7.745902e-04 | 3.111 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 8.133437e-04 | 3.090 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 7.964162e-04 | 3.099 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 8.545324e-04 | 3.068 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 8.545508e-04 | 3.068 | 1 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 9.157405e-04 | 3.038 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 9.157405e-04 | 3.038 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 9.305152e-04 | 3.031 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 9.805056e-04 | 3.009 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 1.003029e-03 | 2.999 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 1.027075e-03 | 2.988 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 1.157833e-03 | 2.936 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 1.214829e-03 | 2.915 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 1.259229e-03 | 2.900 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 1.358509e-03 | 2.867 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 1.412017e-03 | 2.850 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 1.530003e-03 | 2.815 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 1.586869e-03 | 2.799 | 1 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 1.594540e-03 | 2.797 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 1.671594e-03 | 2.777 | 1 | 0 |
| Reproduction | R-HSA-1474165 | 1.710759e-03 | 2.767 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 1.825751e-03 | 2.739 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 1.858279e-03 | 2.731 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 1.876227e-03 | 2.727 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 1.968945e-03 | 2.706 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 2.086912e-03 | 2.680 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 2.245098e-03 | 2.649 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 2.190251e-03 | 2.660 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 2.266621e-03 | 2.645 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 2.424747e-03 | 2.615 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 2.525859e-03 | 2.598 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 2.544017e-03 | 2.594 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 2.544017e-03 | 2.594 | 0 | 0 |
| Kinesins | R-HSA-983189 | 2.592768e-03 | 2.586 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 2.613368e-03 | 2.583 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 2.792834e-03 | 2.554 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 2.792834e-03 | 2.554 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 2.792834e-03 | 2.554 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 2.846975e-03 | 2.546 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 3.014548e-03 | 2.521 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 3.014548e-03 | 2.521 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 3.014548e-03 | 2.521 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 3.121613e-03 | 2.506 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 3.124271e-03 | 2.505 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 3.191306e-03 | 2.496 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 3.445090e-03 | 2.463 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 4.066749e-03 | 2.391 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 4.053170e-03 | 2.392 | 1 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 4.031177e-03 | 2.395 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 4.016065e-03 | 2.396 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 4.004818e-03 | 2.397 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 4.351705e-03 | 2.361 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 4.533047e-03 | 2.344 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 4.547109e-03 | 2.342 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 4.663686e-03 | 2.331 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 4.779708e-03 | 2.321 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 4.791994e-03 | 2.319 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 4.791994e-03 | 2.319 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 5.218083e-03 | 2.282 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 5.218083e-03 | 2.282 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 4.897404e-03 | 2.310 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 4.867069e-03 | 2.313 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 4.867069e-03 | 2.313 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 5.225446e-03 | 2.282 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 5.270904e-03 | 2.278 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 5.290652e-03 | 2.276 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 5.378822e-03 | 2.269 | 1 | 0 |
| Cell junction organization | R-HSA-446728 | 5.474631e-03 | 2.262 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 5.542825e-03 | 2.256 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 5.671855e-03 | 2.246 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 5.873525e-03 | 2.231 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 6.043351e-03 | 2.219 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 5.985720e-03 | 2.223 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 5.671855e-03 | 2.246 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 5.671855e-03 | 2.246 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 6.182219e-03 | 2.209 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 6.282923e-03 | 2.202 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 6.363573e-03 | 2.196 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 6.514939e-03 | 2.186 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 6.631487e-03 | 2.178 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 6.631487e-03 | 2.178 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 6.803672e-03 | 2.167 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 7.105013e-03 | 2.148 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 7.118136e-03 | 2.148 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 7.121883e-03 | 2.147 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 7.329512e-03 | 2.135 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 7.491698e-03 | 2.125 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 7.937659e-03 | 2.100 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 8.461368e-03 | 2.073 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 8.535751e-03 | 2.069 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 8.749097e-03 | 2.058 | 0 | 0 |
| Transcriptional activation of cell cycle inhibitor p21 | R-HSA-69895 | 9.091766e-03 | 2.041 | 0 | 0 |
| Transcriptional activation of p53 responsive genes | R-HSA-69560 | 9.091766e-03 | 2.041 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 9.770431e-03 | 2.010 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 1.005795e-02 | 1.997 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 1.016403e-02 | 1.993 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 1.024258e-02 | 1.990 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 1.039480e-02 | 1.983 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 1.039480e-02 | 1.983 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 1.039574e-02 | 1.983 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 1.049120e-02 | 1.979 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 1.049120e-02 | 1.979 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 1.052444e-02 | 1.978 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 1.177894e-02 | 1.929 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 1.098430e-02 | 1.959 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 1.067778e-02 | 1.972 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 1.098430e-02 | 1.959 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 1.177894e-02 | 1.929 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 1.221607e-02 | 1.913 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 1.221607e-02 | 1.913 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 1.227500e-02 | 1.911 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 1.250271e-02 | 1.903 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 1.250271e-02 | 1.903 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 1.256615e-02 | 1.901 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 1.273462e-02 | 1.895 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 1.316667e-02 | 1.881 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 1.340868e-02 | 1.873 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 1.356891e-02 | 1.867 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 1.373339e-02 | 1.862 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 1.373339e-02 | 1.862 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 1.427311e-02 | 1.845 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 1.429100e-02 | 1.845 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 1.442690e-02 | 1.841 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 1.514377e-02 | 1.820 | 0 | 0 |
| Adenylate cyclase inhibitory pathway | R-HSA-170670 | 1.514377e-02 | 1.820 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 1.654812e-02 | 1.781 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 1.588358e-02 | 1.799 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 1.515774e-02 | 1.819 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 1.492046e-02 | 1.826 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 1.657816e-02 | 1.780 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 1.683117e-02 | 1.774 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 1.683117e-02 | 1.774 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 1.698196e-02 | 1.770 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 1.707059e-02 | 1.768 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 1.721654e-02 | 1.764 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 1.767395e-02 | 1.753 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 1.771924e-02 | 1.752 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 1.821956e-02 | 1.739 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 1.821956e-02 | 1.739 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 1.906809e-02 | 1.720 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 1.907538e-02 | 1.720 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 2.189214e-02 | 1.660 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 2.189214e-02 | 1.660 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 2.189214e-02 | 1.660 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 2.084122e-02 | 1.681 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 2.084122e-02 | 1.681 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 2.084122e-02 | 1.681 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 2.084122e-02 | 1.681 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 2.127113e-02 | 1.672 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 2.068340e-02 | 1.684 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 2.068340e-02 | 1.684 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 2.160382e-02 | 1.665 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 2.024978e-02 | 1.694 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 1.939991e-02 | 1.712 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 2.189214e-02 | 1.660 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 2.135965e-02 | 1.670 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 2.135965e-02 | 1.670 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 2.078869e-02 | 1.682 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 2.005609e-02 | 1.698 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 2.024978e-02 | 1.694 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 2.196087e-02 | 1.658 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 2.206804e-02 | 1.656 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 2.323006e-02 | 1.634 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 2.338448e-02 | 1.631 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 2.338448e-02 | 1.631 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 2.338448e-02 | 1.631 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 2.371241e-02 | 1.625 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 2.399273e-02 | 1.620 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 2.406448e-02 | 1.619 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 2.442828e-02 | 1.612 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 2.442828e-02 | 1.612 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 2.512960e-02 | 1.600 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 2.538534e-02 | 1.595 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 2.986386e-02 | 1.525 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 2.986386e-02 | 1.525 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 2.986386e-02 | 1.525 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 2.986386e-02 | 1.525 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 2.986386e-02 | 1.525 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 2.986386e-02 | 1.525 | 0 | 0 |
| Loss of MECP2 binding ability to 5hmC-DNA | R-HSA-9022534 | 2.986386e-02 | 1.525 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 2.986386e-02 | 1.525 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 2.986386e-02 | 1.525 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 3.025700e-02 | 1.519 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 2.824903e-02 | 1.549 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 2.824903e-02 | 1.549 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 2.946627e-02 | 1.531 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 2.820047e-02 | 1.550 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 2.941627e-02 | 1.531 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 2.794864e-02 | 1.554 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 2.820047e-02 | 1.550 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 3.080583e-02 | 1.511 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 2.675899e-02 | 1.573 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 3.118687e-02 | 1.506 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 2.904227e-02 | 1.537 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 3.126059e-02 | 1.505 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 3.182485e-02 | 1.497 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 3.250138e-02 | 1.488 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 3.260763e-02 | 1.487 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 3.289266e-02 | 1.483 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 3.317987e-02 | 1.479 | 1 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 3.319067e-02 | 1.479 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 3.381909e-02 | 1.471 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 3.581446e-02 | 1.446 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 3.677678e-02 | 1.434 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 3.730984e-02 | 1.428 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 3.734182e-02 | 1.428 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 3.734182e-02 | 1.428 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 3.966808e-02 | 1.402 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 3.966808e-02 | 1.402 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 3.967767e-02 | 1.401 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 3.967767e-02 | 1.401 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 3.967767e-02 | 1.401 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 4.036912e-02 | 1.394 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 4.045662e-02 | 1.393 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 4.148296e-02 | 1.382 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 4.184165e-02 | 1.378 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 4.261298e-02 | 1.370 | 0 | 0 |
| Depurination | R-HSA-73927 | 4.261298e-02 | 1.370 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 4.429530e-02 | 1.354 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 4.434195e-02 | 1.353 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 4.434195e-02 | 1.353 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 4.466739e-02 | 1.350 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 4.749406e-02 | 1.323 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 4.749406e-02 | 1.323 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 5.273149e-02 | 1.278 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 5.273149e-02 | 1.278 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 5.416535e-02 | 1.266 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 5.416535e-02 | 1.266 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 5.326431e-02 | 1.274 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 4.559829e-02 | 1.341 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 5.208826e-02 | 1.283 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 5.208826e-02 | 1.283 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 5.208826e-02 | 1.283 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 5.208826e-02 | 1.283 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 5.196622e-02 | 1.284 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of cell cycle factors | R-HSA-8866911 | 4.749406e-02 | 1.323 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 5.136323e-02 | 1.289 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 5.059751e-02 | 1.296 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 4.851667e-02 | 1.314 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 5.326431e-02 | 1.274 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 5.038095e-02 | 1.298 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 4.837512e-02 | 1.315 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 5.489974e-02 | 1.260 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 5.859964e-02 | 1.232 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 5.916336e-02 | 1.228 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 5.953497e-02 | 1.225 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 5.953497e-02 | 1.225 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 5.953497e-02 | 1.225 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 5.953497e-02 | 1.225 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 5.953497e-02 | 1.225 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 5.953497e-02 | 1.225 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 6.015361e-02 | 1.221 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 6.143141e-02 | 1.212 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 6.143141e-02 | 1.212 | 0 | 0 |
| Oligomerization of connexins into connexons | R-HSA-190704 | 6.163355e-02 | 1.210 | 0 | 0 |
| Transport of glycerol from adipocytes to the liver by Aquaporins | R-HSA-432030 | 6.163355e-02 | 1.210 | 0 | 0 |
| TGFBR3 regulates FGF2 signaling | R-HSA-9839397 | 6.163355e-02 | 1.210 | 0 | 0 |
| Transport of connexins along the secretory pathway | R-HSA-190827 | 6.163355e-02 | 1.210 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 6.291109e-02 | 1.201 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 6.291109e-02 | 1.201 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 6.291109e-02 | 1.201 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 6.291109e-02 | 1.201 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 6.291109e-02 | 1.201 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 6.349858e-02 | 1.197 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 6.378475e-02 | 1.195 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 6.520512e-02 | 1.186 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 6.520512e-02 | 1.186 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 6.558525e-02 | 1.183 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 6.558525e-02 | 1.183 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 6.558525e-02 | 1.183 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 6.558525e-02 | 1.183 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 6.558525e-02 | 1.183 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 6.558525e-02 | 1.183 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 6.683610e-02 | 1.175 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 6.815933e-02 | 1.166 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 6.815933e-02 | 1.166 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 6.856071e-02 | 1.164 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 6.856071e-02 | 1.164 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 6.874901e-02 | 1.163 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 7.894023e-02 | 1.103 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 7.894023e-02 | 1.103 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 7.746504e-02 | 1.111 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 7.337500e-02 | 1.134 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 7.337500e-02 | 1.134 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 8.490147e-02 | 1.071 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 7.260732e-02 | 1.139 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 8.202944e-02 | 1.086 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 8.202944e-02 | 1.086 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 7.511555e-02 | 1.124 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 7.583785e-02 | 1.120 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 7.481766e-02 | 1.126 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 7.527937e-02 | 1.123 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 7.894023e-02 | 1.103 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 8.528034e-02 | 1.069 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 8.400722e-02 | 1.076 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 7.511555e-02 | 1.124 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 7.731503e-02 | 1.112 | 0 | 0 |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | R-HSA-8877330 | 8.003058e-02 | 1.097 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 8.202944e-02 | 1.086 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 8.227821e-02 | 1.085 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 7.872767e-02 | 1.104 | 1 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 7.894023e-02 | 1.103 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 7.746504e-02 | 1.111 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 7.725105e-02 | 1.112 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 7.612162e-02 | 1.118 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 7.733879e-02 | 1.112 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 8.344149e-02 | 1.079 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 8.779034e-02 | 1.057 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 7.733879e-02 | 1.112 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 7.813335e-02 | 1.107 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 8.958189e-02 | 1.048 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 9.093339e-02 | 1.041 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 9.093339e-02 | 1.041 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 9.093339e-02 | 1.041 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 9.093339e-02 | 1.041 | 0 | 0 |
| S Phase | R-HSA-69242 | 9.151065e-02 | 1.039 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 9.151065e-02 | 1.039 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 9.215398e-02 | 1.035 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 9.215398e-02 | 1.035 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 9.299313e-02 | 1.032 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 9.310630e-02 | 1.031 | 0 | 0 |
| Drug resistance of KIT mutants | R-HSA-9669937 | 1.249354e-01 | 0.903 | 0 | 0 |
| Drug resistance of PDGFR mutants | R-HSA-9674415 | 1.249354e-01 | 0.903 | 0 | 0 |
| KIT mutants bind TKIs | R-HSA-9669921 | 1.249354e-01 | 0.903 | 0 | 0 |
| PDGFR mutants bind TKIs | R-HSA-9674428 | 1.249354e-01 | 0.903 | 0 | 0 |
| Regorafenib-resistant KIT mutants | R-HSA-9669929 | 1.249354e-01 | 0.903 | 0 | 0 |
| Nilotinib-resistant KIT mutants | R-HSA-9669926 | 1.249354e-01 | 0.903 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to p14ARF Defects | R-HSA-9646304 | 1.249354e-01 | 0.903 | 0 | 0 |
| Masitinib-resistant KIT mutants | R-HSA-9669924 | 1.249354e-01 | 0.903 | 0 | 0 |
| Defective translocation of RB1 mutants to the nucleus | R-HSA-9661070 | 1.249354e-01 | 0.903 | 0 | 0 |
| Loss of Function of TP53 in Cancer | R-HSA-9723907 | 1.249354e-01 | 0.903 | 0 | 0 |
| Sorafenib-resistant PDGFR mutants | R-HSA-9674404 | 1.249354e-01 | 0.903 | 0 | 0 |
| Imatinib-resistant PDGFR mutants | R-HSA-9674396 | 1.249354e-01 | 0.903 | 0 | 0 |
| Imatinib-resistant KIT mutants | R-HSA-9669917 | 1.249354e-01 | 0.903 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 1.249354e-01 | 0.903 | 0 | 0 |
| Dasatinib-resistant KIT mutants | R-HSA-9669914 | 1.249354e-01 | 0.903 | 0 | 0 |
| Loss of function of TP53 in cancer due to loss of tetramerization ability | R-HSA-9723905 | 1.249354e-01 | 0.903 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to p14ARF Defects | R-HSA-9646303 | 1.249354e-01 | 0.903 | 0 | 0 |
| Regorafenib-resistant PDGFR mutants | R-HSA-9674403 | 1.249354e-01 | 0.903 | 0 | 0 |
| Sorafenib-resistant KIT mutants | R-HSA-9669936 | 1.249354e-01 | 0.903 | 0 | 0 |
| Sunitinib-resistant PDGFR mutants | R-HSA-9674401 | 1.249354e-01 | 0.903 | 0 | 0 |
| Sunitinib-resistant KIT mutants | R-HSA-9669934 | 1.249354e-01 | 0.903 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 1.006080e-01 | 0.997 | 0 | 0 |
| Regulation of TP53 Expression | R-HSA-6804754 | 1.006080e-01 | 0.997 | 0 | 0 |
| Stimulation of the cell death response by PAK-2p34 | R-HSA-211736 | 1.006080e-01 | 0.997 | 0 | 0 |
| Diseases of Cellular Senescence | R-HSA-9630747 | 1.006080e-01 | 0.997 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 1.006080e-01 | 0.997 | 0 | 0 |
| Diseases of cellular response to stress | R-HSA-9675132 | 1.006080e-01 | 0.997 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 1.006080e-01 | 0.997 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 1.006080e-01 | 0.997 | 0 | 0 |
| Potassium transport channels | R-HSA-1296067 | 1.006080e-01 | 0.997 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 1.006080e-01 | 0.997 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 1.006080e-01 | 0.997 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 1.006080e-01 | 0.997 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 1.006080e-01 | 0.997 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 1.006080e-01 | 0.997 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 1.006080e-01 | 0.997 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 1.006080e-01 | 0.997 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 1.006080e-01 | 0.997 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 1.206988e-01 | 0.918 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 9.839985e-02 | 1.007 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 9.839985e-02 | 1.007 | 0 | 0 |
| Cross-presentation of particulate exogenous antigens (phagosomes) | R-HSA-1236973 | 9.839985e-02 | 1.007 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 1.198532e-01 | 0.921 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 1.198532e-01 | 0.921 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 1.198532e-01 | 0.921 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 1.198532e-01 | 0.921 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 9.602756e-02 | 1.018 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 9.602756e-02 | 1.018 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 1.135127e-01 | 0.945 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 1.135127e-01 | 0.945 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 1.135127e-01 | 0.945 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 1.055837e-01 | 0.976 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 9.740080e-02 | 1.011 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 1.108553e-01 | 0.955 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 1.108553e-01 | 0.955 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 1.108553e-01 | 0.955 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 1.108553e-01 | 0.955 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 1.029776e-01 | 0.987 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 1.058740e-01 | 0.975 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 1.210578e-01 | 0.917 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 1.055837e-01 | 0.976 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 1.034325e-01 | 0.985 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 1.027779e-01 | 0.988 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 9.839985e-02 | 1.007 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 1.142696e-01 | 0.942 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 1.248884e-01 | 0.903 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 1.014018e-01 | 0.994 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 1.058740e-01 | 0.975 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 1.182352e-01 | 0.927 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 1.120403e-01 | 0.951 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 1.232408e-01 | 0.909 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 1.244992e-01 | 0.905 | 0 | 0 |
| Lipid particle organization | R-HSA-8964572 | 1.206988e-01 | 0.918 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 1.001290e-01 | 0.999 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 9.950341e-02 | 1.002 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 1.055837e-01 | 0.976 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 1.109046e-01 | 0.955 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 1.034325e-01 | 0.985 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 9.986399e-02 | 1.001 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 1.114973e-01 | 0.953 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 1.138674e-01 | 0.944 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 1.134609e-01 | 0.945 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 1.256797e-01 | 0.901 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 1.256797e-01 | 0.901 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 1.261274e-01 | 0.899 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 1.281854e-01 | 0.892 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 1.285156e-01 | 0.891 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 1.298611e-01 | 0.887 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 1.315692e-01 | 0.881 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 1.319206e-01 | 0.880 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 1.323015e-01 | 0.878 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 1.323015e-01 | 0.878 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 1.347802e-01 | 0.870 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 1.351136e-01 | 0.869 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 1.375887e-01 | 0.861 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 1.382580e-01 | 0.859 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 1.393605e-01 | 0.856 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 1.395387e-01 | 0.855 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 1.405147e-01 | 0.852 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 1.431176e-01 | 0.844 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 1.431176e-01 | 0.844 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 1.431176e-01 | 0.844 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 1.431176e-01 | 0.844 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 1.431176e-01 | 0.844 | 0 | 0 |
| Axonal growth stimulation | R-HSA-209563 | 1.444926e-01 | 0.840 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 1.444926e-01 | 0.840 | 0 | 0 |
| Diseases of Mismatch Repair (MMR) | R-HSA-5423599 | 1.444926e-01 | 0.840 | 0 | 0 |
| CASP5-mediated substrate cleavage | R-HSA-9960525 | 1.444926e-01 | 0.840 | 0 | 0 |
| CASP4-mediated substrate cleavage | R-HSA-9960519 | 1.444926e-01 | 0.840 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 1.500198e-01 | 0.824 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 1.500677e-01 | 0.824 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | R-HSA-2892245 | 1.508644e-01 | 0.821 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 1.508644e-01 | 0.821 | 0 | 0 |
| Ca2+ activated K+ channels | R-HSA-1296052 | 1.508644e-01 | 0.821 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 1.508644e-01 | 0.821 | 0 | 0 |
| Phase 3 - rapid repolarisation | R-HSA-5576890 | 1.508644e-01 | 0.821 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 1.508644e-01 | 0.821 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 1.510278e-01 | 0.821 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 1.525949e-01 | 0.816 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 1.525949e-01 | 0.816 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 1.537969e-01 | 0.813 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 1.544348e-01 | 0.811 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 1.553603e-01 | 0.809 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 1.561664e-01 | 0.806 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 1.561664e-01 | 0.806 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 1.562652e-01 | 0.806 | 1 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 1.577428e-01 | 0.802 | 1 | 0 |
| Drug-mediated inhibition of MET activation | R-HSA-9734091 | 2.342682e-01 | 0.630 | 0 | 0 |
| Defective Mismatch Repair Associated With PMS2 | R-HSA-5632987 | 2.342682e-01 | 0.630 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH6 | R-HSA-5632968 | 2.342682e-01 | 0.630 | 0 | 0 |
| Defective Mismatch Repair Associated With MLH1 | R-HSA-5545483 | 2.342682e-01 | 0.630 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 | R-HSA-9630791 | 2.342682e-01 | 0.630 | 0 | 0 |
| Impaired BRCA2 translocation to the nucleus | R-HSA-9709275 | 2.342682e-01 | 0.630 | 0 | 0 |
| Impaired BRCA2 binding to SEM1 (DSS1) | R-HSA-9763198 | 2.342682e-01 | 0.630 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 | R-HSA-9632697 | 2.342682e-01 | 0.630 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis Due to p14ARF Loss of Function | R-HSA-9645722 | 2.342682e-01 | 0.630 | 0 | 0 |
| MECP2 regulates transcription of genes involved in GABA signaling | R-HSA-9022927 | 1.914535e-01 | 0.718 | 0 | 0 |
| Regulation of HMOX1 expression and activity | R-HSA-9707587 | 1.914535e-01 | 0.718 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 1.914535e-01 | 0.718 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 1.914535e-01 | 0.718 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 1.914535e-01 | 0.718 | 0 | 0 |
| Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling | R-HSA-2644607 | 1.914535e-01 | 0.718 | 0 | 0 |
| FBXW7 Mutants and NOTCH1 in Cancer | R-HSA-2644605 | 1.914535e-01 | 0.718 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 1.914535e-01 | 0.718 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 2.400378e-01 | 0.620 | 0 | 0 |
| Phosphorylation and nuclear translocation of BMAL1 (ARNTL) and CLOCK | R-HSA-9931529 | 2.400378e-01 | 0.620 | 0 | 0 |
| IRS activation | R-HSA-74713 | 2.400378e-01 | 0.620 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 2.400378e-01 | 0.620 | 0 | 0 |
| G2 Phase | R-HSA-68911 | 2.400378e-01 | 0.620 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 2.400378e-01 | 0.620 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 1.831161e-01 | 0.737 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 1.831161e-01 | 0.737 | 0 | 0 |
| FGFR1b ligand binding and activation | R-HSA-190370 | 1.831161e-01 | 0.737 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 1.679878e-01 | 0.775 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 1.679878e-01 | 0.775 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 2.169755e-01 | 0.664 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 2.169755e-01 | 0.664 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 2.169755e-01 | 0.664 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 2.169755e-01 | 0.664 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 1.942440e-01 | 0.712 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 2.216589e-01 | 0.654 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 2.216589e-01 | 0.654 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 1.750286e-01 | 0.757 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 1.735722e-01 | 0.761 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 1.912489e-01 | 0.718 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 2.152874e-01 | 0.667 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 2.096126e-01 | 0.679 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 2.096126e-01 | 0.679 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 2.285992e-01 | 0.641 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 2.285992e-01 | 0.641 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 2.285992e-01 | 0.641 | 1 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 1.610139e-01 | 0.793 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 1.610139e-01 | 0.793 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 1.979545e-01 | 0.703 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 2.290826e-01 | 0.640 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 1.666620e-01 | 0.778 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 2.261797e-01 | 0.646 | 1 | 1 |
| PKR-mediated signaling | R-HSA-9833482 | 2.047779e-01 | 0.689 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 1.867823e-01 | 0.729 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 1.818321e-01 | 0.740 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 1.818321e-01 | 0.740 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 1.947644e-01 | 0.710 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 2.039093e-01 | 0.691 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 2.356586e-01 | 0.628 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 1.679878e-01 | 0.775 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 2.290826e-01 | 0.640 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 1.630979e-01 | 0.788 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 1.610139e-01 | 0.793 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 2.198576e-01 | 0.658 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 2.365063e-01 | 0.626 | 1 | 1 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 1.783459e-01 | 0.749 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 1.630979e-01 | 0.788 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 1.630979e-01 | 0.788 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 1.964204e-01 | 0.707 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 2.356586e-01 | 0.628 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 2.356586e-01 | 0.628 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 1.867823e-01 | 0.729 | 0 | 0 |
| Activation of NOXA and translocation to mitochondria | R-HSA-111448 | 1.914535e-01 | 0.718 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 1.739761e-01 | 0.760 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 2.088559e-01 | 0.680 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 1.822999e-01 | 0.739 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 2.169755e-01 | 0.664 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 2.290826e-01 | 0.640 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 2.400378e-01 | 0.620 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 1.679878e-01 | 0.775 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 2.047779e-01 | 0.689 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 1.722928e-01 | 0.764 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 2.096126e-01 | 0.679 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 1.660036e-01 | 0.780 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 2.128403e-01 | 0.672 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 1.915707e-01 | 0.718 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 1.611120e-01 | 0.793 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 2.400378e-01 | 0.620 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 2.216589e-01 | 0.654 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 1.707436e-01 | 0.768 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 1.867823e-01 | 0.729 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 1.942440e-01 | 0.712 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 1.777300e-01 | 0.750 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 2.051536e-01 | 0.688 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 1.679878e-01 | 0.775 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 1.964204e-01 | 0.707 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 1.803408e-01 | 0.744 | 1 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 1.970775e-01 | 0.705 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 1.603041e-01 | 0.795 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 2.092833e-01 | 0.679 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 2.290826e-01 | 0.640 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 2.202523e-01 | 0.657 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 2.116760e-01 | 0.674 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 1.683461e-01 | 0.774 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 2.164707e-01 | 0.665 | 0 | 0 |
| Formation of editosomes by ADAR proteins | R-HSA-77042 | 2.342682e-01 | 0.630 | 0 | 0 |
| Inhibition of PKR | R-HSA-169131 | 2.342682e-01 | 0.630 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 1.914535e-01 | 0.718 | 0 | 0 |
| MTF1 activates gene expression | R-HSA-5660489 | 1.914535e-01 | 0.718 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 2.400378e-01 | 0.620 | 0 | 0 |
| Negative regulation of activity of TFAP2 (AP-2) family transcription factors | R-HSA-8866904 | 1.831161e-01 | 0.737 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 2.169755e-01 | 0.664 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 2.169755e-01 | 0.664 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 1.942440e-01 | 0.712 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 1.735722e-01 | 0.761 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 1.656069e-01 | 0.781 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 1.703061e-01 | 0.769 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 2.331286e-01 | 0.632 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 2.206483e-01 | 0.656 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 2.206483e-01 | 0.656 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 2.152874e-01 | 0.667 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 1.794576e-01 | 0.746 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 2.167512e-01 | 0.664 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 1.831161e-01 | 0.737 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 1.942440e-01 | 0.712 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in invasion | R-HSA-9854909 | 2.400378e-01 | 0.620 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 1.964204e-01 | 0.707 | 1 | 1 |
| Inositol phosphate metabolism | R-HSA-1483249 | 2.272322e-01 | 0.644 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 2.217058e-01 | 0.654 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 1.647856e-01 | 0.783 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 1.679878e-01 | 0.775 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 2.400378e-01 | 0.620 | 0 | 0 |
| Co-inhibition by BTLA | R-HSA-9927353 | 2.400378e-01 | 0.620 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 2.021327e-01 | 0.694 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 2.216589e-01 | 0.654 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 2.406530e-01 | 0.619 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 2.408088e-01 | 0.618 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 2.408587e-01 | 0.618 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 2.439620e-01 | 0.613 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 2.439620e-01 | 0.613 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 2.439620e-01 | 0.613 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 2.457644e-01 | 0.609 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 2.481205e-01 | 0.605 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 2.481415e-01 | 0.605 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 2.497670e-01 | 0.602 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 2.500043e-01 | 0.602 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 2.500043e-01 | 0.602 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 2.500043e-01 | 0.602 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 2.500043e-01 | 0.602 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 2.501398e-01 | 0.602 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 2.519867e-01 | 0.599 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 2.519867e-01 | 0.599 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 2.519867e-01 | 0.599 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 2.519867e-01 | 0.599 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 2.519867e-01 | 0.599 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 2.519867e-01 | 0.599 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 2.524667e-01 | 0.598 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 2.531972e-01 | 0.597 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 2.549321e-01 | 0.594 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 2.573958e-01 | 0.589 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 2.583271e-01 | 0.588 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 2.583271e-01 | 0.588 | 0 | 0 |
| PI and PC transport between ER and Golgi membranes | R-HSA-1483196 | 3.299463e-01 | 0.482 | 0 | 0 |
| Signaling by extracellular domain mutants of KIT | R-HSA-9680187 | 3.299463e-01 | 0.482 | 0 | 0 |
| Signaling by juxtamembrane domain KIT mutants | R-HSA-9669935 | 3.299463e-01 | 0.482 | 0 | 0 |
| Interactions of Tat with host cellular proteins | R-HSA-176034 | 3.299463e-01 | 0.482 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to p16INK4A Defects | R-HSA-9630750 | 3.299463e-01 | 0.482 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to p16INK4A Defects | R-HSA-9632693 | 3.299463e-01 | 0.482 | 0 | 0 |
| Abasic sugar-phosphate removal via the single-nucleotide replacement pathway | R-HSA-73930 | 3.299463e-01 | 0.482 | 0 | 0 |
| Mitochondrial transcription initiation | R-HSA-163282 | 3.299463e-01 | 0.482 | 0 | 0 |
| NFG and proNGF binds to p75NTR | R-HSA-205017 | 3.299463e-01 | 0.482 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 | R-HSA-9632700 | 3.299463e-01 | 0.482 | 0 | 0 |
| XAV939 stabilizes AXIN | R-HSA-5545619 | 3.299463e-01 | 0.482 | 0 | 0 |
| MPS IIID - Sanfilippo syndrome D | R-HSA-2206305 | 3.299463e-01 | 0.482 | 0 | 0 |
| Defective PGM1 causes PGM1-CDG | R-HSA-5609974 | 3.299463e-01 | 0.482 | 0 | 0 |
| Signaling by kinase domain mutants of KIT | R-HSA-9669933 | 3.299463e-01 | 0.482 | 0 | 0 |
| Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS) | R-HSA-5660724 | 3.299463e-01 | 0.482 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 | R-HSA-9630794 | 3.299463e-01 | 0.482 | 0 | 0 |
| TWIK-releated acid-sensitive K+ channel (TASK) | R-HSA-1299316 | 3.299463e-01 | 0.482 | 0 | 0 |
| Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS) | R-HSA-5619081 | 3.299463e-01 | 0.482 | 0 | 0 |
| Intestinal infectious diseases | R-HSA-8942233 | 3.299463e-01 | 0.482 | 0 | 0 |
| Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) | R-HSA-5619054 | 3.299463e-01 | 0.482 | 0 | 0 |
| Defective SLC6A2 causes orthostatic intolerance (OI) | R-HSA-5619109 | 3.299463e-01 | 0.482 | 0 | 0 |
| GLI proteins bind promoters of Hh responsive genes to promote transcription | R-HSA-5635851 | 2.891076e-01 | 0.539 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 2.891076e-01 | 0.539 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 2.891076e-01 | 0.539 | 0 | 0 |
| Defective PAPSS2 causes SEMD-PA | R-HSA-3560796 | 4.136743e-01 | 0.383 | 0 | 0 |
| Glycogen storage disease type 0 (muscle GYS1) | R-HSA-3828062 | 4.136743e-01 | 0.383 | 0 | 0 |
| Glycogen storage disease type XV (GYG1) | R-HSA-3814836 | 4.136743e-01 | 0.383 | 0 | 0 |
| Mitotic Metaphase/Anaphase Transition | R-HSA-68881 | 4.136743e-01 | 0.383 | 0 | 0 |
| Defective SLC6A5 causes hyperekplexia 3 (HKPX3) | R-HSA-5619089 | 4.136743e-01 | 0.383 | 0 | 0 |
| Defective DHDDS causes RP59 | R-HSA-4755609 | 4.136743e-01 | 0.383 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 3.377835e-01 | 0.471 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in WNT signaling | R-HSA-8939256 | 3.377835e-01 | 0.471 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 3.377835e-01 | 0.471 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 2.877268e-01 | 0.541 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 2.877268e-01 | 0.541 | 0 | 0 |
| Presynaptic depolarization and calcium channel opening | R-HSA-112308 | 2.877268e-01 | 0.541 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 2.790552e-01 | 0.554 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 3.238112e-01 | 0.490 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 3.238112e-01 | 0.490 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 3.238112e-01 | 0.490 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 3.853984e-01 | 0.414 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 3.853984e-01 | 0.414 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 3.853984e-01 | 0.414 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 3.853984e-01 | 0.414 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose | R-HSA-9031528 | 3.853984e-01 | 0.414 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 3.853984e-01 | 0.414 | 0 | 0 |
| SLBP independent Processing of Histone Pre-mRNAs | R-HSA-111367 | 3.853984e-01 | 0.414 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 3.853984e-01 | 0.414 | 0 | 0 |
| The NLRP1 inflammasome | R-HSA-844455 | 4.869442e-01 | 0.313 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 4.869442e-01 | 0.313 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of other transcription factors | R-HSA-8866906 | 4.869442e-01 | 0.313 | 0 | 0 |
| Adrenaline signalling through Alpha-2 adrenergic receptor | R-HSA-392023 | 4.869442e-01 | 0.313 | 0 | 0 |
| Classical Kir channels | R-HSA-1296053 | 4.869442e-01 | 0.313 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 4.869442e-01 | 0.313 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 4.869442e-01 | 0.313 | 0 | 0 |
| Defective GCLC causes HAGGSD | R-HSA-5578999 | 4.869442e-01 | 0.313 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 3.598971e-01 | 0.444 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 3.598971e-01 | 0.444 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 3.598971e-01 | 0.444 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 3.598971e-01 | 0.444 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 2.806538e-01 | 0.552 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 3.384172e-01 | 0.471 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 3.384172e-01 | 0.471 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 4.314576e-01 | 0.365 | 0 | 0 |
| RSK activation | R-HSA-444257 | 4.314576e-01 | 0.365 | 0 | 0 |
| SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | R-HSA-77588 | 4.314576e-01 | 0.365 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 4.314576e-01 | 0.365 | 0 | 0 |
| Activation of RAS in B cells | R-HSA-1169092 | 4.314576e-01 | 0.365 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 4.314576e-01 | 0.365 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 4.314576e-01 | 0.365 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 4.314576e-01 | 0.365 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 2.681699e-01 | 0.572 | 1 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 3.033901e-01 | 0.518 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 3.956843e-01 | 0.403 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 3.956843e-01 | 0.403 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 3.956843e-01 | 0.403 | 0 | 0 |
| Adenylate cyclase activating pathway | R-HSA-170660 | 3.956843e-01 | 0.403 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 3.956843e-01 | 0.403 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 3.956843e-01 | 0.403 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 2.886134e-01 | 0.540 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 3.683299e-01 | 0.434 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 3.683299e-01 | 0.434 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 3.264403e-01 | 0.486 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 3.094004e-01 | 0.509 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 2.980204e-01 | 0.526 | 0 | 0 |
| Thromboxane signalling through TP receptor | R-HSA-428930 | 3.718673e-01 | 0.430 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 3.718673e-01 | 0.430 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 3.981553e-01 | 0.400 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 4.309145e-01 | 0.366 | 0 | 0 |
| cGMP effects | R-HSA-418457 | 4.309145e-01 | 0.366 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 4.756067e-01 | 0.323 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 4.277324e-01 | 0.369 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 4.277324e-01 | 0.369 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 4.653700e-01 | 0.332 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 4.653700e-01 | 0.332 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 3.711880e-01 | 0.430 | 0 | 0 |
| Synthesis, secretion, and deacylation of Ghrelin | R-HSA-422085 | 4.569165e-01 | 0.340 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 4.569165e-01 | 0.340 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 4.569165e-01 | 0.340 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 5.176039e-01 | 0.286 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 5.176039e-01 | 0.286 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 5.176039e-01 | 0.286 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 5.176039e-01 | 0.286 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 4.496551e-01 | 0.347 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 4.496551e-01 | 0.347 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 2.979933e-01 | 0.526 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 4.084599e-01 | 0.389 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 4.988708e-01 | 0.302 | 0 | 0 |
| Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion | R-HSA-434316 | 4.988708e-01 | 0.302 | 0 | 0 |
| Phase 4 - resting membrane potential | R-HSA-5576886 | 4.988708e-01 | 0.302 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 4.320734e-01 | 0.364 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 4.855799e-01 | 0.314 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 4.855799e-01 | 0.314 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 4.271155e-01 | 0.369 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 4.750904e-01 | 0.323 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 4.663088e-01 | 0.331 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 4.518878e-01 | 0.345 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 5.001281e-01 | 0.301 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 4.826759e-01 | 0.316 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 4.066394e-01 | 0.391 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 5.090608e-01 | 0.293 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 5.001281e-01 | 0.301 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 5.163027e-01 | 0.287 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 3.680157e-01 | 0.434 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 2.681699e-01 | 0.572 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 2.802771e-01 | 0.552 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 3.198309e-01 | 0.495 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 4.847135e-01 | 0.315 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 4.847135e-01 | 0.315 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 4.855799e-01 | 0.314 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 4.569165e-01 | 0.340 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 4.277324e-01 | 0.369 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 4.569165e-01 | 0.340 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 3.238112e-01 | 0.490 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 3.085948e-01 | 0.511 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 3.328822e-01 | 0.478 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 4.756067e-01 | 0.323 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 3.522402e-01 | 0.453 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 4.309145e-01 | 0.366 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 4.653700e-01 | 0.332 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 4.653700e-01 | 0.332 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 4.239081e-01 | 0.373 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 3.846569e-01 | 0.415 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 4.314576e-01 | 0.365 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 4.797717e-01 | 0.319 | 0 | 0 |
| Formation of lateral plate mesoderm | R-HSA-9758920 | 2.891076e-01 | 0.539 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 3.853984e-01 | 0.414 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 3.853984e-01 | 0.414 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 2.886134e-01 | 0.540 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 4.569165e-01 | 0.340 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 5.176039e-01 | 0.286 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 3.094004e-01 | 0.509 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 4.911094e-01 | 0.309 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 2.696033e-01 | 0.569 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 4.139327e-01 | 0.383 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 3.683299e-01 | 0.434 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 2.675873e-01 | 0.573 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 3.026867e-01 | 0.519 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 4.653700e-01 | 0.332 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 12 | R-HSA-392170 | 4.569165e-01 | 0.340 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 3.416567e-01 | 0.466 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 4.199486e-01 | 0.377 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 3.693250e-01 | 0.433 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 5.154033e-01 | 0.288 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 4.224708e-01 | 0.374 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 4.224708e-01 | 0.374 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 4.224708e-01 | 0.374 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 4.224708e-01 | 0.374 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 4.988708e-01 | 0.302 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 3.079128e-01 | 0.512 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 5.009355e-01 | 0.300 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 3.517191e-01 | 0.454 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 2.741024e-01 | 0.562 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 4.906734e-01 | 0.309 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 2.891076e-01 | 0.539 | 0 | 0 |
| Transcription from mitochondrial promoters | R-HSA-75944 | 4.136743e-01 | 0.383 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 2.790552e-01 | 0.554 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 3.238112e-01 | 0.490 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 4.314576e-01 | 0.365 | 0 | 0 |
| Astrocytic Glutamate-Glutamine Uptake And Metabolism | R-HSA-210455 | 4.314576e-01 | 0.365 | 0 | 0 |
| Neurotransmitter uptake and metabolism In glial cells | R-HSA-112313 | 4.314576e-01 | 0.365 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 3.033901e-01 | 0.518 | 0 | 0 |
| FGFR1c ligand binding and activation | R-HSA-190373 | 3.956843e-01 | 0.403 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 2.941314e-01 | 0.531 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 3.979442e-01 | 0.400 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 5.176039e-01 | 0.286 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 4.496551e-01 | 0.347 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 3.199098e-01 | 0.495 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 4.733921e-01 | 0.325 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 4.239081e-01 | 0.373 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 2.886134e-01 | 0.540 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 4.277324e-01 | 0.369 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 2.877268e-01 | 0.541 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 2.761058e-01 | 0.559 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 3.965503e-01 | 0.402 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 4.988708e-01 | 0.302 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 2.824778e-01 | 0.549 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 3.342666e-01 | 0.476 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 2.597124e-01 | 0.586 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 4.891286e-01 | 0.311 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 4.861823e-01 | 0.313 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 2.891076e-01 | 0.539 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 4.653700e-01 | 0.332 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 5.136117e-01 | 0.289 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 5.174583e-01 | 0.286 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 3.897460e-01 | 0.409 | 1 | 0 |
| Cardiogenesis | R-HSA-9733709 | 2.681699e-01 | 0.572 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 2.806776e-01 | 0.552 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 3.522402e-01 | 0.453 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 3.193022e-01 | 0.496 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 4.454126e-01 | 0.351 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 2.913853e-01 | 0.536 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 4.251469e-01 | 0.371 | 1 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 2.681699e-01 | 0.572 | 0 | 0 |
| mRNA Editing | R-HSA-75072 | 4.756067e-01 | 0.323 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 2.682235e-01 | 0.572 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 3.680157e-01 | 0.434 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 4.212306e-01 | 0.375 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 3.304592e-01 | 0.481 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 4.054221e-01 | 0.392 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH2 | R-HSA-5632928 | 3.299463e-01 | 0.482 | 0 | 0 |
| mRNA Editing: A to I Conversion | R-HSA-75064 | 4.136743e-01 | 0.383 | 0 | 0 |
| Regulation of cortical dendrite branching | R-HSA-8985801 | 4.136743e-01 | 0.383 | 0 | 0 |
| C6 deamination of adenosine | R-HSA-75102 | 4.136743e-01 | 0.383 | 0 | 0 |
| Neurophilin interactions with VEGF and VEGFR | R-HSA-194306 | 4.136743e-01 | 0.383 | 0 | 0 |
| TGFBR3 regulates TGF-beta signaling | R-HSA-9839389 | 3.853984e-01 | 0.414 | 0 | 0 |
| MET activates STAT3 | R-HSA-8875791 | 4.869442e-01 | 0.313 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 4.869442e-01 | 0.313 | 0 | 0 |
| Activation of BIM and translocation to mitochondria | R-HSA-111446 | 4.869442e-01 | 0.313 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 2.802771e-01 | 0.552 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 3.187697e-01 | 0.497 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 4.988708e-01 | 0.302 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 4.715811e-01 | 0.326 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 5.001281e-01 | 0.301 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 5.001281e-01 | 0.301 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 4.911094e-01 | 0.309 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 3.514662e-01 | 0.454 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 3.514662e-01 | 0.454 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 4.224708e-01 | 0.374 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 2.806538e-01 | 0.552 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 4.239081e-01 | 0.373 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 3.179360e-01 | 0.498 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 3.922690e-01 | 0.406 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 3.956843e-01 | 0.403 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 4.750904e-01 | 0.323 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 5.116230e-01 | 0.291 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 2.877268e-01 | 0.541 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 4.314576e-01 | 0.365 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 4.756067e-01 | 0.323 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 4.569165e-01 | 0.340 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 3.872500e-01 | 0.412 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 3.350402e-01 | 0.475 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 4.988708e-01 | 0.302 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 4.855799e-01 | 0.314 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 2.802771e-01 | 0.552 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 4.988708e-01 | 0.302 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 3.525647e-01 | 0.453 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 4.730056e-01 | 0.325 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 4.756067e-01 | 0.323 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 4.756067e-01 | 0.323 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 4.277324e-01 | 0.369 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 5.136117e-01 | 0.289 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 2.802771e-01 | 0.552 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 3.416567e-01 | 0.466 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 5.116230e-01 | 0.291 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 3.133859e-01 | 0.504 | 0 | 0 |
| DSCAM interactions | R-HSA-376172 | 4.136743e-01 | 0.383 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 3.238112e-01 | 0.490 | 0 | 0 |
| Intracellular oxygen transport | R-HSA-8981607 | 4.869442e-01 | 0.313 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 2.681699e-01 | 0.572 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 3.956843e-01 | 0.403 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 3.683299e-01 | 0.434 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 4.756067e-01 | 0.323 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 4.756067e-01 | 0.323 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 3.187697e-01 | 0.497 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 4.457293e-01 | 0.351 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 2.806538e-01 | 0.552 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 2.777095e-01 | 0.556 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 2.687827e-01 | 0.571 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 3.377835e-01 | 0.471 | 0 | 0 |
| Histamine receptors | R-HSA-390650 | 4.869442e-01 | 0.313 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 4.199486e-01 | 0.377 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 4.160207e-01 | 0.381 | 0 | 0 |
| Release of apoptotic factors from the mitochondria | R-HSA-111457 | 2.891076e-01 | 0.539 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in metabolism | R-HSA-9854907 | 4.869442e-01 | 0.313 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 4.314576e-01 | 0.365 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 5.135917e-01 | 0.289 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 3.981553e-01 | 0.400 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 4.653700e-01 | 0.332 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 3.034286e-01 | 0.518 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 3.683299e-01 | 0.434 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 3.164491e-01 | 0.500 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 3.915056e-01 | 0.407 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 3.956843e-01 | 0.403 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 4.796064e-01 | 0.319 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 4.309145e-01 | 0.366 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 5.190912e-01 | 0.285 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 5.246915e-01 | 0.280 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 5.246915e-01 | 0.280 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 5.246915e-01 | 0.280 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 5.259564e-01 | 0.279 | 1 | 0 |
| Phase 2 - plateau phase | R-HSA-5576893 | 5.312718e-01 | 0.275 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 5.312718e-01 | 0.275 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 5.312718e-01 | 0.275 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 5.312718e-01 | 0.275 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 5.312718e-01 | 0.275 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 5.336796e-01 | 0.273 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 5.368590e-01 | 0.270 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 5.368590e-01 | 0.270 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 5.409169e-01 | 0.267 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 5.409169e-01 | 0.267 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 5.409169e-01 | 0.267 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 5.429303e-01 | 0.265 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 5.510616e-01 | 0.259 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 5.510616e-01 | 0.259 | 0 | 0 |
| Nucleotide catabolism defects | R-HSA-9735786 | 5.510616e-01 | 0.259 | 0 | 0 |
| ATP sensitive Potassium channels | R-HSA-1296025 | 5.510616e-01 | 0.259 | 0 | 0 |
| Defective PNP disrupts phosphorolysis of (deoxy)guanosine and (deoxy)inosine | R-HSA-9735763 | 5.510616e-01 | 0.259 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 5.510616e-01 | 0.259 | 0 | 0 |
| Signaling by MAP2K mutants | R-HSA-9652169 | 5.510616e-01 | 0.259 | 0 | 0 |
| Defective LFNG causes SCDO3 | R-HSA-5083630 | 5.510616e-01 | 0.259 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 5.510616e-01 | 0.259 | 0 | 0 |
| Dopamine receptors | R-HSA-390651 | 5.510616e-01 | 0.259 | 0 | 0 |
| p75NTR negatively regulates cell cycle via SC1 | R-HSA-193670 | 5.510616e-01 | 0.259 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 5.510616e-01 | 0.259 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 5.572976e-01 | 0.254 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 5.572976e-01 | 0.254 | 0 | 0 |
| FGFR2b ligand binding and activation | R-HSA-190377 | 5.572976e-01 | 0.254 | 0 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 5.572976e-01 | 0.254 | 0 | 0 |
| Chylomicron assembly | R-HSA-8963888 | 5.572976e-01 | 0.254 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 5.572976e-01 | 0.254 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 5.572976e-01 | 0.254 | 0 | 0 |
| Prostanoid ligand receptors | R-HSA-391908 | 5.572976e-01 | 0.254 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 5.572976e-01 | 0.254 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 5.624600e-01 | 0.250 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 5.624600e-01 | 0.250 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 5.624600e-01 | 0.250 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 5.624600e-01 | 0.250 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 5.624600e-01 | 0.250 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 5.624600e-01 | 0.250 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 5.624600e-01 | 0.250 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 5.653014e-01 | 0.248 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 5.674159e-01 | 0.246 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 5.674159e-01 | 0.246 | 0 | 0 |
| Assembly of active LPL and LIPC lipase complexes | R-HSA-8963889 | 5.674159e-01 | 0.246 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 5.721337e-01 | 0.243 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 5.766135e-01 | 0.239 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 5.785236e-01 | 0.238 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 5.808729e-01 | 0.236 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 5.808729e-01 | 0.236 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 5.864579e-01 | 0.232 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 5.888155e-01 | 0.230 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 5.900650e-01 | 0.229 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 5.923506e-01 | 0.227 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 5.923506e-01 | 0.227 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 5.923506e-01 | 0.227 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 5.923506e-01 | 0.227 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 5.923506e-01 | 0.227 | 0 | 0 |
| FGFR1 ligand binding and activation | R-HSA-190242 | 5.923506e-01 | 0.227 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 5.923506e-01 | 0.227 | 0 | 0 |
| PKA activation | R-HSA-163615 | 5.923506e-01 | 0.227 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 5.923506e-01 | 0.227 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 5.923506e-01 | 0.227 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 5.927003e-01 | 0.227 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 5.927003e-01 | 0.227 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 5.927003e-01 | 0.227 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 5.930438e-01 | 0.227 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 5.930438e-01 | 0.227 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 5.930438e-01 | 0.227 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 5.930438e-01 | 0.227 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 5.946076e-01 | 0.226 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 5.946076e-01 | 0.226 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 5.946076e-01 | 0.226 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 5.946076e-01 | 0.226 | 0 | 0 |
| Signaling by activated point mutants of FGFR1 | R-HSA-1839122 | 5.946076e-01 | 0.226 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 5.946076e-01 | 0.226 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 5.949037e-01 | 0.226 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 5.949037e-01 | 0.226 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 5.972951e-01 | 0.224 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 5.972951e-01 | 0.224 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 6.027063e-01 | 0.220 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 6.027063e-01 | 0.220 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 6.027063e-01 | 0.220 | 0 | 0 |
| Protein folding | R-HSA-391251 | 6.028952e-01 | 0.220 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 6.031477e-01 | 0.220 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 6.031477e-01 | 0.220 | 0 | 0 |
| Activation of AMPA receptors | R-HSA-399710 | 6.071694e-01 | 0.217 | 0 | 0 |
| NOSIP mediated eNOS trafficking | R-HSA-203754 | 6.071694e-01 | 0.217 | 0 | 0 |
| Defective SLC1A3 causes episodic ataxia 6 (EA6) | R-HSA-5619062 | 6.071694e-01 | 0.217 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 6.071694e-01 | 0.217 | 0 | 0 |
| Activation of AKT2 | R-HSA-165158 | 6.071694e-01 | 0.217 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 6.071694e-01 | 0.217 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in interleukin signaling | R-HSA-8939247 | 6.071694e-01 | 0.217 | 0 | 0 |
| Trafficking of myristoylated proteins to the cilium | R-HSA-5624138 | 6.071694e-01 | 0.217 | 0 | 0 |
| Suppression of autophagy | R-HSA-9636569 | 6.071694e-01 | 0.217 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 6.071694e-01 | 0.217 | 0 | 0 |
| Muscarinic acetylcholine receptors | R-HSA-390648 | 6.071694e-01 | 0.217 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 6.071694e-01 | 0.217 | 0 | 0 |
| Zinc efflux and compartmentalization by the SLC30 family | R-HSA-435368 | 6.071694e-01 | 0.217 | 0 | 0 |
| Nectin/Necl trans heterodimerization | R-HSA-420597 | 6.071694e-01 | 0.217 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 6.083365e-01 | 0.216 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 6.088598e-01 | 0.215 | 1 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 6.156488e-01 | 0.211 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 6.156488e-01 | 0.211 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 6.166415e-01 | 0.210 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 6.174242e-01 | 0.209 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 6.177492e-01 | 0.209 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 6.208843e-01 | 0.207 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 6.208843e-01 | 0.207 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 6.208843e-01 | 0.207 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 6.208843e-01 | 0.207 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 6.208843e-01 | 0.207 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 6.208843e-01 | 0.207 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 6.219769e-01 | 0.206 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 6.238292e-01 | 0.205 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 6.238292e-01 | 0.205 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 6.258835e-01 | 0.204 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 6.271307e-01 | 0.203 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 6.295098e-01 | 0.201 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 6.295098e-01 | 0.201 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 6.295098e-01 | 0.201 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 6.295098e-01 | 0.201 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 6.295098e-01 | 0.201 | 0 | 0 |
| Estrogen biosynthesis | R-HSA-193144 | 6.295098e-01 | 0.201 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 6.295098e-01 | 0.201 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 6.295098e-01 | 0.201 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 6.365319e-01 | 0.196 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 6.383325e-01 | 0.195 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 6.383325e-01 | 0.195 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 6.388604e-01 | 0.195 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 6.388604e-01 | 0.195 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 6.390001e-01 | 0.194 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 6.414931e-01 | 0.193 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 6.414931e-01 | 0.193 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 6.414931e-01 | 0.193 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 6.480239e-01 | 0.188 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 6.538351e-01 | 0.185 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 6.538351e-01 | 0.185 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 6.542973e-01 | 0.184 | 0 | 0 |
| TRAIL signaling | R-HSA-75158 | 6.562678e-01 | 0.183 | 0 | 0 |
| Plus-strand DNA synthesis | R-HSA-164525 | 6.562678e-01 | 0.183 | 0 | 0 |
| Nef Mediated CD8 Down-regulation | R-HSA-182218 | 6.562678e-01 | 0.183 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 6.562678e-01 | 0.183 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 6.562678e-01 | 0.183 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 6.562678e-01 | 0.183 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 6.562678e-01 | 0.183 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 6.562678e-01 | 0.183 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 6.562678e-01 | 0.183 | 0 | 0 |
| Signaling by MAPK mutants | R-HSA-9652817 | 6.562678e-01 | 0.183 | 0 | 0 |
| Phase 1 - inactivation of fast Na+ channels | R-HSA-5576894 | 6.562678e-01 | 0.183 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 6.562678e-01 | 0.183 | 0 | 0 |
| Toxicity of botulinum toxin type E (botE) | R-HSA-5250992 | 6.562678e-01 | 0.183 | 0 | 0 |
| Synthesis of PS | R-HSA-1483101 | 6.562678e-01 | 0.183 | 0 | 0 |
| Formation of the Editosome | R-HSA-75094 | 6.562678e-01 | 0.183 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 6.562678e-01 | 0.183 | 0 | 0 |
| CDC6 association with the ORC:origin complex | R-HSA-68689 | 6.562678e-01 | 0.183 | 0 | 0 |
| Ceramide signalling | R-HSA-193681 | 6.562678e-01 | 0.183 | 0 | 0 |
| VEGF binds to VEGFR leading to receptor dimerization | R-HSA-195399 | 6.562678e-01 | 0.183 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 6.562678e-01 | 0.183 | 0 | 0 |
| VEGF ligand-receptor interactions | R-HSA-194313 | 6.562678e-01 | 0.183 | 0 | 0 |
| Acetylcholine inhibits contraction of outer hair cells | R-HSA-9667769 | 6.562678e-01 | 0.183 | 0 | 0 |
| Sodium-coupled phosphate cotransporters | R-HSA-427652 | 6.562678e-01 | 0.183 | 0 | 0 |
| Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660826 | 6.562678e-01 | 0.183 | 0 | 0 |
| Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660825 | 6.562678e-01 | 0.183 | 0 | 0 |
| TYSND1 cleaves peroxisomal proteins | R-HSA-9033500 | 6.562678e-01 | 0.183 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 6.568918e-01 | 0.183 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 6.568918e-01 | 0.183 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 6.589307e-01 | 0.181 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 6.589307e-01 | 0.181 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 6.589307e-01 | 0.181 | 0 | 0 |
| FGFR2c ligand binding and activation | R-HSA-190375 | 6.620232e-01 | 0.179 | 0 | 0 |
| Chylomicron remodeling | R-HSA-8963901 | 6.620232e-01 | 0.179 | 0 | 0 |
| FGFR4 ligand binding and activation | R-HSA-190322 | 6.620232e-01 | 0.179 | 0 | 0 |
| Signaling by activated point mutants of FGFR3 | R-HSA-1839130 | 6.620232e-01 | 0.179 | 0 | 0 |
| FGFR3 mutant receptor activation | R-HSA-2033514 | 6.620232e-01 | 0.179 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 6.620232e-01 | 0.179 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 6.620232e-01 | 0.179 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 6.642480e-01 | 0.178 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 6.642480e-01 | 0.178 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 6.642480e-01 | 0.178 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 6.642480e-01 | 0.178 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 6.678683e-01 | 0.175 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 6.678683e-01 | 0.175 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 6.694462e-01 | 0.174 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 6.737512e-01 | 0.172 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 6.737512e-01 | 0.172 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 6.737512e-01 | 0.172 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 6.737512e-01 | 0.172 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 6.737512e-01 | 0.172 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 6.742345e-01 | 0.171 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 6.787561e-01 | 0.168 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 6.787561e-01 | 0.168 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 6.787561e-01 | 0.168 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 6.818485e-01 | 0.166 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 6.835447e-01 | 0.165 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 6.835447e-01 | 0.165 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 6.859966e-01 | 0.164 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 6.859966e-01 | 0.164 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 6.859966e-01 | 0.164 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 6.879616e-01 | 0.162 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 6.879616e-01 | 0.162 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 6.879616e-01 | 0.162 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR3 | R-HSA-5654227 | 6.921997e-01 | 0.160 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 6.921997e-01 | 0.160 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 6.921997e-01 | 0.160 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 6.921997e-01 | 0.160 | 0 | 0 |
| FGFR3c ligand binding and activation | R-HSA-190372 | 6.921997e-01 | 0.160 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 6.921997e-01 | 0.160 | 0 | 0 |
| Non-canonical inflammasome activation | R-HSA-9686114 | 6.921997e-01 | 0.160 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 6.939034e-01 | 0.159 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 6.939034e-01 | 0.159 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 6.958236e-01 | 0.158 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 6.958236e-01 | 0.158 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 6.958236e-01 | 0.158 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 6.977954e-01 | 0.156 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 6.980645e-01 | 0.156 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 6.980645e-01 | 0.156 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 6.980645e-01 | 0.156 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 6.980645e-01 | 0.156 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 6.992321e-01 | 0.155 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 6.992321e-01 | 0.155 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 6.992321e-01 | 0.155 | 0 | 0 |
| Autointegration results in viral DNA circles | R-HSA-177539 | 6.992321e-01 | 0.155 | 0 | 0 |
| Uncoating of the HIV Virion | R-HSA-162585 | 6.992321e-01 | 0.155 | 0 | 0 |
| Highly sodium permeable postsynaptic acetylcholine nicotinic receptors | R-HSA-629587 | 6.992321e-01 | 0.155 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 6.992321e-01 | 0.155 | 0 | 0 |
| MET Receptor Activation | R-HSA-6806942 | 6.992321e-01 | 0.155 | 0 | 0 |
| Toxicity of botulinum toxin type F (botF) | R-HSA-5250981 | 6.992321e-01 | 0.155 | 0 | 0 |
| Toxicity of botulinum toxin type D (botD) | R-HSA-5250955 | 6.992321e-01 | 0.155 | 0 | 0 |
| Intracellular metabolism of fatty acids regulates insulin secretion | R-HSA-434313 | 6.992321e-01 | 0.155 | 0 | 0 |
| Integration of viral DNA into host genomic DNA | R-HSA-175567 | 6.992321e-01 | 0.155 | 0 | 0 |
| Abacavir transmembrane transport | R-HSA-2161517 | 6.992321e-01 | 0.155 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 6.992321e-01 | 0.155 | 0 | 0 |
| NADPH regeneration | R-HSA-389542 | 6.992321e-01 | 0.155 | 0 | 0 |
| Small interfering RNA (siRNA) biogenesis | R-HSA-426486 | 6.992321e-01 | 0.155 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 6.992321e-01 | 0.155 | 0 | 0 |
| VLDL assembly | R-HSA-8866423 | 6.992321e-01 | 0.155 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 7.004553e-01 | 0.155 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 7.004553e-01 | 0.155 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 7.039803e-01 | 0.152 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 7.039803e-01 | 0.152 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 7.058025e-01 | 0.151 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 7.067310e-01 | 0.151 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 7.067310e-01 | 0.151 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 7.067310e-01 | 0.151 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 7.067310e-01 | 0.151 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 7.119462e-01 | 0.148 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 7.119462e-01 | 0.148 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 7.151328e-01 | 0.146 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 7.151328e-01 | 0.146 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 7.158476e-01 | 0.145 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 7.160409e-01 | 0.145 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 7.201153e-01 | 0.143 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 7.201153e-01 | 0.143 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 7.201153e-01 | 0.143 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 7.201153e-01 | 0.143 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 7.201153e-01 | 0.143 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 7.201153e-01 | 0.143 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR4 | R-HSA-5654228 | 7.201153e-01 | 0.143 | 0 | 0 |
| FGFR3 ligand binding and activation | R-HSA-190239 | 7.201153e-01 | 0.143 | 0 | 0 |
| Lysosphingolipid and LPA receptors | R-HSA-419408 | 7.201153e-01 | 0.143 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 7.201153e-01 | 0.143 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 7.201153e-01 | 0.143 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 7.209760e-01 | 0.142 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 7.209760e-01 | 0.142 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 7.209760e-01 | 0.142 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 7.209760e-01 | 0.142 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 7.209760e-01 | 0.142 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 7.209760e-01 | 0.142 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 7.253275e-01 | 0.139 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 7.253568e-01 | 0.139 | 1 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 7.264511e-01 | 0.139 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 7.264511e-01 | 0.139 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 7.264511e-01 | 0.139 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 7.275755e-01 | 0.138 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 7.334904e-01 | 0.135 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 7.348951e-01 | 0.134 | 0 | 0 |
| RUNX1 regulates estrogen receptor mediated transcription | R-HSA-8931987 | 7.368283e-01 | 0.133 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 7.368283e-01 | 0.133 | 0 | 0 |
| PP2A-mediated dephosphorylation of key metabolic factors | R-HSA-163767 | 7.368283e-01 | 0.133 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 7.368283e-01 | 0.133 | 0 | 0 |
| Defective HLCS causes multiple carboxylase deficiency | R-HSA-3371599 | 7.368283e-01 | 0.133 | 0 | 0 |
| FGFR3b ligand binding and activation | R-HSA-190371 | 7.368283e-01 | 0.133 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 7.368283e-01 | 0.133 | 0 | 0 |
| Pre-NOTCH Processing in the Endoplasmic Reticulum | R-HSA-1912399 | 7.368283e-01 | 0.133 | 0 | 0 |
| mRNA Editing: C to U Conversion | R-HSA-72200 | 7.368283e-01 | 0.133 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 7.368283e-01 | 0.133 | 0 | 0 |
| Cysteine formation from homocysteine | R-HSA-1614603 | 7.368283e-01 | 0.133 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 7.368283e-01 | 0.133 | 0 | 0 |
| LDL remodeling | R-HSA-8964041 | 7.368283e-01 | 0.133 | 0 | 0 |
| Synthesis of PIPs in the nucleus | R-HSA-8847453 | 7.368283e-01 | 0.133 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 7.368283e-01 | 0.133 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 7.368283e-01 | 0.133 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 7.382954e-01 | 0.132 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 7.410495e-01 | 0.130 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 7.425093e-01 | 0.129 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 7.430324e-01 | 0.129 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 7.451644e-01 | 0.128 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 7.451644e-01 | 0.128 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 7.458638e-01 | 0.127 | 0 | 0 |
| Atorvastatin ADME | R-HSA-9754706 | 7.458638e-01 | 0.127 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 7.458638e-01 | 0.127 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 7.458638e-01 | 0.127 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 7.487001e-01 | 0.126 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 7.487001e-01 | 0.126 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 7.501461e-01 | 0.125 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 7.501461e-01 | 0.125 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 7.501461e-01 | 0.125 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 7.501461e-01 | 0.125 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 7.501461e-01 | 0.125 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 7.501461e-01 | 0.125 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 7.501461e-01 | 0.125 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 7.501461e-01 | 0.125 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 7.624877e-01 | 0.118 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 7.626972e-01 | 0.118 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 7.626972e-01 | 0.118 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 7.626972e-01 | 0.118 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 7.650476e-01 | 0.116 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 7.660147e-01 | 0.116 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 7.695506e-01 | 0.114 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 7.695506e-01 | 0.114 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 7.695506e-01 | 0.114 | 0 | 0 |
| Passive transport by Aquaporins | R-HSA-432047 | 7.695506e-01 | 0.114 | 0 | 0 |
| Galactose catabolism | R-HSA-70370 | 7.695506e-01 | 0.114 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) | R-HSA-400511 | 7.695506e-01 | 0.114 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 7.695506e-01 | 0.114 | 0 | 0 |
| Response to metal ions | R-HSA-5660526 | 7.695506e-01 | 0.114 | 0 | 0 |
| Reverse Transcription of HIV RNA | R-HSA-162589 | 7.697268e-01 | 0.114 | 0 | 0 |
| Minus-strand DNA synthesis | R-HSA-164516 | 7.697268e-01 | 0.114 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 7.697268e-01 | 0.114 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 7.697268e-01 | 0.114 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 7.697268e-01 | 0.114 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 7.697268e-01 | 0.114 | 0 | 0 |
| Highly calcium permeable nicotinic acetylcholine receptors | R-HSA-629597 | 7.697268e-01 | 0.114 | 0 | 0 |
| Regulation by c-FLIP | R-HSA-3371378 | 7.697268e-01 | 0.114 | 0 | 0 |
| Fructose biosynthesis | R-HSA-5652227 | 7.697268e-01 | 0.114 | 0 | 0 |
| Co-stimulation by ICOS | R-HSA-9927354 | 7.697268e-01 | 0.114 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 7.697268e-01 | 0.114 | 1 | 1 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 7.697268e-01 | 0.114 | 0 | 0 |
| Dimerization of procaspase-8 | R-HSA-69416 | 7.697268e-01 | 0.114 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 7.697268e-01 | 0.114 | 0 | 0 |
| Alpha-defensins | R-HSA-1462054 | 7.697268e-01 | 0.114 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 7.697268e-01 | 0.114 | 0 | 0 |
| Interleukin-23 signaling | R-HSA-9020933 | 7.697268e-01 | 0.114 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 7.754393e-01 | 0.110 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 7.755894e-01 | 0.110 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 7.761238e-01 | 0.110 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 7.783930e-01 | 0.109 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 7.784271e-01 | 0.109 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 7.796289e-01 | 0.108 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 7.796289e-01 | 0.108 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 7.810724e-01 | 0.107 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 7.811065e-01 | 0.107 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 7.811065e-01 | 0.107 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 7.811065e-01 | 0.107 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 7.815801e-01 | 0.107 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 7.815801e-01 | 0.107 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 7.891348e-01 | 0.103 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 7.906205e-01 | 0.102 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 7.912887e-01 | 0.102 | 0 | 0 |
| Phospholipase C-mediated cascade: FGFR1 | R-HSA-5654219 | 7.912887e-01 | 0.102 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 7.912887e-01 | 0.102 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 7.912887e-01 | 0.102 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 7.954219e-01 | 0.099 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 7.954219e-01 | 0.099 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 7.954219e-01 | 0.099 | 0 | 0 |
| Estrogen-stimulated signaling through PRKCZ | R-HSA-9634635 | 7.985145e-01 | 0.098 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 7.985145e-01 | 0.098 | 0 | 0 |
| CASP8 activity is inhibited | R-HSA-5218900 | 7.985145e-01 | 0.098 | 0 | 0 |
| Defects in biotin (Btn) metabolism | R-HSA-3323169 | 7.985145e-01 | 0.098 | 0 | 0 |
| Toxicity of botulinum toxin type A (botA) | R-HSA-5250968 | 7.985145e-01 | 0.098 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 7.985145e-01 | 0.098 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 7.985145e-01 | 0.098 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 7.985145e-01 | 0.098 | 0 | 0 |
| MAPK1 (ERK2) activation | R-HSA-112411 | 7.985145e-01 | 0.098 | 0 | 0 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 7.985145e-01 | 0.098 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 7.985145e-01 | 0.098 | 0 | 0 |
| Regulation of NPAS4 gene transcription | R-HSA-9768777 | 7.985145e-01 | 0.098 | 0 | 0 |
| Zinc influx into cells by the SLC39 gene family | R-HSA-442380 | 7.985145e-01 | 0.098 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 7.985145e-01 | 0.098 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 7.992043e-01 | 0.097 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 7.992043e-01 | 0.097 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 7.992043e-01 | 0.097 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 8.027141e-01 | 0.095 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 8.055281e-01 | 0.094 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 8.090163e-01 | 0.092 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 8.099355e-01 | 0.092 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 8.105546e-01 | 0.091 | 0 | 0 |
| Activated point mutants of FGFR2 | R-HSA-2033519 | 8.111952e-01 | 0.091 | 0 | 0 |
| Vitamin D (calciferol) metabolism | R-HSA-196791 | 8.111952e-01 | 0.091 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 8.146591e-01 | 0.089 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 8.150713e-01 | 0.089 | 1 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 8.150713e-01 | 0.089 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 8.156204e-01 | 0.089 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 8.156204e-01 | 0.089 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 8.211157e-01 | 0.086 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 8.218288e-01 | 0.085 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 8.218288e-01 | 0.085 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 8.218693e-01 | 0.085 | 0 | 0 |
| DNA replication initiation | R-HSA-68952 | 8.237047e-01 | 0.084 | 0 | 0 |
| Highly calcium permeable postsynaptic nicotinic acetylcholine receptors | R-HSA-629594 | 8.237047e-01 | 0.084 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 8.237047e-01 | 0.084 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 8.237047e-01 | 0.084 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 8.237047e-01 | 0.084 | 0 | 0 |
| Formation of intermediate mesoderm | R-HSA-9761174 | 8.237047e-01 | 0.084 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 8.237047e-01 | 0.084 | 0 | 0 |
| Maturation of spike protein | R-HSA-9683686 | 8.237047e-01 | 0.084 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 8.237047e-01 | 0.084 | 0 | 0 |
| Metal sequestration by antimicrobial proteins | R-HSA-6799990 | 8.237047e-01 | 0.084 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 8.237047e-01 | 0.084 | 0 | 0 |
| Tandem pore domain potassium channels | R-HSA-1296346 | 8.237047e-01 | 0.084 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 8.242626e-01 | 0.084 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 8.242626e-01 | 0.084 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 8.258325e-01 | 0.083 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 8.258325e-01 | 0.083 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 8.293880e-01 | 0.081 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 8.293880e-01 | 0.081 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 8.293880e-01 | 0.081 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 8.308821e-01 | 0.080 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 8.308821e-01 | 0.080 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 8.331239e-01 | 0.079 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 8.340145e-01 | 0.079 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 8.340145e-01 | 0.079 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 8.353087e-01 | 0.078 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 8.373719e-01 | 0.077 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 8.450452e-01 | 0.073 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 8.450452e-01 | 0.073 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 8.450452e-01 | 0.073 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 8.454742e-01 | 0.073 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 8.457468e-01 | 0.073 | 0 | 0 |
| FGFRL1 modulation of FGFR1 signaling | R-HSA-5658623 | 8.457468e-01 | 0.073 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 8.457468e-01 | 0.073 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 8.457468e-01 | 0.073 | 0 | 0 |
| Cholesterol biosynthesis via desmosterol | R-HSA-6807047 | 8.457468e-01 | 0.073 | 0 | 0 |
| Transport of RCbl within the body | R-HSA-9758890 | 8.457468e-01 | 0.073 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 8.457468e-01 | 0.073 | 0 | 0 |
| LGI-ADAM interactions | R-HSA-5682910 | 8.457468e-01 | 0.073 | 0 | 0 |
| SARS-CoV-2 modulates autophagy | R-HSA-9754560 | 8.457468e-01 | 0.073 | 0 | 0 |
| Synthesis of PIPs at the ER membrane | R-HSA-1483248 | 8.457468e-01 | 0.073 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 8.457468e-01 | 0.073 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 8.459845e-01 | 0.073 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR2 | R-HSA-5654221 | 8.459845e-01 | 0.073 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 8.459845e-01 | 0.073 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 8.459845e-01 | 0.073 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 8.459845e-01 | 0.073 | 0 | 0 |
| Pregnenolone biosynthesis | R-HSA-196108 | 8.459845e-01 | 0.073 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 8.459845e-01 | 0.073 | 0 | 0 |
| Eicosanoid ligand-binding receptors | R-HSA-391903 | 8.459845e-01 | 0.073 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 8.509721e-01 | 0.070 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 8.533325e-01 | 0.069 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 8.536231e-01 | 0.069 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 8.562719e-01 | 0.067 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 8.562719e-01 | 0.067 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 8.581667e-01 | 0.066 | 0 | 0 |
| G-protein activation | R-HSA-202040 | 8.610994e-01 | 0.065 | 0 | 0 |
| FGFR2 ligand binding and activation | R-HSA-190241 | 8.610994e-01 | 0.065 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 8.610994e-01 | 0.065 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 8.610994e-01 | 0.065 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 8.610994e-01 | 0.065 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 8.610994e-01 | 0.065 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 8.610994e-01 | 0.065 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 8.623493e-01 | 0.064 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 8.623493e-01 | 0.064 | 0 | 0 |
| Immune System | R-HSA-168256 | 8.637278e-01 | 0.064 | 1 | 0 |
| Presynaptic nicotinic acetylcholine receptors | R-HSA-622323 | 8.650342e-01 | 0.063 | 0 | 0 |
| Endosomal/Vacuolar pathway | R-HSA-1236977 | 8.650342e-01 | 0.063 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 8.650342e-01 | 0.063 | 0 | 0 |
| Sodium/Calcium exchangers | R-HSA-425561 | 8.650342e-01 | 0.063 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 8.664321e-01 | 0.062 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 8.664321e-01 | 0.062 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 8.703036e-01 | 0.060 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 8.703036e-01 | 0.060 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 8.718630e-01 | 0.060 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 8.718630e-01 | 0.060 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 8.726538e-01 | 0.059 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 8.726538e-01 | 0.059 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 8.748436e-01 | 0.058 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 8.759798e-01 | 0.058 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 8.764755e-01 | 0.057 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 8.782425e-01 | 0.056 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 8.819109e-01 | 0.055 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 8.819109e-01 | 0.055 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 8.819109e-01 | 0.055 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 8.819109e-01 | 0.055 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 8.819109e-01 | 0.055 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 8.819109e-01 | 0.055 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 8.819109e-01 | 0.055 | 0 | 0 |
| Trafficking and processing of endosomal TLR | R-HSA-1679131 | 8.819109e-01 | 0.055 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 8.819109e-01 | 0.055 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 8.819109e-01 | 0.055 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 8.852971e-01 | 0.053 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 8.872656e-01 | 0.052 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 8.873235e-01 | 0.052 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 8.873235e-01 | 0.052 | 0 | 0 |
| Free fatty acid receptors | R-HSA-444209 | 8.873235e-01 | 0.052 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 8.873235e-01 | 0.052 | 0 | 0 |
| Fructose metabolism | R-HSA-5652084 | 8.873235e-01 | 0.052 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 8.873235e-01 | 0.052 | 0 | 0 |
| Cholesterol biosynthesis via lathosterol | R-HSA-6807062 | 8.873235e-01 | 0.052 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 8.911837e-01 | 0.050 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 8.911837e-01 | 0.050 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 8.918508e-01 | 0.050 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 8.919676e-01 | 0.050 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 8.942007e-01 | 0.049 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 8.963680e-01 | 0.048 | 0 | 0 |
| Acetylcholine binding and downstream events | R-HSA-181431 | 8.966781e-01 | 0.047 | 0 | 0 |
| Postsynaptic nicotinic acetylcholine receptors | R-HSA-622327 | 8.966781e-01 | 0.047 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 8.966781e-01 | 0.047 | 0 | 0 |
| Diseases of nucleotide metabolism | R-HSA-9735804 | 8.966781e-01 | 0.047 | 0 | 0 |
| Mtb iron assimilation by chelation | R-HSA-1222449 | 8.966781e-01 | 0.047 | 0 | 0 |
| Reversible hydration of carbon dioxide | R-HSA-1475029 | 8.966781e-01 | 0.047 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 8.966781e-01 | 0.047 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 8.966781e-01 | 0.047 | 0 | 0 |
| Acyl chain remodeling of DAG and TAG | R-HSA-1482883 | 8.966781e-01 | 0.047 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 8.968212e-01 | 0.047 | 1 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 8.968838e-01 | 0.047 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 8.986404e-01 | 0.046 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 8.986404e-01 | 0.046 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 8.986404e-01 | 0.046 | 0 | 0 |
| Synthesis of pyrophosphates in the cytosol | R-HSA-1855167 | 8.986404e-01 | 0.046 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 8.986404e-01 | 0.046 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 8.998503e-01 | 0.046 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 9.007195e-01 | 0.045 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 9.012055e-01 | 0.045 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 9.012055e-01 | 0.045 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 9.013720e-01 | 0.045 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 9.039389e-01 | 0.044 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 9.040322e-01 | 0.044 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 9.088898e-01 | 0.041 | 0 | 0 |
| Synthesis of dolichyl-phosphate | R-HSA-446199 | 9.088898e-01 | 0.041 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 9.088898e-01 | 0.041 | 0 | 0 |
| TNFs bind their physiological receptors | R-HSA-5669034 | 9.088898e-01 | 0.041 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 9.088898e-01 | 0.041 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 9.095994e-01 | 0.041 | 0 | 0 |
| Synthesis of IPs in the nucleus | R-HSA-1855191 | 9.095994e-01 | 0.041 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 9.095994e-01 | 0.041 | 0 | 0 |
| N-glycan trimming and elongation in the cis-Golgi | R-HSA-964739 | 9.095994e-01 | 0.041 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 9.095994e-01 | 0.041 | 0 | 0 |
| Prolactin receptor signaling | R-HSA-1170546 | 9.095994e-01 | 0.041 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 9.095994e-01 | 0.041 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 9.095994e-01 | 0.041 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 9.095994e-01 | 0.041 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 9.095994e-01 | 0.041 | 0 | 0 |
| P2Y receptors | R-HSA-417957 | 9.095994e-01 | 0.041 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 9.101297e-01 | 0.041 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 9.101297e-01 | 0.041 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 9.101297e-01 | 0.041 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 9.147798e-01 | 0.039 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 9.170546e-01 | 0.038 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 9.181617e-01 | 0.037 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 9.181617e-01 | 0.037 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 9.181617e-01 | 0.037 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 9.181617e-01 | 0.037 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 9.181617e-01 | 0.037 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 9.181753e-01 | 0.037 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 9.183489e-01 | 0.037 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 9.198927e-01 | 0.036 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 9.209055e-01 | 0.036 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 9.209055e-01 | 0.036 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 9.209055e-01 | 0.036 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 9.209055e-01 | 0.036 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 9.209055e-01 | 0.036 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 9.209055e-01 | 0.036 | 0 | 0 |
| Transport and metabolism of PAPS | R-HSA-174362 | 9.209055e-01 | 0.036 | 0 | 0 |
| Biotin transport and metabolism | R-HSA-196780 | 9.209055e-01 | 0.036 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 9.209055e-01 | 0.036 | 0 | 0 |
| Dopamine clearance from the synaptic cleft | R-HSA-379401 | 9.209055e-01 | 0.036 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 9.222982e-01 | 0.035 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 9.222982e-01 | 0.035 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 9.255580e-01 | 0.034 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 9.255580e-01 | 0.034 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 9.255580e-01 | 0.034 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 9.265403e-01 | 0.033 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 9.265403e-01 | 0.033 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 9.265403e-01 | 0.033 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 9.275537e-01 | 0.033 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 9.278225e-01 | 0.033 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 9.287098e-01 | 0.032 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 9.290883e-01 | 0.032 | 0 | 0 |
| Activation of the phototransduction cascade | R-HSA-2485179 | 9.307981e-01 | 0.031 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 9.307981e-01 | 0.031 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 9.307981e-01 | 0.031 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 9.307981e-01 | 0.031 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 9.307981e-01 | 0.031 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 9.307981e-01 | 0.031 | 0 | 0 |
| Fructose catabolism | R-HSA-70350 | 9.307981e-01 | 0.031 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 9.307981e-01 | 0.031 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 9.307981e-01 | 0.031 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 9.315781e-01 | 0.031 | 1 | 1 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 9.323248e-01 | 0.030 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 9.341039e-01 | 0.030 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 9.341039e-01 | 0.030 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 9.341039e-01 | 0.030 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 9.341039e-01 | 0.030 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 9.341039e-01 | 0.030 | 0 | 0 |
| ER Quality Control Compartment (ERQC) | R-HSA-901032 | 9.341039e-01 | 0.030 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 9.341039e-01 | 0.030 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 9.385206e-01 | 0.028 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 9.385206e-01 | 0.028 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 9.394539e-01 | 0.027 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 9.394539e-01 | 0.027 | 0 | 0 |
| Scavenging by Class B Receptors | R-HSA-3000471 | 9.394539e-01 | 0.027 | 0 | 0 |
| Vitamin B6 activation to pyridoxal phosphate | R-HSA-964975 | 9.394539e-01 | 0.027 | 0 | 0 |
| Biosynthesis of maresin-like SPMs | R-HSA-9027307 | 9.394539e-01 | 0.027 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 9.394539e-01 | 0.027 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 9.409253e-01 | 0.026 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 9.409253e-01 | 0.026 | 0 | 0 |
| Prednisone ADME | R-HSA-9757110 | 9.409253e-01 | 0.026 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.436987e-01 | 0.025 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 9.441878e-01 | 0.025 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 9.441878e-01 | 0.025 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 9.441878e-01 | 0.025 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 9.464423e-01 | 0.024 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 9.470275e-01 | 0.024 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 9.470275e-01 | 0.024 | 0 | 0 |
| Metabolism of ingested H2SeO4 and H2SeO3 into H2Se | R-HSA-2408550 | 9.470275e-01 | 0.024 | 0 | 0 |
| Sulfide oxidation to sulfate | R-HSA-1614517 | 9.470275e-01 | 0.024 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 9.470275e-01 | 0.024 | 0 | 0 |
| GDP-fucose biosynthesis | R-HSA-6787639 | 9.470275e-01 | 0.024 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 9.470717e-01 | 0.024 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 9.470717e-01 | 0.024 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 9.470717e-01 | 0.024 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 9.493663e-01 | 0.023 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 9.493663e-01 | 0.023 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 9.520046e-01 | 0.021 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 9.526053e-01 | 0.021 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 9.526053e-01 | 0.021 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 9.533565e-01 | 0.021 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 9.536541e-01 | 0.021 | 1 | 1 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 9.536541e-01 | 0.021 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 9.536541e-01 | 0.021 | 0 | 0 |
| Cytosolic iron-sulfur cluster assembly | R-HSA-2564830 | 9.536541e-01 | 0.021 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 9.536541e-01 | 0.021 | 0 | 0 |
| Nucleotide-like (purinergic) receptors | R-HSA-418038 | 9.536541e-01 | 0.021 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 9.540940e-01 | 0.020 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 9.540940e-01 | 0.020 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.540940e-01 | 0.020 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 9.541363e-01 | 0.020 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.551946e-01 | 0.020 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 9.575831e-01 | 0.019 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 9.575831e-01 | 0.019 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 9.584062e-01 | 0.018 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 9.584062e-01 | 0.018 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 9.584062e-01 | 0.018 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 9.584062e-01 | 0.018 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 9.584062e-01 | 0.018 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 9.584062e-01 | 0.018 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 9.594521e-01 | 0.018 | 0 | 0 |
| Methionine salvage pathway | R-HSA-1237112 | 9.594521e-01 | 0.018 | 0 | 0 |
| HDL remodeling | R-HSA-8964058 | 9.594521e-01 | 0.018 | 0 | 0 |
| Strand-asynchronous mitochondrial DNA replication | R-HSA-9913635 | 9.594521e-01 | 0.018 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 9.594521e-01 | 0.018 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 9.613862e-01 | 0.017 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 9.615362e-01 | 0.017 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 9.623360e-01 | 0.017 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 9.623360e-01 | 0.017 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 9.644988e-01 | 0.016 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 9.645250e-01 | 0.016 | 0 | 0 |
| Creatine metabolism | R-HSA-71288 | 9.645250e-01 | 0.016 | 0 | 0 |
| Keratan sulfate degradation | R-HSA-2022857 | 9.645250e-01 | 0.016 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 9.645250e-01 | 0.016 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 9.659144e-01 | 0.015 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 9.659144e-01 | 0.015 | 0 | 0 |
| Defective B3GALTL causes PpS | R-HSA-5083635 | 9.660768e-01 | 0.015 | 0 | 0 |
| Diseases associated with glycosylation precursor biosynthesis | R-HSA-5609975 | 9.660768e-01 | 0.015 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 9.689635e-01 | 0.014 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 9.691703e-01 | 0.014 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 9.691703e-01 | 0.014 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 9.696845e-01 | 0.013 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 9.698070e-01 | 0.013 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 9.702774e-01 | 0.013 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 9.709570e-01 | 0.013 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.717759e-01 | 0.012 | 1 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 9.721304e-01 | 0.012 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 9.721304e-01 | 0.012 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 9.721304e-01 | 0.012 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.721780e-01 | 0.012 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 9.728469e-01 | 0.012 | 0 | 0 |
| Molybdenum cofactor biosynthesis | R-HSA-947581 | 9.728469e-01 | 0.012 | 0 | 0 |
| Glutathione synthesis and recycling | R-HSA-174403 | 9.728469e-01 | 0.012 | 0 | 0 |
| Ribavirin ADME | R-HSA-9755088 | 9.728469e-01 | 0.012 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 9.728469e-01 | 0.012 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 9.729208e-01 | 0.012 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.735388e-01 | 0.012 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.735812e-01 | 0.012 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 9.736048e-01 | 0.012 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 9.748197e-01 | 0.011 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 9.748197e-01 | 0.011 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.750523e-01 | 0.011 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 9.758221e-01 | 0.011 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 9.762446e-01 | 0.010 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 9.762446e-01 | 0.010 | 0 | 0 |
| Neurotoxicity of clostridium toxins | R-HSA-168799 | 9.762446e-01 | 0.010 | 0 | 0 |
| Ethanol oxidation | R-HSA-71384 | 9.762446e-01 | 0.010 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 9.762446e-01 | 0.010 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 9.776236e-01 | 0.010 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 9.780696e-01 | 0.010 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 9.784215e-01 | 0.009 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 9.784215e-01 | 0.009 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 9.784215e-01 | 0.009 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 9.785394e-01 | 0.009 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 9.792174e-01 | 0.009 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 9.792174e-01 | 0.009 | 0 | 0 |
| Biosynthesis of maresins | R-HSA-9018682 | 9.792174e-01 | 0.009 | 0 | 0 |
| Interleukin-20 family signaling | R-HSA-8854691 | 9.792174e-01 | 0.009 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 9.800507e-01 | 0.009 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 9.803543e-01 | 0.009 | 0 | 0 |
| O-glycosylation of TSR domain-containing proteins | R-HSA-5173214 | 9.807491e-01 | 0.008 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 9.807491e-01 | 0.008 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 9.807491e-01 | 0.008 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 9.807491e-01 | 0.008 | 0 | 0 |
| NCAM1 interactions | R-HSA-419037 | 9.807491e-01 | 0.008 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 9.807491e-01 | 0.008 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 9.818182e-01 | 0.008 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 9.818182e-01 | 0.008 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 9.818619e-01 | 0.008 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.818619e-01 | 0.008 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.822610e-01 | 0.008 | 0 | 0 |
| Purine salvage | R-HSA-74217 | 9.828323e-01 | 0.008 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 9.830325e-01 | 0.007 | 1 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 9.833038e-01 | 0.007 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 9.835167e-01 | 0.007 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 9.840937e-01 | 0.007 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 9.840937e-01 | 0.007 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 9.846958e-01 | 0.007 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.849205e-01 | 0.007 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.849205e-01 | 0.007 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 9.849514e-01 | 0.007 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 9.849514e-01 | 0.007 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 9.857970e-01 | 0.006 | 0 | 0 |
| Urea cycle | R-HSA-70635 | 9.860846e-01 | 0.006 | 0 | 0 |
| Abacavir ADME | R-HSA-2161522 | 9.860846e-01 | 0.006 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 9.864424e-01 | 0.006 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 9.874537e-01 | 0.005 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 9.877910e-01 | 0.005 | 0 | 0 |
| Triglyceride biosynthesis | R-HSA-75109 | 9.878263e-01 | 0.005 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 9.878263e-01 | 0.005 | 0 | 0 |
| Synthesis of PE | R-HSA-1483213 | 9.878263e-01 | 0.005 | 0 | 0 |
| Synthesis of bile acids and bile salts via 27-hydroxycholesterol | R-HSA-193807 | 9.878263e-01 | 0.005 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 9.878508e-01 | 0.005 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.892315e-01 | 0.005 | 0 | 0 |
| Pyrimidine salvage | R-HSA-73614 | 9.893502e-01 | 0.005 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 9.898543e-01 | 0.004 | 0 | 0 |
| Metabolism of steroid hormones | R-HSA-196071 | 9.898543e-01 | 0.004 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 9.899648e-01 | 0.004 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 9.903682e-01 | 0.004 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.906630e-01 | 0.004 | 0 | 0 |
| Thyroxine biosynthesis | R-HSA-209968 | 9.906834e-01 | 0.004 | 0 | 0 |
| Activation of Matrix Metalloproteinases | R-HSA-1592389 | 9.906834e-01 | 0.004 | 0 | 0 |
| Regulation of pyruvate dehydrogenase (PDH) complex | R-HSA-204174 | 9.906834e-01 | 0.004 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.908094e-01 | 0.004 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 9.914280e-01 | 0.004 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 9.915760e-01 | 0.004 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 9.918497e-01 | 0.004 | 0 | 0 |
| Mucopolysaccharidoses | R-HSA-2206281 | 9.918497e-01 | 0.004 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 9.923734e-01 | 0.003 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 9.928701e-01 | 0.003 | 0 | 0 |
| Synthesis of glycosylphosphatidylinositol (GPI) | R-HSA-162710 | 9.928701e-01 | 0.003 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.929576e-01 | 0.003 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 9.932166e-01 | 0.003 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 9.932166e-01 | 0.003 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 9.932402e-01 | 0.003 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 9.935434e-01 | 0.003 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 9.935434e-01 | 0.003 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 9.937628e-01 | 0.003 | 0 | 0 |
| HS-GAG degradation | R-HSA-2024096 | 9.937628e-01 | 0.003 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.938214e-01 | 0.003 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 9.942014e-01 | 0.003 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 9.942014e-01 | 0.003 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 9.945095e-01 | 0.002 | 0 | 0 |
| Recycling of bile acids and salts | R-HSA-159418 | 9.945438e-01 | 0.002 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.946381e-01 | 0.002 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 9.947941e-01 | 0.002 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.949470e-01 | 0.002 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 9.952270e-01 | 0.002 | 0 | 0 |
| Glutamate and glutamine metabolism | R-HSA-8964539 | 9.952270e-01 | 0.002 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 9.952270e-01 | 0.002 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 9.952348e-01 | 0.002 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.953697e-01 | 0.002 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.954044e-01 | 0.002 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.955028e-01 | 0.002 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.955028e-01 | 0.002 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 9.958247e-01 | 0.002 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 9.958247e-01 | 0.002 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 9.958247e-01 | 0.002 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 9.963476e-01 | 0.002 | 0 | 0 |
| Defects in vitamin and cofactor metabolism | R-HSA-3296482 | 9.963476e-01 | 0.002 | 0 | 0 |
| Metabolism of ingested SeMet, Sec, MeSec into H2Se | R-HSA-2408508 | 9.963476e-01 | 0.002 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 9.966168e-01 | 0.001 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 9.966350e-01 | 0.001 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 9.966602e-01 | 0.001 | 1 | 1 |
| Infectious disease | R-HSA-5663205 | 9.967149e-01 | 0.001 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 9.968050e-01 | 0.001 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.969788e-01 | 0.001 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.970170e-01 | 0.001 | 0 | 0 |
| SLC-mediated transport of organic cations | R-HSA-549127 | 9.972052e-01 | 0.001 | 0 | 0 |
| Beta-oxidation of very long chain fatty acids | R-HSA-390247 | 9.972052e-01 | 0.001 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 9.972052e-01 | 0.001 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 9.975552e-01 | 0.001 | 0 | 0 |
| alpha-linolenic acid (ALA) metabolism | R-HSA-2046106 | 9.975552e-01 | 0.001 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 9.975552e-01 | 0.001 | 0 | 0 |
| Translation | R-HSA-72766 | 9.977704e-01 | 0.001 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 9.978615e-01 | 0.001 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 9.978615e-01 | 0.001 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 9.978615e-01 | 0.001 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.978884e-01 | 0.001 | 0 | 0 |
| Maturation of TCA enzymes and regulation of TCA cycle | R-HSA-9854311 | 9.981294e-01 | 0.001 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 9.982598e-01 | 0.001 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.982598e-01 | 0.001 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.983509e-01 | 0.001 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.983542e-01 | 0.001 | 0 | 0 |
| Aflatoxin activation and detoxification | R-HSA-5423646 | 9.983637e-01 | 0.001 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.983696e-01 | 0.001 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.984072e-01 | 0.001 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 9.985687e-01 | 0.001 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.986775e-01 | 0.001 | 0 | 0 |
| Disease | R-HSA-1643685 | 9.986906e-01 | 0.001 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 9.987183e-01 | 0.001 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 9.988096e-01 | 0.001 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.988639e-01 | 0.000 | 0 | 0 |
| Defensins | R-HSA-1461973 | 9.989049e-01 | 0.000 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 9.989335e-01 | 0.000 | 0 | 0 |
| Endogenous sterols | R-HSA-211976 | 9.989932e-01 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.990001e-01 | 0.000 | 0 | 0 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | R-HSA-196741 | 9.990421e-01 | 0.000 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.991156e-01 | 0.000 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 9.991334e-01 | 0.000 | 0 | 0 |
| Diseases associated with glycosaminoglycan metabolism | R-HSA-3560782 | 9.991622e-01 | 0.000 | 0 | 0 |
| Degradation of cysteine and homocysteine | R-HSA-1614558 | 9.991622e-01 | 0.000 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.992097e-01 | 0.000 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 9.993000e-01 | 0.000 | 0 | 0 |
| Xenobiotics | R-HSA-211981 | 9.993000e-01 | 0.000 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 9.993590e-01 | 0.000 | 0 | 0 |
| alpha-linolenic (omega3) and linoleic (omega6) acid metabolism | R-HSA-2046104 | 9.993590e-01 | 0.000 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 9.994339e-01 | 0.000 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.994437e-01 | 0.000 | 0 | 0 |
| Keratan sulfate/keratin metabolism | R-HSA-1638074 | 9.995096e-01 | 0.000 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.995096e-01 | 0.000 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.995141e-01 | 0.000 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 9.995711e-01 | 0.000 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 9.996074e-01 | 0.000 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.996249e-01 | 0.000 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.996631e-01 | 0.000 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.996631e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid catabolism | R-HSA-9840310 | 9.996631e-01 | 0.000 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.996926e-01 | 0.000 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.997019e-01 | 0.000 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.997019e-01 | 0.000 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.997019e-01 | 0.000 | 0 | 0 |
| Sulfur amino acid metabolism | R-HSA-1614635 | 9.997145e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.997346e-01 | 0.000 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.997473e-01 | 0.000 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.997668e-01 | 0.000 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.997805e-01 | 0.000 | 0 | 0 |
| Metabolism of amine-derived hormones | R-HSA-209776 | 9.998080e-01 | 0.000 | 0 | 0 |
| Digestion | R-HSA-8935690 | 9.998080e-01 | 0.000 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.998176e-01 | 0.000 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 9.998176e-01 | 0.000 | 0 | 0 |
| Heparan sulfate/heparin (HS-GAG) metabolism | R-HSA-1638091 | 9.998716e-01 | 0.000 | 0 | 0 |
| Sialic acid metabolism | R-HSA-4085001 | 9.998716e-01 | 0.000 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 9.998740e-01 | 0.000 | 1 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.998740e-01 | 0.000 | 0 | 0 |
| Glutathione conjugation | R-HSA-156590 | 9.998877e-01 | 0.000 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.998877e-01 | 0.000 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 9.999184e-01 | 0.000 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.999230e-01 | 0.000 | 0 | 0 |
| Digestion and absorption | R-HSA-8963743 | 9.999249e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.999252e-01 | 0.000 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.999289e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.999289e-01 | 0.000 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.999292e-01 | 0.000 | 0 | 0 |
| Latent infection - Other responses of Mtb to phagocytosis | R-HSA-1222499 | 9.999425e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.999437e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.999451e-01 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.999473e-01 | 0.000 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.999560e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | R-HSA-193368 | 9.999560e-01 | 0.000 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.999574e-01 | 0.000 | 0 | 0 |
| Class C/3 (Metabotropic glutamate/pheromone receptors) | R-HSA-420499 | 9.999678e-01 | 0.000 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.999687e-01 | 0.000 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 9.999775e-01 | 0.000 | 0 | 0 |
| Aspirin ADME | R-HSA-9749641 | 9.999803e-01 | 0.000 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.999848e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.999863e-01 | 0.000 | 0 | 0 |
| Sensory perception of sweet, bitter, and umami (glutamate) taste | R-HSA-9717207 | 9.999869e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.999892e-01 | 0.000 | 0 | 0 |
| Metabolic disorders of biological oxidation enzymes | R-HSA-5579029 | 9.999912e-01 | 0.000 | 0 | 0 |
| Biosynthesis of DHA-derived SPMs | R-HSA-9018677 | 9.999933e-01 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.999934e-01 | 0.000 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 9.999955e-01 | 0.000 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.999958e-01 | 0.000 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 9.999958e-01 | 0.000 | 0 | 0 |
| Synthesis of substrates in N-glycan biosythesis | R-HSA-446219 | 9.999958e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.999964e-01 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.999969e-01 | 0.000 | 0 | 0 |
| Post-translational modification: synthesis of GPI-anchored proteins | R-HSA-163125 | 9.999970e-01 | 0.000 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.999982e-01 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.999983e-01 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 9.999994e-01 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.999998e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 9.999998e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid metabolism | R-HSA-1660662 | 9.999998e-01 | 0.000 | 0 | 0 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | R-HSA-446193 | 9.999998e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 1.000000e+00 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 1.000000e+00 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 1.000000e+00 | 0.000 | 0 | 0 |
| Regulation of Complement cascade | R-HSA-977606 | 1.000000e+00 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 1.000000e+00 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 1.000000e+00 | 0.000 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 1.000000e+00 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 1.000000e+00 | 0.000 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 1.000000e+00 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 1.000000e+00 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biosynthesis of specialized proresolving mediators (SPMs) | R-HSA-9018678 | 1.000000e+00 | 0.000 | 0 | 0 |
| Complement cascade | R-HSA-166658 | 1.000000e+00 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 1.000000e+00 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 1.000000e+00 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 1.000000e+00 | 0.000 | 0 | 0 |
| Expression and translocation of olfactory receptors | R-HSA-9752946 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Olfactory Signaling Pathway | R-HSA-381753 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | -0.000 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 1.000000e+00 | 0.000 | 1 | 1 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 1.000000e+00 | 0.000 | 1 | 1 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 1.110223e-16 | 15.955 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 1.110223e-16 | 15.955 | 0 | 0 |
| M Phase | R-HSA-68886 | 1.110223e-16 | 15.955 | 1 | 0 |
| Axon guidance | R-HSA-422475 | 1.110223e-16 | 15.955 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 1.110223e-16 | 15.955 | 1 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 1.110223e-16 | 15.955 | 1 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 1.110223e-16 | 15.955 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 1.110223e-16 | 15.955 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 2.220446e-16 | 15.654 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 4.440892e-16 | 15.353 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 1.443290e-15 | 14.841 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 1.443290e-15 | 14.841 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 1.665335e-15 | 14.778 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 5.218048e-15 | 14.282 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 7.327472e-15 | 14.135 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 9.769963e-15 | 14.010 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 9.547918e-15 | 14.020 | 1 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 3.663736e-14 | 13.436 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 4.507505e-14 | 13.346 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 1.564304e-13 | 12.806 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 2.087219e-13 | 12.680 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 2.615685e-13 | 12.582 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 2.901013e-13 | 12.537 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 7.941425e-13 | 12.100 | 1 | 0 |
| Influenza Infection | R-HSA-168255 | 8.695267e-13 | 12.061 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 1.751932e-12 | 11.756 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 2.005951e-12 | 11.698 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 2.253420e-12 | 11.647 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 2.253420e-12 | 11.647 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 2.903788e-12 | 11.537 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 3.306244e-12 | 11.481 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 4.052869e-12 | 11.392 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 8.459122e-12 | 11.073 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 1.305789e-11 | 10.884 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 1.516109e-11 | 10.819 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 3.388612e-11 | 10.470 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 3.685363e-11 | 10.434 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 5.859457e-11 | 10.232 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 6.870982e-11 | 10.163 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 1.343483e-10 | 9.872 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 1.547190e-10 | 9.810 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 3.177306e-10 | 9.498 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 3.275910e-10 | 9.485 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 3.208549e-10 | 9.494 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 4.505706e-10 | 9.346 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 4.937356e-10 | 9.307 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 6.835499e-10 | 9.165 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 1.066939e-09 | 8.972 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 1.071874e-09 | 8.970 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 1.128456e-09 | 8.948 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 1.375581e-09 | 8.862 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 1.448300e-09 | 8.839 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 1.579185e-09 | 8.802 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 1.985037e-09 | 8.702 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 2.211594e-09 | 8.655 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 2.553697e-09 | 8.593 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 4.168168e-09 | 8.380 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 4.349222e-09 | 8.362 | 1 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 4.661087e-09 | 8.332 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 5.638072e-09 | 8.249 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 6.899305e-09 | 8.161 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 7.284698e-09 | 8.138 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 9.439228e-09 | 8.025 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 9.288183e-09 | 8.032 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 9.288183e-09 | 8.032 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 1.038627e-08 | 7.984 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 1.435952e-08 | 7.843 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 1.452911e-08 | 7.838 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 1.468844e-08 | 7.833 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 1.559519e-08 | 7.807 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 1.687760e-08 | 7.773 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 1.687760e-08 | 7.773 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 2.057907e-08 | 7.687 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 2.057907e-08 | 7.687 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 2.007206e-08 | 7.697 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 2.039733e-08 | 7.690 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 2.386517e-08 | 7.622 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 2.944691e-08 | 7.531 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 3.345381e-08 | 7.476 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 3.808054e-08 | 7.419 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 3.973370e-08 | 7.401 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 4.116285e-08 | 7.385 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 6.386825e-08 | 7.195 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 6.922957e-08 | 7.160 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 7.946605e-08 | 7.100 | 0 | 0 |
| Depurination | R-HSA-73927 | 9.397134e-08 | 7.027 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 9.409809e-08 | 7.026 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 9.915598e-08 | 7.004 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 1.085140e-07 | 6.965 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 1.170425e-07 | 6.932 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 1.170425e-07 | 6.932 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 1.170425e-07 | 6.932 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 1.170425e-07 | 6.932 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 1.269947e-07 | 6.896 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 1.269947e-07 | 6.896 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 1.264849e-07 | 6.898 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 1.493215e-07 | 6.826 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 1.767017e-07 | 6.753 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 1.897713e-07 | 6.722 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 1.928004e-07 | 6.715 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 1.978468e-07 | 6.704 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 1.897713e-07 | 6.722 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 2.067459e-07 | 6.685 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 2.084792e-07 | 6.681 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 2.439987e-07 | 6.613 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 2.742941e-07 | 6.562 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 2.821229e-07 | 6.550 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 3.050526e-07 | 6.516 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 4.403468e-07 | 6.356 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 4.461531e-07 | 6.351 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 4.541178e-07 | 6.343 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 4.992109e-07 | 6.302 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 4.999242e-07 | 6.301 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 5.368608e-07 | 6.270 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 5.742293e-07 | 6.241 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 5.896339e-07 | 6.229 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 6.937700e-07 | 6.159 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 7.865102e-07 | 6.104 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 8.341686e-07 | 6.079 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 9.233815e-07 | 6.035 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 8.738368e-07 | 6.059 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 8.739141e-07 | 6.059 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 9.134584e-07 | 6.039 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 1.082524e-06 | 5.966 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 1.207998e-06 | 5.918 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 1.292134e-06 | 5.889 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 1.437635e-06 | 5.842 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 1.689434e-06 | 5.772 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 1.754851e-06 | 5.756 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 1.851104e-06 | 5.733 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 1.908260e-06 | 5.719 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 2.111209e-06 | 5.675 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 2.144084e-06 | 5.669 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 2.161178e-06 | 5.665 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 2.182530e-06 | 5.661 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 2.183660e-06 | 5.661 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 2.192355e-06 | 5.659 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 2.611707e-06 | 5.583 | 1 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 2.629139e-06 | 5.580 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 2.630088e-06 | 5.580 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 2.922001e-06 | 5.534 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 3.349558e-06 | 5.475 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 3.315830e-06 | 5.479 | 1 | 0 |
| Reproduction | R-HSA-1474165 | 3.323704e-06 | 5.478 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 3.526337e-06 | 5.453 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 3.526337e-06 | 5.453 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 3.917470e-06 | 5.407 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 4.006941e-06 | 5.397 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 4.082342e-06 | 5.389 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 5.271802e-06 | 5.278 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 5.418425e-06 | 5.266 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 5.418425e-06 | 5.266 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 5.423407e-06 | 5.266 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 5.789273e-06 | 5.237 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 6.157052e-06 | 5.211 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 6.638938e-06 | 5.178 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 6.653924e-06 | 5.177 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 8.240150e-06 | 5.084 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 9.478655e-06 | 5.023 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 1.004687e-05 | 4.998 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 1.038857e-05 | 4.983 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 1.059066e-05 | 4.975 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 1.061616e-05 | 4.974 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 1.097790e-05 | 4.959 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 1.228388e-05 | 4.911 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 1.413637e-05 | 4.850 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 1.469547e-05 | 4.833 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 1.570168e-05 | 4.804 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 1.802471e-05 | 4.744 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 1.705337e-05 | 4.768 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 1.720334e-05 | 4.764 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 1.805370e-05 | 4.743 | 1 | 0 |
| UCH proteinases | R-HSA-5689603 | 1.818455e-05 | 4.740 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 1.855173e-05 | 4.732 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 2.053772e-05 | 4.687 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 2.087648e-05 | 4.680 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 2.336390e-05 | 4.631 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 2.378903e-05 | 4.624 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 2.387826e-05 | 4.622 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 2.647823e-05 | 4.577 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 2.721274e-05 | 4.565 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 2.873020e-05 | 4.542 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 3.008216e-05 | 4.522 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 3.614487e-05 | 4.442 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 4.028652e-05 | 4.395 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 3.679008e-05 | 4.434 | 1 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 4.125011e-05 | 4.385 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 4.174739e-05 | 4.379 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 4.174739e-05 | 4.379 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 4.256286e-05 | 4.371 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 4.950732e-05 | 4.305 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 5.371045e-05 | 4.270 | 1 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 5.437934e-05 | 4.265 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 5.472681e-05 | 4.262 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 5.555817e-05 | 4.255 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 5.562262e-05 | 4.255 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 5.562262e-05 | 4.255 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 6.332724e-05 | 4.198 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 6.457681e-05 | 4.190 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 8.225504e-05 | 4.085 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 8.225504e-05 | 4.085 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 8.100161e-05 | 4.092 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 9.011041e-05 | 4.045 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 9.011041e-05 | 4.045 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 9.156927e-05 | 4.038 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 9.207274e-05 | 4.036 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 9.207274e-05 | 4.036 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 9.207274e-05 | 4.036 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 9.435322e-05 | 4.025 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 1.089880e-04 | 3.963 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 1.091857e-04 | 3.962 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 1.198062e-04 | 3.922 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 1.208778e-04 | 3.918 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 1.268242e-04 | 3.897 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 1.312845e-04 | 3.882 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 1.376206e-04 | 3.861 | 1 | 0 |
| Glucose metabolism | R-HSA-70326 | 1.379259e-04 | 3.860 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 1.423626e-04 | 3.847 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 1.451811e-04 | 3.838 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 1.505301e-04 | 3.822 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 1.553048e-04 | 3.809 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 1.693863e-04 | 3.771 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 1.696599e-04 | 3.770 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 1.827753e-04 | 3.738 | 1 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 1.924462e-04 | 3.716 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 2.000933e-04 | 3.699 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 2.010974e-04 | 3.697 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 2.053104e-04 | 3.688 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 2.066009e-04 | 3.685 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 2.169569e-04 | 3.664 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 2.526194e-04 | 3.598 | 1 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 2.648735e-04 | 3.577 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 2.648735e-04 | 3.577 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 3.006415e-04 | 3.522 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 3.019329e-04 | 3.520 | 1 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 3.033941e-04 | 3.518 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 3.082665e-04 | 3.511 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 3.082665e-04 | 3.511 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 3.124216e-04 | 3.505 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 3.428607e-04 | 3.465 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 3.507853e-04 | 3.455 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 3.534205e-04 | 3.452 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 3.592153e-04 | 3.445 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 3.662350e-04 | 3.436 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 3.804313e-04 | 3.420 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 3.957748e-04 | 3.403 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 3.957748e-04 | 3.403 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 3.999783e-04 | 3.398 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 4.332303e-04 | 3.363 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 4.782745e-04 | 3.320 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 4.789921e-04 | 3.320 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 4.900030e-04 | 3.310 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 4.993612e-04 | 3.302 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 5.141717e-04 | 3.289 | 1 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 5.591577e-04 | 3.252 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 5.591577e-04 | 3.252 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 5.591577e-04 | 3.252 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 5.591577e-04 | 3.252 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 6.027703e-04 | 3.220 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 6.240158e-04 | 3.205 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 6.240158e-04 | 3.205 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 5.769612e-04 | 3.239 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 6.258574e-04 | 3.204 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 6.336505e-04 | 3.198 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 6.778011e-04 | 3.169 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 7.369231e-04 | 3.133 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 7.520350e-04 | 3.124 | 0 | 0 |
| Immune System | R-HSA-168256 | 7.645071e-04 | 3.117 | 1 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 7.743896e-04 | 3.111 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 7.958695e-04 | 3.099 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 7.986909e-04 | 3.098 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 9.136571e-04 | 3.039 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 9.516443e-04 | 3.022 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 9.830766e-04 | 3.007 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 1.006096e-03 | 2.997 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 1.006096e-03 | 2.997 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 1.045602e-03 | 2.981 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 1.083001e-03 | 2.965 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 1.083001e-03 | 2.965 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 1.117687e-03 | 2.952 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 1.176736e-03 | 2.929 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 1.199977e-03 | 2.921 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 1.199977e-03 | 2.921 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 1.219072e-03 | 2.914 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 1.264144e-03 | 2.898 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 1.264144e-03 | 2.898 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 1.321650e-03 | 2.879 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 1.393102e-03 | 2.856 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 1.409642e-03 | 2.851 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 1.432560e-03 | 2.844 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 1.505002e-03 | 2.822 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 1.601701e-03 | 2.795 | 0 | 0 |
| Translation | R-HSA-72766 | 1.602942e-03 | 2.795 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 1.651722e-03 | 2.782 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 1.651722e-03 | 2.782 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 1.663979e-03 | 2.779 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 1.677641e-03 | 2.775 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 1.904940e-03 | 2.720 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 1.945423e-03 | 2.711 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 1.957395e-03 | 2.708 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 2.018978e-03 | 2.695 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 2.111874e-03 | 2.675 | 1 | 0 |
| Interferon Signaling | R-HSA-913531 | 2.219733e-03 | 2.654 | 0 | 0 |
| Kinesins | R-HSA-983189 | 2.355153e-03 | 2.628 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 2.011694e-03 | 2.696 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 1.977383e-03 | 2.704 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 2.141131e-03 | 2.669 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 2.367223e-03 | 2.626 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 2.384822e-03 | 2.623 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 2.384822e-03 | 2.623 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 2.430994e-03 | 2.614 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 2.430994e-03 | 2.614 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 2.430994e-03 | 2.614 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 2.556707e-03 | 2.592 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 2.557998e-03 | 2.592 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 2.557998e-03 | 2.592 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 2.557998e-03 | 2.592 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 2.557998e-03 | 2.592 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 2.564108e-03 | 2.591 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 2.621015e-03 | 2.582 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 2.624520e-03 | 2.581 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 2.673247e-03 | 2.573 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 2.673247e-03 | 2.573 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 2.759923e-03 | 2.559 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 2.901916e-03 | 2.537 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 3.039246e-03 | 2.517 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 3.039246e-03 | 2.517 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 3.039246e-03 | 2.517 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 3.094573e-03 | 2.509 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 3.108058e-03 | 2.508 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 3.129276e-03 | 2.505 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 3.137153e-03 | 2.503 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 3.197333e-03 | 2.495 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 3.217114e-03 | 2.493 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 3.219320e-03 | 2.492 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 3.403269e-03 | 2.468 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 3.506373e-03 | 2.455 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 3.506373e-03 | 2.455 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 3.611042e-03 | 2.442 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 3.611042e-03 | 2.442 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 3.659401e-03 | 2.437 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 3.787691e-03 | 2.422 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 3.787691e-03 | 2.422 | 1 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 3.844061e-03 | 2.415 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 3.844061e-03 | 2.415 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 3.844061e-03 | 2.415 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 3.850791e-03 | 2.414 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 3.854340e-03 | 2.414 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 3.992669e-03 | 2.399 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 3.992669e-03 | 2.399 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 4.496220e-03 | 2.347 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 4.496220e-03 | 2.347 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 3.891875e-03 | 2.410 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 3.945524e-03 | 2.404 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 4.080022e-03 | 2.389 | 1 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 4.834007e-03 | 2.316 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 4.208452e-03 | 2.376 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 4.208452e-03 | 2.376 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 3.945524e-03 | 2.404 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 4.208452e-03 | 2.376 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 4.208452e-03 | 2.376 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 4.100964e-03 | 2.387 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 4.100964e-03 | 2.387 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 3.992669e-03 | 2.399 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 3.996876e-03 | 2.398 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 5.018967e-03 | 2.299 | 0 | 0 |
| MTF1 activates gene expression | R-HSA-5660489 | 5.074982e-03 | 2.295 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 5.160692e-03 | 2.287 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 5.160692e-03 | 2.287 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 5.171166e-03 | 2.286 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 5.245223e-03 | 2.280 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 5.288886e-03 | 2.277 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 5.288886e-03 | 2.277 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 5.374388e-03 | 2.270 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 5.436330e-03 | 2.265 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 5.486096e-03 | 2.261 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 5.543529e-03 | 2.256 | 1 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 5.606465e-03 | 2.251 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 5.689192e-03 | 2.245 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 5.856125e-03 | 2.232 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 5.856125e-03 | 2.232 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 5.860377e-03 | 2.232 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 6.032116e-03 | 2.220 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 6.167920e-03 | 2.210 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 6.230644e-03 | 2.205 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 6.298167e-03 | 2.201 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 6.418859e-03 | 2.193 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 6.418859e-03 | 2.193 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 6.418859e-03 | 2.193 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 6.421074e-03 | 2.192 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 6.530492e-03 | 2.185 | 1 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 6.591931e-03 | 2.181 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 6.605811e-03 | 2.180 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 6.605811e-03 | 2.180 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 6.605811e-03 | 2.180 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 6.633993e-03 | 2.178 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 7.011045e-03 | 2.154 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 7.011045e-03 | 2.154 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 7.208430e-03 | 2.142 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 7.216666e-03 | 2.142 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 7.216666e-03 | 2.142 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 7.265936e-03 | 2.139 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 7.307288e-03 | 2.136 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 7.307288e-03 | 2.136 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 7.318459e-03 | 2.136 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 7.318459e-03 | 2.136 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 7.491195e-03 | 2.125 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 7.660354e-03 | 2.116 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 7.660354e-03 | 2.116 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 7.727697e-03 | 2.112 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 7.727697e-03 | 2.112 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 7.727697e-03 | 2.112 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 8.613701e-03 | 2.065 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 8.765551e-03 | 2.057 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 8.318573e-03 | 2.080 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 7.905415e-03 | 2.102 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 9.554516e-03 | 2.020 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 1.034396e-02 | 1.985 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 8.216554e-03 | 2.085 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 9.578265e-03 | 2.019 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 9.911604e-03 | 2.004 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 7.885532e-03 | 2.103 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 9.313204e-03 | 2.031 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 9.578265e-03 | 2.019 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 8.355495e-03 | 2.078 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 8.355495e-03 | 2.078 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 8.361132e-03 | 2.078 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 8.036315e-03 | 2.095 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 9.307826e-03 | 2.031 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 1.034396e-02 | 1.985 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 9.147597e-03 | 2.039 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 8.575100e-03 | 2.067 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 8.765551e-03 | 2.057 | 0 | 0 |
| S Phase | R-HSA-69242 | 9.307826e-03 | 2.031 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 8.318573e-03 | 2.080 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 8.355495e-03 | 2.078 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 9.637516e-03 | 2.016 | 1 | 1 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 8.355495e-03 | 2.078 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 9.084159e-03 | 2.042 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 8.619732e-03 | 2.065 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 8.765551e-03 | 2.057 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 9.578265e-03 | 2.019 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 9.140589e-03 | 2.039 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 8.375348e-03 | 2.077 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 1.037316e-02 | 1.984 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 1.047289e-02 | 1.980 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 1.047289e-02 | 1.980 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 1.047289e-02 | 1.980 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 1.060278e-02 | 1.975 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 1.060278e-02 | 1.975 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 1.070419e-02 | 1.970 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 1.085100e-02 | 1.965 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 1.088955e-02 | 1.963 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 1.088955e-02 | 1.963 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 1.088955e-02 | 1.963 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 1.088955e-02 | 1.963 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 1.088955e-02 | 1.963 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 1.088955e-02 | 1.963 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 1.088955e-02 | 1.963 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 1.088955e-02 | 1.963 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 1.088955e-02 | 1.963 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 1.088955e-02 | 1.963 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 1.088955e-02 | 1.963 | 0 | 0 |
| Signaling by RAS GAP mutants | R-HSA-9753510 | 1.088955e-02 | 1.963 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 1.088955e-02 | 1.963 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 1.089352e-02 | 1.963 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 1.093236e-02 | 1.961 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 1.110893e-02 | 1.954 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 1.126894e-02 | 1.948 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 1.226842e-02 | 1.911 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 1.230486e-02 | 1.910 | 0 | 0 |
| Estrogen-stimulated signaling through PRKCZ | R-HSA-9634635 | 1.237248e-02 | 1.908 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 1.237248e-02 | 1.908 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 1.237248e-02 | 1.908 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 1.240125e-02 | 1.907 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 1.246753e-02 | 1.904 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 1.267280e-02 | 1.897 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 1.271339e-02 | 1.896 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 1.271339e-02 | 1.896 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 1.271339e-02 | 1.896 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 1.271339e-02 | 1.896 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 1.290607e-02 | 1.889 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 1.294404e-02 | 1.888 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 1.311506e-02 | 1.882 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 1.321429e-02 | 1.879 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 1.342934e-02 | 1.872 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 1.346761e-02 | 1.871 | 0 | 0 |
| Maturation of protein E | R-HSA-9694493 | 1.346761e-02 | 1.871 | 0 | 0 |
| Maturation of protein E | R-HSA-9683683 | 1.346761e-02 | 1.871 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 1.347947e-02 | 1.870 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 1.349068e-02 | 1.870 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 1.360451e-02 | 1.866 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 1.444032e-02 | 1.840 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 1.444032e-02 | 1.840 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 1.458544e-02 | 1.836 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 1.469018e-02 | 1.833 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 1.512820e-02 | 1.820 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 1.516834e-02 | 1.819 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 1.541234e-02 | 1.812 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 1.580190e-02 | 1.801 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 1.605381e-02 | 1.794 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 1.656050e-02 | 1.781 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 1.656050e-02 | 1.781 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 1.676180e-02 | 1.776 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 1.676180e-02 | 1.776 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 1.676180e-02 | 1.776 | 1 | 1 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 1.684429e-02 | 1.774 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 1.684429e-02 | 1.774 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 1.684429e-02 | 1.774 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 1.687078e-02 | 1.773 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 1.687078e-02 | 1.773 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 1.687078e-02 | 1.773 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 1.687078e-02 | 1.773 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 1.698211e-02 | 1.770 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 1.704440e-02 | 1.768 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 1.709434e-02 | 1.767 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 1.723409e-02 | 1.764 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 1.784461e-02 | 1.748 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 1.784461e-02 | 1.748 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 1.853430e-02 | 1.732 | 1 | 1 |
| Syndecan interactions | R-HSA-3000170 | 1.860729e-02 | 1.730 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 1.952263e-02 | 1.709 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 1.952263e-02 | 1.709 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 1.957293e-02 | 1.708 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 1.963488e-02 | 1.707 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 1.963488e-02 | 1.707 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 1.977888e-02 | 1.704 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 1.979678e-02 | 1.703 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 2.055659e-02 | 1.687 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 2.055659e-02 | 1.687 | 0 | 0 |
| Loss of MECP2 binding ability to 5hmC-DNA | R-HSA-9022534 | 2.184051e-02 | 1.661 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 3.120322e-02 | 1.506 | 0 | 0 |
| Dopamine receptors | R-HSA-390651 | 3.120322e-02 | 1.506 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 3.120322e-02 | 1.506 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 3.120322e-02 | 1.506 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 2.765054e-02 | 1.558 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 2.765054e-02 | 1.558 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 2.765054e-02 | 1.558 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 2.884173e-02 | 1.540 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 2.884173e-02 | 1.540 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 2.205170e-02 | 1.657 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 2.205170e-02 | 1.657 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 2.736766e-02 | 1.563 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 2.491131e-02 | 1.604 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 2.985888e-02 | 1.525 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 2.623475e-02 | 1.581 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 2.656392e-02 | 1.576 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 2.999230e-02 | 1.523 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 2.926333e-02 | 1.534 | 1 | 1 |
| Protein ubiquitination | R-HSA-8852135 | 2.918631e-02 | 1.535 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 2.166414e-02 | 1.664 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 2.748334e-02 | 1.561 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 2.284998e-02 | 1.641 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 2.244405e-02 | 1.649 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 2.999230e-02 | 1.523 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 2.884173e-02 | 1.540 | 0 | 0 |
| Protein folding | R-HSA-391251 | 2.545630e-02 | 1.594 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 2.205170e-02 | 1.657 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 2.456644e-02 | 1.610 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 2.170139e-02 | 1.664 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 3.098509e-02 | 1.509 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 3.098509e-02 | 1.509 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 2.491131e-02 | 1.604 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 2.917009e-02 | 1.535 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 2.781119e-02 | 1.556 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 2.736766e-02 | 1.563 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 3.098509e-02 | 1.509 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 2.752443e-02 | 1.560 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 2.244405e-02 | 1.649 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 2.284998e-02 | 1.641 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 2.580902e-02 | 1.588 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 2.765054e-02 | 1.558 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 2.752443e-02 | 1.560 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 2.764076e-02 | 1.558 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 2.884173e-02 | 1.540 | 0 | 0 |
| Regulation of BACH1 activity | R-HSA-9708530 | 2.736766e-02 | 1.563 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 2.657553e-02 | 1.576 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 2.736766e-02 | 1.563 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 2.518131e-02 | 1.599 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 3.249622e-02 | 1.488 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 3.253610e-02 | 1.488 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 3.286825e-02 | 1.483 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 3.286825e-02 | 1.483 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 3.346785e-02 | 1.475 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 3.346785e-02 | 1.475 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 3.346785e-02 | 1.475 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 3.446051e-02 | 1.463 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 3.493337e-02 | 1.457 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 3.510519e-02 | 1.455 | 1 | 1 |
| Integrin signaling | R-HSA-354192 | 3.523033e-02 | 1.453 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 3.523033e-02 | 1.453 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 3.542835e-02 | 1.451 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 3.542835e-02 | 1.451 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 3.580362e-02 | 1.446 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 3.642909e-02 | 1.439 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 3.642909e-02 | 1.439 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 3.642909e-02 | 1.439 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 3.642909e-02 | 1.439 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 3.642909e-02 | 1.439 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 3.642909e-02 | 1.439 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 3.642909e-02 | 1.439 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 3.642909e-02 | 1.439 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 3.642909e-02 | 1.439 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 3.642909e-02 | 1.439 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 3.642909e-02 | 1.439 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 3.642909e-02 | 1.439 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 3.708905e-02 | 1.431 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 3.714671e-02 | 1.430 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 3.714671e-02 | 1.430 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 3.714671e-02 | 1.430 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 3.714671e-02 | 1.430 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 3.714671e-02 | 1.430 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 3.714671e-02 | 1.430 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 3.714671e-02 | 1.430 | 0 | 0 |
| Activation of RAS in B cells | R-HSA-1169092 | 3.714671e-02 | 1.430 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 3.714671e-02 | 1.430 | 0 | 0 |
| Modulation by Mtb of host immune system | R-HSA-9637628 | 3.714671e-02 | 1.430 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 3.815651e-02 | 1.418 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 3.815651e-02 | 1.418 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 3.856798e-02 | 1.414 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 4.038514e-02 | 1.394 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 4.101058e-02 | 1.387 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 4.101058e-02 | 1.387 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 4.129049e-02 | 1.384 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 4.141929e-02 | 1.383 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 4.164453e-02 | 1.380 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 4.164453e-02 | 1.380 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 4.274675e-02 | 1.369 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 4.428532e-02 | 1.354 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 4.504488e-02 | 1.346 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 4.513565e-02 | 1.345 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 4.513565e-02 | 1.345 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 4.513565e-02 | 1.345 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 4.566321e-02 | 1.340 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 4.566321e-02 | 1.340 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 4.566321e-02 | 1.340 | 0 | 0 |
| Defective Base Excision Repair Associated with OGG1 | R-HSA-9656249 | 4.567276e-02 | 1.340 | 0 | 0 |
| Oligomerization of connexins into connexons | R-HSA-190704 | 4.567276e-02 | 1.340 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 4.567276e-02 | 1.340 | 0 | 0 |
| Transport of glycerol from adipocytes to the liver by Aquaporins | R-HSA-432030 | 4.567276e-02 | 1.340 | 0 | 0 |
| Transport of connexins along the secretory pathway | R-HSA-190827 | 4.567276e-02 | 1.340 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 4.567276e-02 | 1.340 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 4.569163e-02 | 1.340 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 4.569163e-02 | 1.340 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 4.571611e-02 | 1.340 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 4.748441e-02 | 1.323 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 4.748441e-02 | 1.323 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 4.748441e-02 | 1.323 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 4.814456e-02 | 1.317 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 4.814456e-02 | 1.317 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 4.827273e-02 | 1.316 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 4.829453e-02 | 1.316 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 4.829453e-02 | 1.316 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 4.829453e-02 | 1.316 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 4.829453e-02 | 1.316 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 4.829453e-02 | 1.316 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 4.869845e-02 | 1.312 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 4.882723e-02 | 1.311 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 5.077744e-02 | 1.294 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 5.157819e-02 | 1.288 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 5.326317e-02 | 1.274 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 5.382767e-02 | 1.269 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 5.415777e-02 | 1.266 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 5.485029e-02 | 1.261 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 5.498071e-02 | 1.260 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 5.498071e-02 | 1.260 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 5.498071e-02 | 1.260 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 5.498071e-02 | 1.260 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 5.676304e-02 | 1.246 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 5.676304e-02 | 1.246 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 5.773802e-02 | 1.239 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 5.797391e-02 | 1.237 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 5.851281e-02 | 1.233 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 6.088068e-02 | 1.216 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 6.108718e-02 | 1.214 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 6.108718e-02 | 1.214 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 6.108718e-02 | 1.214 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 6.108718e-02 | 1.214 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 6.280746e-02 | 1.202 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 6.292751e-02 | 1.201 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 6.292751e-02 | 1.201 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 6.292751e-02 | 1.201 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 6.292751e-02 | 1.201 | 0 | 0 |
| PKA-mediated phosphorylation of key metabolic factors | R-HSA-163358 | 6.292751e-02 | 1.201 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 6.292751e-02 | 1.201 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 6.485886e-02 | 1.188 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 6.485886e-02 | 1.188 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 6.596856e-02 | 1.181 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 6.596856e-02 | 1.181 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 6.596856e-02 | 1.181 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 6.596856e-02 | 1.181 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 6.596856e-02 | 1.181 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 6.596856e-02 | 1.181 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 6.596856e-02 | 1.181 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 6.596856e-02 | 1.181 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 6.614014e-02 | 1.180 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 6.624936e-02 | 1.179 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 6.706965e-02 | 1.173 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 6.817243e-02 | 1.166 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 6.817243e-02 | 1.166 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 6.817243e-02 | 1.166 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 6.860829e-02 | 1.164 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 7.063148e-02 | 1.151 | 1 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 7.330817e-02 | 1.135 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 7.330817e-02 | 1.135 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 7.445458e-02 | 1.128 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 7.493689e-02 | 1.125 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 7.548767e-02 | 1.122 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 7.548767e-02 | 1.122 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 7.548767e-02 | 1.122 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 7.548767e-02 | 1.122 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 7.548767e-02 | 1.122 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 7.548767e-02 | 1.122 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 7.548767e-02 | 1.122 | 0 | 0 |
| Regulation of TP53 Expression | R-HSA-6804754 | 7.552027e-02 | 1.122 | 0 | 0 |
| Diseases of Cellular Senescence | R-HSA-9630747 | 7.552027e-02 | 1.122 | 0 | 0 |
| Diseases of cellular response to stress | R-HSA-9675132 | 7.552027e-02 | 1.122 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 7.617639e-02 | 1.118 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 7.660421e-02 | 1.116 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 7.661542e-02 | 1.116 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 7.763044e-02 | 1.110 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 7.763044e-02 | 1.110 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 7.763044e-02 | 1.110 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 7.817913e-02 | 1.107 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 7.846668e-02 | 1.105 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 8.103229e-02 | 1.091 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 8.134270e-02 | 1.090 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 8.167719e-02 | 1.088 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 8.167719e-02 | 1.088 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 8.210915e-02 | 1.086 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 8.213330e-02 | 1.085 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 8.271061e-02 | 1.082 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 8.271061e-02 | 1.082 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 8.271061e-02 | 1.082 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 8.296354e-02 | 1.081 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 8.561976e-02 | 1.067 | 0 | 0 |
| Drug resistance of KIT mutants | R-HSA-9669937 | 1.064842e-01 | 0.973 | 0 | 0 |
| KIT mutants bind TKIs | R-HSA-9669921 | 1.064842e-01 | 0.973 | 0 | 0 |
| Dasatinib-resistant KIT mutants | R-HSA-9669914 | 1.064842e-01 | 0.973 | 0 | 0 |
| Imatinib-resistant KIT mutants | R-HSA-9669917 | 1.064842e-01 | 0.973 | 0 | 0 |
| Nilotinib-resistant KIT mutants | R-HSA-9669926 | 1.064842e-01 | 0.973 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to p14ARF Defects | R-HSA-9646304 | 1.064842e-01 | 0.973 | 0 | 0 |
| Defective OGG1 Substrate Binding | R-HSA-9656255 | 1.064842e-01 | 0.973 | 0 | 0 |
| Loss of function of TP53 in cancer due to loss of tetramerization ability | R-HSA-9723905 | 1.064842e-01 | 0.973 | 0 | 0 |
| Regorafenib-resistant KIT mutants | R-HSA-9669929 | 1.064842e-01 | 0.973 | 0 | 0 |
| Defective OGG1 Localization | R-HSA-9657050 | 1.064842e-01 | 0.973 | 0 | 0 |
| Loss of Function of TP53 in Cancer | R-HSA-9723907 | 1.064842e-01 | 0.973 | 0 | 0 |
| Sorafenib-resistant KIT mutants | R-HSA-9669936 | 1.064842e-01 | 0.973 | 0 | 0 |
| Masitinib-resistant KIT mutants | R-HSA-9669924 | 1.064842e-01 | 0.973 | 0 | 0 |
| Sunitinib-resistant KIT mutants | R-HSA-9669934 | 1.064842e-01 | 0.973 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to p14ARF Defects | R-HSA-9646303 | 1.064842e-01 | 0.973 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 1.098332e-01 | 0.959 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 1.098332e-01 | 0.959 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 1.098332e-01 | 0.959 | 0 | 0 |
| MECP2 regulates transcription of genes involved in GABA signaling | R-HSA-9022927 | 1.473231e-01 | 0.832 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 1.473231e-01 | 0.832 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 1.473231e-01 | 0.832 | 0 | 0 |
| FBXW7 Mutants and NOTCH1 in Cancer | R-HSA-2644605 | 1.473231e-01 | 0.832 | 0 | 0 |
| TGFBR1 KD Mutants in Cancer | R-HSA-3656532 | 1.473231e-01 | 0.832 | 0 | 0 |
| Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling | R-HSA-2644607 | 1.473231e-01 | 0.832 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 1.047938e-01 | 0.980 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 1.047938e-01 | 0.980 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 1.047938e-01 | 0.980 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 1.047938e-01 | 0.980 | 1 | 1 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 9.143295e-02 | 1.039 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 9.143295e-02 | 1.039 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 1.088382e-01 | 0.963 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 1.088382e-01 | 0.963 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 1.088382e-01 | 0.963 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 9.131949e-02 | 1.039 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 9.131949e-02 | 1.039 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 1.276008e-01 | 0.894 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 8.782047e-02 | 1.056 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 1.476046e-01 | 0.831 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 1.476046e-01 | 0.831 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 1.209564e-01 | 0.917 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 1.209564e-01 | 0.917 | 1 | 1 |
| PKA activation in glucagon signalling | R-HSA-164378 | 1.209564e-01 | 0.917 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 1.687236e-01 | 0.773 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 8.661951e-02 | 1.062 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 1.264569e-01 | 0.898 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 1.544750e-01 | 0.811 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 9.618952e-02 | 1.017 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 1.409049e-01 | 0.851 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 1.409049e-01 | 0.851 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 1.725272e-01 | 0.763 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 1.719277e-01 | 0.765 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 1.719277e-01 | 0.765 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 8.900851e-02 | 1.051 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 1.048349e-01 | 0.979 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 1.524367e-01 | 0.817 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 1.063346e-01 | 0.973 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 9.988352e-02 | 1.001 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 8.849803e-02 | 1.053 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 8.849803e-02 | 1.053 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 1.544750e-01 | 0.811 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 1.490466e-01 | 0.827 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 1.725272e-01 | 0.763 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 1.401132e-01 | 0.854 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 1.687236e-01 | 0.773 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 1.547442e-01 | 0.810 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 1.687236e-01 | 0.773 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 1.691603e-01 | 0.772 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 1.348630e-01 | 0.870 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 1.501788e-01 | 0.823 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 1.476046e-01 | 0.831 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 1.067507e-01 | 0.972 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 1.613762e-01 | 0.792 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 1.209564e-01 | 0.917 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 1.490466e-01 | 0.827 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 8.825701e-02 | 1.054 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 8.825701e-02 | 1.054 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 8.825701e-02 | 1.054 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 8.825701e-02 | 1.054 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 1.547442e-01 | 0.810 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 1.276008e-01 | 0.894 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 1.063346e-01 | 0.973 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 1.063346e-01 | 0.973 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 9.737667e-02 | 1.012 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 9.737667e-02 | 1.012 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 1.063346e-01 | 0.973 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 1.389597e-01 | 0.857 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 9.131949e-02 | 1.039 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 1.477461e-01 | 0.830 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 1.560765e-01 | 0.807 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 1.276008e-01 | 0.894 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 1.063346e-01 | 0.973 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 1.560765e-01 | 0.807 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 9.131949e-02 | 1.039 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 1.272306e-01 | 0.895 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 1.272306e-01 | 0.895 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 1.647338e-01 | 0.783 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 9.331310e-02 | 1.030 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 1.043475e-01 | 0.982 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 9.737667e-02 | 1.012 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 1.269588e-01 | 0.896 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 1.377738e-01 | 0.861 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 1.490466e-01 | 0.827 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 1.557101e-01 | 0.808 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 1.559656e-01 | 0.807 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 1.043475e-01 | 0.982 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 1.549925e-01 | 0.810 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 1.031298e-01 | 0.987 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 1.607623e-01 | 0.794 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 1.607623e-01 | 0.794 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 8.825701e-02 | 1.054 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 1.473231e-01 | 0.832 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 1.473231e-01 | 0.832 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 9.143295e-02 | 1.039 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 9.143295e-02 | 1.039 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 1.547442e-01 | 0.810 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 1.056240e-01 | 0.976 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 1.409049e-01 | 0.851 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 1.725272e-01 | 0.763 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 1.170455e-01 | 0.932 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 1.283101e-01 | 0.892 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 9.672806e-02 | 1.014 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 1.030667e-01 | 0.987 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 1.549925e-01 | 0.810 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 1.377738e-01 | 0.861 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 1.161442e-01 | 0.935 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 1.200915e-01 | 0.920 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 1.061373e-01 | 0.974 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 1.043197e-01 | 0.982 | 1 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 1.577357e-01 | 0.802 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 1.150075e-01 | 0.939 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 1.088382e-01 | 0.963 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 8.661951e-02 | 1.062 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 1.547442e-01 | 0.810 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 1.476046e-01 | 0.831 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 1.048349e-01 | 0.979 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 1.047938e-01 | 0.980 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 1.047938e-01 | 0.980 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 1.687236e-01 | 0.773 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 8.661951e-02 | 1.062 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 1.719277e-01 | 0.765 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 1.560765e-01 | 0.807 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 1.700028e-01 | 0.770 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 1.047938e-01 | 0.980 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 1.129211e-01 | 0.947 | 1 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 1.241939e-01 | 0.906 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 1.711042e-01 | 0.767 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 8.775176e-02 | 1.057 | 0 | 0 |
| Disease | R-HSA-1643685 | 1.196295e-01 | 0.922 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 1.084067e-01 | 0.965 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 1.179624e-01 | 0.928 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 1.549925e-01 | 0.810 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 1.088382e-01 | 0.963 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 1.088382e-01 | 0.963 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 1.687236e-01 | 0.773 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 1.284111e-01 | 0.891 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 9.548753e-02 | 1.020 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 1.018633e-01 | 0.992 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 8.849803e-02 | 1.053 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 1.687236e-01 | 0.773 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 9.387725e-02 | 1.027 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 9.618952e-02 | 1.017 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 1.720492e-01 | 0.764 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 8.782047e-02 | 1.056 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 1.133266e-01 | 0.946 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 1.719277e-01 | 0.765 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 1.010515e-01 | 0.995 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 1.725272e-01 | 0.763 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 1.372613e-01 | 0.862 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 1.687236e-01 | 0.773 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 1.409049e-01 | 0.851 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 1.544750e-01 | 0.811 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 1.710901e-01 | 0.767 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 1.820293e-01 | 0.740 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 1.820293e-01 | 0.740 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 1.820293e-01 | 0.740 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 1.820293e-01 | 0.740 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 1.820293e-01 | 0.740 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 1.820293e-01 | 0.740 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 1.830523e-01 | 0.737 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 1.838705e-01 | 0.735 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 1.838705e-01 | 0.735 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 1.838705e-01 | 0.735 | 0 | 0 |
| Co-inhibition by BTLA | R-HSA-9927353 | 1.869253e-01 | 0.728 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 1.869253e-01 | 0.728 | 0 | 0 |
| IRS activation | R-HSA-74713 | 1.869253e-01 | 0.728 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 1.869253e-01 | 0.728 | 0 | 0 |
| SMAD2/3 Phosphorylation Motif Mutants in Cancer | R-HSA-3304356 | 1.869253e-01 | 0.728 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 1.869253e-01 | 0.728 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 1.869253e-01 | 0.728 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 1.869253e-01 | 0.728 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 1.869253e-01 | 0.728 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 1.869253e-01 | 0.728 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 1.869253e-01 | 0.728 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 1.869253e-01 | 0.728 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 1.869253e-01 | 0.728 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 1.884105e-01 | 0.725 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 1.888917e-01 | 0.724 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 1.905679e-01 | 0.720 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 1.908249e-01 | 0.719 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 1.908249e-01 | 0.719 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 1.908249e-01 | 0.719 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 1.908249e-01 | 0.719 | 1 | 1 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 1.908249e-01 | 0.719 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 1.913426e-01 | 0.718 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 1.913426e-01 | 0.718 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 1.913426e-01 | 0.718 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 1.923126e-01 | 0.716 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 1.943730e-01 | 0.711 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 1.947899e-01 | 0.710 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 1.978542e-01 | 0.704 | 0 | 0 |
| Activation, translocation and oligomerization of BAX | R-HSA-114294 | 2.016350e-01 | 0.695 | 0 | 0 |
| Defective OGG1 Substrate Processing | R-HSA-9656256 | 2.016350e-01 | 0.695 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 2.016350e-01 | 0.695 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 2.016350e-01 | 0.695 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 2.016350e-01 | 0.695 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 2.016350e-01 | 0.695 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH6 | R-HSA-5632968 | 2.016350e-01 | 0.695 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 | R-HSA-9630791 | 2.016350e-01 | 0.695 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 | R-HSA-9632697 | 2.016350e-01 | 0.695 | 0 | 0 |
| Hereditary fructose intolerance | R-HSA-5657560 | 2.016350e-01 | 0.695 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 2.016350e-01 | 0.695 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 2.016350e-01 | 0.695 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis Due to p14ARF Loss of Function | R-HSA-9645722 | 2.016350e-01 | 0.695 | 0 | 0 |
| Inhibition of PKR | R-HSA-169131 | 2.016350e-01 | 0.695 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 2.025496e-01 | 0.693 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 2.028043e-01 | 0.693 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 2.059974e-01 | 0.686 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 2.064897e-01 | 0.685 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 2.064897e-01 | 0.685 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 2.104695e-01 | 0.677 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 2.104695e-01 | 0.677 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 2.108418e-01 | 0.676 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 2.108418e-01 | 0.676 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 2.108418e-01 | 0.676 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 2.137721e-01 | 0.670 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 2.137721e-01 | 0.670 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 2.137721e-01 | 0.670 | 0 | 0 |
| Response to metal ions | R-HSA-5660526 | 2.137721e-01 | 0.670 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 2.155760e-01 | 0.666 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 2.210630e-01 | 0.655 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 2.210630e-01 | 0.655 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 2.230641e-01 | 0.652 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 2.253444e-01 | 0.647 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 2.277654e-01 | 0.643 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 2.277654e-01 | 0.643 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 2.277654e-01 | 0.643 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 2.277654e-01 | 0.643 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 2.277654e-01 | 0.643 | 0 | 0 |
| CDC6 association with the ORC:origin complex | R-HSA-68689 | 2.277654e-01 | 0.643 | 0 | 0 |
| Diseases of Base Excision Repair | R-HSA-9605308 | 2.277654e-01 | 0.643 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 2.282268e-01 | 0.642 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 2.294872e-01 | 0.639 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 2.309429e-01 | 0.636 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 2.309429e-01 | 0.636 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 2.337549e-01 | 0.631 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 2.360023e-01 | 0.627 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 2.374277e-01 | 0.624 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 2.374277e-01 | 0.624 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 2.374277e-01 | 0.624 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 2.374277e-01 | 0.624 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 2.393120e-01 | 0.621 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 2.397891e-01 | 0.620 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 2.397891e-01 | 0.620 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 2.397891e-01 | 0.620 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 2.397891e-01 | 0.620 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 2.411255e-01 | 0.618 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 2.474021e-01 | 0.607 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 2.512765e-01 | 0.600 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 2.512765e-01 | 0.600 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 2.515625e-01 | 0.599 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 2.515625e-01 | 0.599 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 2.515625e-01 | 0.599 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 2.517828e-01 | 0.599 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 2.547876e-01 | 0.594 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 2.596010e-01 | 0.586 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 2.596010e-01 | 0.586 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 2.616557e-01 | 0.582 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 2.616557e-01 | 0.582 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 2.616557e-01 | 0.582 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 2.616557e-01 | 0.582 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 2.616557e-01 | 0.582 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 2.642585e-01 | 0.578 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 2.668533e-01 | 0.574 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 2.691312e-01 | 0.570 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 2.691312e-01 | 0.570 | 0 | 0 |
| Autointegration results in viral DNA circles | R-HSA-177539 | 2.691312e-01 | 0.570 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 2.691312e-01 | 0.570 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 2.691312e-01 | 0.570 | 0 | 0 |
| Integration of viral DNA into host genomic DNA | R-HSA-175567 | 2.691312e-01 | 0.570 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 2.697283e-01 | 0.569 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 2.697283e-01 | 0.569 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 2.697283e-01 | 0.569 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 2.697283e-01 | 0.569 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 2.697283e-01 | 0.569 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 2.697283e-01 | 0.569 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 2.697283e-01 | 0.569 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 2.697283e-01 | 0.569 | 0 | 0 |
| Estrogen biosynthesis | R-HSA-193144 | 2.697283e-01 | 0.569 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 2.726169e-01 | 0.564 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 2.726169e-01 | 0.564 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 2.741934e-01 | 0.562 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 2.784329e-01 | 0.555 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 2.784329e-01 | 0.555 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 2.812501e-01 | 0.551 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 2.814205e-01 | 0.551 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 2.814205e-01 | 0.551 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 2.814205e-01 | 0.551 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 2.826998e-01 | 0.549 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 2.828802e-01 | 0.548 | 0 | 0 |
| Prostacyclin signalling through prostacyclin receptor | R-HSA-392851 | 2.863230e-01 | 0.543 | 0 | 0 |
| Signaling by juxtamembrane domain KIT mutants | R-HSA-9669935 | 2.866582e-01 | 0.543 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to p16INK4A Defects | R-HSA-9632693 | 2.866582e-01 | 0.543 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to p16INK4A Defects | R-HSA-9630750 | 2.866582e-01 | 0.543 | 0 | 0 |
| Interactions of Tat with host cellular proteins | R-HSA-176034 | 2.866582e-01 | 0.543 | 0 | 0 |
| Signaling by extracellular domain mutants of KIT | R-HSA-9680187 | 2.866582e-01 | 0.543 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 | R-HSA-9630794 | 2.866582e-01 | 0.543 | 0 | 0 |
| IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR) | R-HSA-5603027 | 2.866582e-01 | 0.543 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 | R-HSA-9632700 | 2.866582e-01 | 0.543 | 0 | 0 |
| Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) | R-HSA-5619054 | 2.866582e-01 | 0.543 | 0 | 0 |
| TALDO1 deficiency: failed conversion of SH7P, GA3P to Fru(6)P, E4P | R-HSA-6791055 | 2.866582e-01 | 0.543 | 0 | 0 |
| TALDO1 deficiency: failed conversion of Fru(6)P, E4P to SH7P, GA3P | R-HSA-6791462 | 2.866582e-01 | 0.543 | 0 | 0 |
| Signaling by kinase domain mutants of KIT | R-HSA-9669933 | 2.866582e-01 | 0.543 | 0 | 0 |
| Defective SLC20A2 causes idiopathic basal ganglia calcification 1 (IBGC1) | R-HSA-5619111 | 2.866582e-01 | 0.543 | 0 | 0 |
| Signaling by TCF7L2 mutants | R-HSA-5339700 | 2.866582e-01 | 0.543 | 0 | 0 |
| Loss of Function of SMAD4 in Cancer | R-HSA-3304347 | 2.866582e-01 | 0.543 | 0 | 0 |
| Defective POMGNT1 causes MDDGA3, MDDGB3 and MDDGC3 | R-HSA-5083628 | 2.866582e-01 | 0.543 | 0 | 0 |
| SMAD2/3 MH2 Domain Mutants in Cancer | R-HSA-3315487 | 2.866582e-01 | 0.543 | 0 | 0 |
| SMAD4 MH2 Domain Mutants in Cancer | R-HSA-3311021 | 2.866582e-01 | 0.543 | 0 | 0 |
| Defective GFPT1 causes CMSTA1 | R-HSA-4085023 | 2.866582e-01 | 0.543 | 0 | 0 |
| IKBKB deficiency causes SCID | R-HSA-5602636 | 2.866582e-01 | 0.543 | 0 | 0 |
| TGFBR3 regulates FGF2 signaling | R-HSA-9839397 | 2.866582e-01 | 0.543 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH2 | R-HSA-5632928 | 2.866582e-01 | 0.543 | 0 | 0 |
| NTRK3 as a dependence receptor | R-HSA-9603505 | 2.866582e-01 | 0.543 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 2.910655e-01 | 0.536 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 2.987826e-01 | 0.525 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 2.987826e-01 | 0.525 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 3.000459e-01 | 0.523 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 3.000459e-01 | 0.523 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 3.000459e-01 | 0.523 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 3.000459e-01 | 0.523 | 0 | 0 |
| Reversible hydration of carbon dioxide | R-HSA-1475029 | 3.000459e-01 | 0.523 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 3.000459e-01 | 0.523 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | R-HSA-2892245 | 3.104481e-01 | 0.508 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 3.104481e-01 | 0.508 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 3.104481e-01 | 0.508 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 3.104481e-01 | 0.508 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 3.104481e-01 | 0.508 | 0 | 0 |
| TGFBR3 regulates TGF-beta signaling | R-HSA-9839389 | 3.104481e-01 | 0.508 | 0 | 0 |
| Synthesis of PIPs in the nucleus | R-HSA-8847453 | 3.104481e-01 | 0.508 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 3.113011e-01 | 0.507 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 3.113011e-01 | 0.507 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 3.113011e-01 | 0.507 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 3.124127e-01 | 0.505 | 1 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 3.130500e-01 | 0.504 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 3.156981e-01 | 0.501 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 3.156981e-01 | 0.501 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 3.156981e-01 | 0.501 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 3.156981e-01 | 0.501 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 3.156981e-01 | 0.501 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 3.164892e-01 | 0.500 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 3.200993e-01 | 0.495 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 3.200993e-01 | 0.495 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 3.200993e-01 | 0.495 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 3.230860e-01 | 0.491 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 3.263779e-01 | 0.486 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 3.305213e-01 | 0.481 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 3.305213e-01 | 0.481 | 0 | 0 |
| Malate-aspartate shuttle | R-HSA-9856872 | 3.305213e-01 | 0.481 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 3.305213e-01 | 0.481 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 3.305213e-01 | 0.481 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 3.364676e-01 | 0.473 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 3.364676e-01 | 0.473 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 3.364676e-01 | 0.473 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 3.364676e-01 | 0.473 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 3.375634e-01 | 0.472 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 3.375634e-01 | 0.472 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 3.375634e-01 | 0.472 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 3.375634e-01 | 0.472 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 3.438667e-01 | 0.464 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 3.449692e-01 | 0.462 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 3.472149e-01 | 0.459 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 3.481124e-01 | 0.458 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 3.512577e-01 | 0.454 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 3.512577e-01 | 0.454 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 3.512577e-01 | 0.454 | 1 | 1 |
| Sodium/Proton exchangers | R-HSA-425986 | 3.512577e-01 | 0.454 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 3.512577e-01 | 0.454 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 3.540139e-01 | 0.451 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 3.561742e-01 | 0.448 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 3.595414e-01 | 0.444 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 3.595414e-01 | 0.444 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 3.595414e-01 | 0.444 | 0 | 0 |
| Glucagon-type ligand receptors | R-HSA-420092 | 3.595414e-01 | 0.444 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 3.609553e-01 | 0.443 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 3.609553e-01 | 0.443 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 3.617069e-01 | 0.442 | 0 | 0 |
| Stimulation of the cell death response by PAK-2p34 | R-HSA-211736 | 3.626312e-01 | 0.441 | 0 | 0 |
| Defective PAPSS2 causes SEMD-PA | R-HSA-3560796 | 3.626312e-01 | 0.441 | 0 | 0 |
| TGFBR1 LBD Mutants in Cancer | R-HSA-3656535 | 3.626312e-01 | 0.441 | 0 | 0 |
| Defective SLC40A1 causes hemochromatosis 4 (HFE4) (duodenum) | R-HSA-5655799 | 3.626312e-01 | 0.441 | 0 | 0 |
| Potassium transport channels | R-HSA-1296067 | 3.626312e-01 | 0.441 | 0 | 0 |
| Defective POMT1 causes MDDGA1, MDDGB1 and MDDGC1 | R-HSA-5083633 | 3.626312e-01 | 0.441 | 0 | 0 |
| Defective POMT2 causes MDDGA2, MDDGB2 and MDDGC2 | R-HSA-5083629 | 3.626312e-01 | 0.441 | 0 | 0 |
| Mitotic Metaphase/Anaphase Transition | R-HSA-68881 | 3.626312e-01 | 0.441 | 0 | 0 |
| TGFBR2 Kinase Domain Mutants in Cancer | R-HSA-3645790 | 3.626312e-01 | 0.441 | 0 | 0 |
| Loss of Function of TGFBR2 in Cancer | R-HSA-3642278 | 3.626312e-01 | 0.441 | 0 | 0 |
| Regulation of cortical dendrite branching | R-HSA-8985801 | 3.626312e-01 | 0.441 | 0 | 0 |
| Vpr-mediated induction of apoptosis by mitochondrial outer membrane permeabilization | R-HSA-180897 | 3.626312e-01 | 0.441 | 0 | 0 |
| DSCAM interactions | R-HSA-376172 | 3.626312e-01 | 0.441 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 3.653705e-01 | 0.437 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 3.703124e-01 | 0.431 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 3.703124e-01 | 0.431 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 3.709700e-01 | 0.431 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 3.815587e-01 | 0.418 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 3.869112e-01 | 0.412 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 3.869112e-01 | 0.412 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 3.908300e-01 | 0.408 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 3.911704e-01 | 0.408 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 3.911704e-01 | 0.408 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 3.911704e-01 | 0.408 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 3.911704e-01 | 0.408 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 3.911995e-01 | 0.408 | 0 | 0 |
| 5-Phosphoribose 1-diphosphate biosynthesis | R-HSA-73843 | 3.911995e-01 | 0.408 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 3.911995e-01 | 0.408 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 3.911995e-01 | 0.408 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 3.911995e-01 | 0.408 | 0 | 0 |
| Regulation of NPAS4 gene transcription | R-HSA-9768777 | 3.911995e-01 | 0.408 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 3.911995e-01 | 0.408 | 0 | 0 |
| Zinc influx into cells by the SLC39 gene family | R-HSA-442380 | 3.911995e-01 | 0.408 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 3.911995e-01 | 0.408 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 3.911995e-01 | 0.408 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 3.911995e-01 | 0.408 | 0 | 0 |
| Butyrophilin (BTN) family interactions | R-HSA-8851680 | 3.911995e-01 | 0.408 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 3.925753e-01 | 0.406 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 3.957132e-01 | 0.403 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 3.978070e-01 | 0.400 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 4.035861e-01 | 0.394 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 4.065239e-01 | 0.391 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 4.065239e-01 | 0.391 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 4.065239e-01 | 0.391 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 4.119806e-01 | 0.385 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 4.119806e-01 | 0.385 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 4.154659e-01 | 0.381 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 4.154659e-01 | 0.381 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 4.154659e-01 | 0.381 | 0 | 0 |
| Passive transport by Aquaporins | R-HSA-432047 | 4.210104e-01 | 0.376 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 4.210104e-01 | 0.376 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 4.210104e-01 | 0.376 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 4.254001e-01 | 0.371 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 4.254345e-01 | 0.371 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 4.254345e-01 | 0.371 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 4.283857e-01 | 0.368 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 4.299958e-01 | 0.367 | 0 | 0 |
| Cross-presentation of particulate exogenous antigens (phagosomes) | R-HSA-1236973 | 4.299958e-01 | 0.367 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 4.299958e-01 | 0.367 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 4.299958e-01 | 0.367 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 4.299958e-01 | 0.367 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 4.299958e-01 | 0.367 | 0 | 0 |
| Axonal growth stimulation | R-HSA-209563 | 4.305168e-01 | 0.366 | 0 | 0 |
| Classical Kir channels | R-HSA-1296053 | 4.305168e-01 | 0.366 | 0 | 0 |
| Defective HPRT1 disrupts guanine and hypoxanthine salvage | R-HSA-9734281 | 4.305168e-01 | 0.366 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 4.305168e-01 | 0.366 | 0 | 0 |
| Invadopodia formation | R-HSA-8941237 | 4.305168e-01 | 0.366 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 4.305168e-01 | 0.366 | 0 | 0 |
| Adrenaline signalling through Alpha-2 adrenergic receptor | R-HSA-392023 | 4.305168e-01 | 0.366 | 0 | 0 |
| Activation of BIM and translocation to mitochondria | R-HSA-111446 | 4.305168e-01 | 0.366 | 0 | 0 |
| Intracellular oxygen transport | R-HSA-8981607 | 4.305168e-01 | 0.366 | 0 | 0 |
| Diseases of Mismatch Repair (MMR) | R-HSA-5423599 | 4.305168e-01 | 0.366 | 0 | 0 |
| Histamine receptors | R-HSA-390650 | 4.305168e-01 | 0.366 | 0 | 0 |
| FasL/ CD95L signaling | R-HSA-75157 | 4.305168e-01 | 0.366 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 4.368236e-01 | 0.360 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 4.368236e-01 | 0.360 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 4.477287e-01 | 0.349 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 4.477287e-01 | 0.349 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 4.503395e-01 | 0.346 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 4.503395e-01 | 0.346 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 4.503395e-01 | 0.346 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 4.605620e-01 | 0.337 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 4.613574e-01 | 0.336 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 4.613574e-01 | 0.336 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 4.653309e-01 | 0.332 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 4.664150e-01 | 0.331 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 4.674375e-01 | 0.330 | 0 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 4.674375e-01 | 0.330 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 4.674375e-01 | 0.330 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 4.674375e-01 | 0.330 | 0 | 0 |
| Transport of RCbl within the body | R-HSA-9758890 | 4.674375e-01 | 0.330 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 4.674375e-01 | 0.330 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 4.674375e-01 | 0.330 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 4.674375e-01 | 0.330 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 4.680871e-01 | 0.330 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 4.740930e-01 | 0.324 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 4.758011e-01 | 0.323 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 4.784875e-01 | 0.320 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 4.790417e-01 | 0.320 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 4.790417e-01 | 0.320 | 0 | 0 |
| PKA activation | R-HSA-163615 | 4.790417e-01 | 0.320 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 4.790417e-01 | 0.320 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 4.851256e-01 | 0.314 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 4.855075e-01 | 0.314 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 4.855075e-01 | 0.314 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 4.855075e-01 | 0.314 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 4.887254e-01 | 0.311 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 4.899283e-01 | 0.310 | 0 | 0 |
| HCN channels | R-HSA-1296061 | 4.911755e-01 | 0.309 | 0 | 0 |
| Signaling by MAP2K mutants | R-HSA-9652169 | 4.911755e-01 | 0.309 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 4.911755e-01 | 0.309 | 0 | 0 |
| Extrinsic Pathway of Fibrin Clot Formation | R-HSA-140834 | 4.911755e-01 | 0.309 | 0 | 0 |
| SARS-CoV-1-mediated effects on programmed cell death | R-HSA-9692913 | 4.911755e-01 | 0.309 | 0 | 0 |
| Transcriptional activation of p53 responsive genes | R-HSA-69560 | 4.911755e-01 | 0.309 | 0 | 0 |
| Transcriptional activation of cell cycle inhibitor p21 | R-HSA-69895 | 4.911755e-01 | 0.309 | 0 | 0 |
| Activation of NOXA and translocation to mitochondria | R-HSA-111448 | 4.911755e-01 | 0.309 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 4.911755e-01 | 0.309 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 4.911755e-01 | 0.309 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 4.911755e-01 | 0.309 | 0 | 0 |
| Regulation of HMOX1 expression and activity | R-HSA-9707587 | 4.911755e-01 | 0.309 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 4.918703e-01 | 0.308 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 5.020135e-01 | 0.299 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 5.033732e-01 | 0.298 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 5.033732e-01 | 0.298 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 5.033732e-01 | 0.298 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 5.033732e-01 | 0.298 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 5.070193e-01 | 0.295 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 5.070193e-01 | 0.295 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 5.070193e-01 | 0.295 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 5.092079e-01 | 0.293 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 5.092079e-01 | 0.293 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 5.092079e-01 | 0.293 | 0 | 0 |
| ER Quality Control Compartment (ERQC) | R-HSA-901032 | 5.092079e-01 | 0.293 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 5.108594e-01 | 0.292 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 5.134407e-01 | 0.290 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 5.223577e-01 | 0.282 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 5.306002e-01 | 0.275 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 5.324010e-01 | 0.274 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 5.341916e-01 | 0.272 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 5.376990e-01 | 0.269 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 5.376990e-01 | 0.269 | 0 | 0 |
| Erythrocytes take up oxygen and release carbon dioxide | R-HSA-1247673 | 5.376990e-01 | 0.269 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 5.376990e-01 | 0.269 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 5.437635e-01 | 0.265 | 0 | 0 |
| Activation of AMPA receptors | R-HSA-399710 | 5.453764e-01 | 0.263 | 0 | 0 |
| NFE2L2 regulating TCA cycle genes | R-HSA-9818025 | 5.453764e-01 | 0.263 | 0 | 0 |
| NOSIP mediated eNOS trafficking | R-HSA-203754 | 5.453764e-01 | 0.263 | 0 | 0 |
| Defective binding of VWF variant to GPIb:IX:V | R-HSA-9846298 | 5.453764e-01 | 0.263 | 0 | 0 |
| Defective F9 activation | R-HSA-9673221 | 5.453764e-01 | 0.263 | 0 | 0 |
| Enhanced binding of GP1BA variant to VWF multimer:collagen | R-HSA-9845620 | 5.453764e-01 | 0.263 | 0 | 0 |
| PTK6 Down-Regulation | R-HSA-8849472 | 5.453764e-01 | 0.263 | 0 | 0 |
| Activation of AKT2 | R-HSA-165158 | 5.453764e-01 | 0.263 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in interleukin signaling | R-HSA-8939247 | 5.453764e-01 | 0.263 | 0 | 0 |
| Reelin signalling pathway | R-HSA-8866376 | 5.453764e-01 | 0.263 | 0 | 0 |
| Nectin/Necl trans heterodimerization | R-HSA-420597 | 5.453764e-01 | 0.263 | 0 | 0 |
| Phosphorylation and nuclear translocation of BMAL1 (ARNTL) and CLOCK | R-HSA-9931529 | 5.453764e-01 | 0.263 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 5.550367e-01 | 0.256 | 0 | 0 |
| G-protein activation | R-HSA-202040 | 5.604938e-01 | 0.251 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 5.604938e-01 | 0.251 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 5.673287e-01 | 0.246 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 5.703501e-01 | 0.244 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 5.703501e-01 | 0.244 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 5.703501e-01 | 0.244 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 5.703501e-01 | 0.244 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 5.703501e-01 | 0.244 | 0 | 0 |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | R-HSA-8877330 | 5.703501e-01 | 0.244 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 5.713459e-01 | 0.243 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 5.762386e-01 | 0.239 | 1 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 5.770727e-01 | 0.239 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 5.770727e-01 | 0.239 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 5.770727e-01 | 0.239 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 5.770727e-01 | 0.239 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 5.777474e-01 | 0.238 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 5.808015e-01 | 0.236 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 5.850134e-01 | 0.233 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 5.906249e-01 | 0.229 | 0 | 0 |
| Plus-strand DNA synthesis | R-HSA-164525 | 5.938065e-01 | 0.226 | 0 | 0 |
| Nef Mediated CD8 Down-regulation | R-HSA-182218 | 5.938065e-01 | 0.226 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 5.938065e-01 | 0.226 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 5.938065e-01 | 0.226 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 5.938065e-01 | 0.226 | 0 | 0 |
| Toxicity of botulinum toxin type E (botE) | R-HSA-5250992 | 5.938065e-01 | 0.226 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 5.938065e-01 | 0.226 | 0 | 0 |
| Release of apoptotic factors from the mitochondria | R-HSA-111457 | 5.938065e-01 | 0.226 | 0 | 0 |
| Pentose phosphate pathway disease | R-HSA-6791465 | 5.938065e-01 | 0.226 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 5.938065e-01 | 0.226 | 0 | 0 |
| Synthesis of PS | R-HSA-1483101 | 5.938065e-01 | 0.226 | 0 | 0 |
| Defects of platelet adhesion to exposed collagen | R-HSA-9823587 | 5.938065e-01 | 0.226 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 5.938065e-01 | 0.226 | 0 | 0 |
| CLEC7A/inflammasome pathway | R-HSA-5660668 | 5.938065e-01 | 0.226 | 0 | 0 |
| Sodium-coupled phosphate cotransporters | R-HSA-427652 | 5.938065e-01 | 0.226 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 5.938065e-01 | 0.226 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 5.938065e-01 | 0.226 | 0 | 0 |
| SLC15A4:TASL-dependent IRF5 activation | R-HSA-9860276 | 5.938065e-01 | 0.226 | 0 | 0 |
| TRAIL signaling | R-HSA-75158 | 5.938065e-01 | 0.226 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 5.984737e-01 | 0.223 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 5.984737e-01 | 0.223 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 6.012938e-01 | 0.221 | 0 | 0 |
| Prolactin receptor signaling | R-HSA-1170546 | 6.012938e-01 | 0.221 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 6.012938e-01 | 0.221 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 6.023188e-01 | 0.220 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 6.052134e-01 | 0.218 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 6.094160e-01 | 0.215 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 6.102985e-01 | 0.214 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 6.102985e-01 | 0.214 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 6.131473e-01 | 0.212 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 6.172504e-01 | 0.210 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 6.192110e-01 | 0.208 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 6.222352e-01 | 0.206 | 1 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 6.305233e-01 | 0.200 | 0 | 0 |
| Lysosphingolipid and LPA receptors | R-HSA-419408 | 6.305233e-01 | 0.200 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 6.305233e-01 | 0.200 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 6.305233e-01 | 0.200 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 6.337372e-01 | 0.198 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 6.357165e-01 | 0.197 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 6.370800e-01 | 0.196 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 6.370800e-01 | 0.196 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 6.370800e-01 | 0.196 | 0 | 0 |
| Uncoating of the HIV Virion | R-HSA-162585 | 6.370800e-01 | 0.196 | 0 | 0 |
| Toxicity of botulinum toxin type D (botD) | R-HSA-5250955 | 6.370800e-01 | 0.196 | 0 | 0 |
| Toxicity of botulinum toxin type F (botF) | R-HSA-5250981 | 6.370800e-01 | 0.196 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 6.370800e-01 | 0.196 | 0 | 0 |
| Abacavir transmembrane transport | R-HSA-2161517 | 6.370800e-01 | 0.196 | 0 | 0 |
| HDL clearance | R-HSA-8964011 | 6.370800e-01 | 0.196 | 0 | 0 |
| Lipid particle organization | R-HSA-8964572 | 6.370800e-01 | 0.196 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 6.370800e-01 | 0.196 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 6.392622e-01 | 0.194 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 6.392622e-01 | 0.194 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 6.392622e-01 | 0.194 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 6.392622e-01 | 0.194 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 6.432943e-01 | 0.192 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 6.467811e-01 | 0.189 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 6.536626e-01 | 0.185 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 6.561755e-01 | 0.183 | 0 | 0 |
| Thromboxane signalling through TP receptor | R-HSA-428930 | 6.561755e-01 | 0.183 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 6.561755e-01 | 0.183 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 6.580526e-01 | 0.182 | 0 | 0 |
| Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion | R-HSA-434316 | 6.580526e-01 | 0.182 | 0 | 0 |
| Atorvastatin ADME | R-HSA-9754706 | 6.580526e-01 | 0.182 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 6.583768e-01 | 0.182 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 6.586108e-01 | 0.181 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 6.586108e-01 | 0.181 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 6.626647e-01 | 0.179 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 6.662930e-01 | 0.176 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 6.662930e-01 | 0.176 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 6.673975e-01 | 0.176 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 6.673975e-01 | 0.176 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 6.700902e-01 | 0.174 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 6.757456e-01 | 0.170 | 0 | 0 |
| PP2A-mediated dephosphorylation of key metabolic factors | R-HSA-163767 | 6.757456e-01 | 0.170 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 6.757456e-01 | 0.170 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose | R-HSA-9031528 | 6.757456e-01 | 0.170 | 0 | 0 |
| DAG1 core M1 glycosylations | R-HSA-8932506 | 6.757456e-01 | 0.170 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to gluconeogenesis | R-HSA-9632974 | 6.757456e-01 | 0.170 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to limit cholesterol uptake | R-HSA-9031525 | 6.757456e-01 | 0.170 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 6.757456e-01 | 0.170 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 6.757456e-01 | 0.170 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 6.757456e-01 | 0.170 | 0 | 0 |
| Microbial modulation of RIPK1-mediated regulated necrosis | R-HSA-9686347 | 6.757456e-01 | 0.170 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 6.757456e-01 | 0.170 | 0 | 0 |
| Insulin effects increased synthesis of Xylulose-5-Phosphate | R-HSA-163754 | 6.757456e-01 | 0.170 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 6.772452e-01 | 0.169 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 6.772452e-01 | 0.169 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 6.772452e-01 | 0.169 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 6.772452e-01 | 0.169 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 6.776066e-01 | 0.169 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 6.776066e-01 | 0.169 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 6.776066e-01 | 0.169 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 6.776066e-01 | 0.169 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 6.825663e-01 | 0.166 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 6.839122e-01 | 0.165 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 6.839122e-01 | 0.165 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 6.839122e-01 | 0.165 | 0 | 0 |
| Biosynthesis of maresin-like SPMs | R-HSA-9027307 | 6.839122e-01 | 0.165 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 6.839122e-01 | 0.165 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 6.863980e-01 | 0.163 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 6.951590e-01 | 0.158 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 6.954255e-01 | 0.158 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 6.980317e-01 | 0.156 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 6.980317e-01 | 0.156 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 7.032193e-01 | 0.153 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 7.032193e-01 | 0.153 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 7.081454e-01 | 0.150 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 7.081454e-01 | 0.150 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 7.081454e-01 | 0.150 | 0 | 0 |
| Reverse Transcription of HIV RNA | R-HSA-162589 | 7.102938e-01 | 0.149 | 0 | 0 |
| Minus-strand DNA synthesis | R-HSA-164516 | 7.102938e-01 | 0.149 | 0 | 0 |
| DAG1 core M2 glycosylations | R-HSA-8932504 | 7.102938e-01 | 0.149 | 0 | 0 |
| phospho-PLA2 pathway | R-HSA-111995 | 7.102938e-01 | 0.149 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 7.102938e-01 | 0.149 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 7.102938e-01 | 0.149 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 7.102938e-01 | 0.149 | 0 | 0 |
| Fructose biosynthesis | R-HSA-5652227 | 7.102938e-01 | 0.149 | 0 | 0 |
| FGFR1b ligand binding and activation | R-HSA-190370 | 7.102938e-01 | 0.149 | 0 | 0 |
| Interleukin-9 signaling | R-HSA-8985947 | 7.102938e-01 | 0.149 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 7.102938e-01 | 0.149 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 7.102938e-01 | 0.149 | 0 | 0 |
| Negative regulation of activity of TFAP2 (AP-2) family transcription factors | R-HSA-8866904 | 7.102938e-01 | 0.149 | 0 | 0 |
| Nucleotide salvage defects | R-HSA-9734207 | 7.102938e-01 | 0.149 | 0 | 0 |
| Alpha-defensins | R-HSA-1462054 | 7.102938e-01 | 0.149 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 7.104042e-01 | 0.148 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 7.109610e-01 | 0.148 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 7.120488e-01 | 0.147 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 7.123498e-01 | 0.147 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 7.123498e-01 | 0.147 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 7.174586e-01 | 0.144 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 7.174586e-01 | 0.144 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 7.174586e-01 | 0.144 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 7.259298e-01 | 0.139 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 7.281701e-01 | 0.138 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 7.288194e-01 | 0.137 | 0 | 0 |
| Cytosolic iron-sulfur cluster assembly | R-HSA-2564830 | 7.308050e-01 | 0.136 | 0 | 0 |
| Vitamin D (calciferol) metabolism | R-HSA-196791 | 7.308050e-01 | 0.136 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 7.308050e-01 | 0.136 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 7.359009e-01 | 0.133 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 7.411629e-01 | 0.130 | 0 | 0 |
| Toxicity of botulinum toxin type A (botA) | R-HSA-5250968 | 7.411629e-01 | 0.130 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 7.411629e-01 | 0.130 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 7.411629e-01 | 0.130 | 0 | 0 |
| Interleukin-21 signaling | R-HSA-9020958 | 7.411629e-01 | 0.130 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 7.411629e-01 | 0.130 | 0 | 0 |
| MAPK1 (ERK2) activation | R-HSA-112411 | 7.411629e-01 | 0.130 | 0 | 0 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 7.411629e-01 | 0.130 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 7.411629e-01 | 0.130 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 7.411629e-01 | 0.130 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 7.411629e-01 | 0.130 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 7.411629e-01 | 0.130 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 7.445730e-01 | 0.128 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 7.504451e-01 | 0.125 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 7.519513e-01 | 0.124 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 7.519513e-01 | 0.124 | 0 | 0 |
| Erythrocytes take up carbon dioxide and release oxygen | R-HSA-1237044 | 7.519513e-01 | 0.124 | 0 | 0 |
| O2/CO2 exchange in erythrocytes | R-HSA-1480926 | 7.519513e-01 | 0.124 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 7.519513e-01 | 0.124 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 7.533773e-01 | 0.123 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 7.596186e-01 | 0.119 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 7.614797e-01 | 0.118 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 7.638451e-01 | 0.117 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 7.638451e-01 | 0.117 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 7.687443e-01 | 0.114 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 7.687443e-01 | 0.114 | 0 | 0 |
| Ion influx/efflux at host-pathogen interface | R-HSA-6803544 | 7.687443e-01 | 0.114 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 7.687443e-01 | 0.114 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 7.687443e-01 | 0.114 | 0 | 0 |
| Defective RIPK1-mediated regulated necrosis | R-HSA-9693928 | 7.687443e-01 | 0.114 | 0 | 0 |
| Interleukin-27 signaling | R-HSA-9020956 | 7.687443e-01 | 0.114 | 0 | 0 |
| Defective factor IX causes hemophilia B | R-HSA-9668250 | 7.687443e-01 | 0.114 | 0 | 0 |
| Metal sequestration by antimicrobial proteins | R-HSA-6799990 | 7.687443e-01 | 0.114 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 7.698369e-01 | 0.114 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 7.699103e-01 | 0.114 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 7.716494e-01 | 0.113 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 7.716494e-01 | 0.113 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 7.716494e-01 | 0.113 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 7.716494e-01 | 0.113 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 7.716494e-01 | 0.113 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 7.716494e-01 | 0.113 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 7.716494e-01 | 0.113 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 7.716494e-01 | 0.113 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 7.739672e-01 | 0.111 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 7.739672e-01 | 0.111 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 7.739672e-01 | 0.111 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 7.739672e-01 | 0.111 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 7.741621e-01 | 0.111 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 7.756673e-01 | 0.110 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 7.789452e-01 | 0.108 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 7.801776e-01 | 0.108 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 7.801776e-01 | 0.108 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 7.855260e-01 | 0.105 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 7.872237e-01 | 0.104 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 7.876320e-01 | 0.104 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 12 | R-HSA-392170 | 7.899678e-01 | 0.102 | 0 | 0 |
| Intrinsic Pathway of Fibrin Clot Formation | R-HSA-140837 | 7.899678e-01 | 0.102 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 7.899678e-01 | 0.102 | 0 | 0 |
| DAG1 core M3 glycosylations | R-HSA-8932505 | 7.933882e-01 | 0.101 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 7.933882e-01 | 0.101 | 0 | 0 |
| LGI-ADAM interactions | R-HSA-5682910 | 7.933882e-01 | 0.101 | 0 | 0 |
| vRNA Synthesis | R-HSA-192814 | 7.933882e-01 | 0.101 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 7.933882e-01 | 0.101 | 0 | 0 |
| Cholesterol biosynthesis via desmosterol | R-HSA-6807047 | 7.933882e-01 | 0.101 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 7.933882e-01 | 0.101 | 0 | 0 |
| SARS-CoV-2 modulates autophagy | R-HSA-9754560 | 7.933882e-01 | 0.101 | 0 | 0 |
| Vitamin B1 (thiamin) metabolism | R-HSA-196819 | 7.933882e-01 | 0.101 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 7.945379e-01 | 0.100 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 7.982323e-01 | 0.098 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 7.991967e-01 | 0.097 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 7.996356e-01 | 0.097 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 8.069767e-01 | 0.093 | 0 | 0 |
| Ribavirin ADME | R-HSA-9755088 | 8.069767e-01 | 0.093 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 8.090276e-01 | 0.092 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 8.135202e-01 | 0.090 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 8.141221e-01 | 0.089 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 8.151328e-01 | 0.089 | 0 | 0 |
| Synthesis of diphthamide-EEF2 | R-HSA-5358493 | 8.154072e-01 | 0.089 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 8.154072e-01 | 0.089 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 8.154072e-01 | 0.089 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 8.154072e-01 | 0.089 | 0 | 0 |
| Viral RNP Complexes in the Host Cell Nucleus | R-HSA-168330 | 8.154072e-01 | 0.089 | 0 | 0 |
| Sodium/Calcium exchangers | R-HSA-425561 | 8.154072e-01 | 0.089 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 8.175810e-01 | 0.087 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 8.227472e-01 | 0.085 | 0 | 0 |
| Fructose metabolism | R-HSA-5652084 | 8.227472e-01 | 0.085 | 0 | 0 |
| Cholesterol biosynthesis via lathosterol | R-HSA-6807062 | 8.227472e-01 | 0.085 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 8.258395e-01 | 0.083 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 8.271655e-01 | 0.082 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 8.271655e-01 | 0.082 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 8.331462e-01 | 0.079 | 1 | 0 |
| Defective EXT2 causes exostoses 2 | R-HSA-3656237 | 8.350807e-01 | 0.078 | 0 | 0 |
| Defective EXT1 causes exostoses 1, TRPS2 and CHDS | R-HSA-3656253 | 8.350807e-01 | 0.078 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 8.350807e-01 | 0.078 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 8.350807e-01 | 0.078 | 0 | 0 |
| Interleukin-35 Signalling | R-HSA-8984722 | 8.350807e-01 | 0.078 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 8.350807e-01 | 0.078 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 8.373500e-01 | 0.077 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 8.373500e-01 | 0.077 | 0 | 0 |
| Interleukin-20 family signaling | R-HSA-8854691 | 8.373500e-01 | 0.077 | 0 | 0 |
| Biosynthesis of maresins | R-HSA-9018682 | 8.373500e-01 | 0.077 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 8.373500e-01 | 0.077 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 8.474658e-01 | 0.072 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 8.488897e-01 | 0.071 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 8.508548e-01 | 0.070 | 0 | 0 |
| PDH complex synthesizes acetyl-CoA from PYR | R-HSA-9861559 | 8.526585e-01 | 0.069 | 0 | 0 |
| FGFR1c ligand binding and activation | R-HSA-190373 | 8.526585e-01 | 0.069 | 0 | 0 |
| IL-6-type cytokine receptor ligand interactions | R-HSA-6788467 | 8.526585e-01 | 0.069 | 0 | 0 |
| Diseases of nucleotide metabolism | R-HSA-9735804 | 8.526585e-01 | 0.069 | 0 | 0 |
| Acyl chain remodeling of DAG and TAG | R-HSA-1482883 | 8.526585e-01 | 0.069 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 8.526585e-01 | 0.069 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 8.562139e-01 | 0.067 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 8.616781e-01 | 0.065 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 8.633296e-01 | 0.064 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 8.633296e-01 | 0.064 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 8.633296e-01 | 0.064 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 8.633296e-01 | 0.064 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 8.633296e-01 | 0.064 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 8.683637e-01 | 0.061 | 0 | 0 |
| cGMP effects | R-HSA-418457 | 8.683637e-01 | 0.061 | 0 | 0 |
| Hydrolysis of LPC | R-HSA-1483115 | 8.683637e-01 | 0.061 | 0 | 0 |
| Biosynthesis of protectins | R-HSA-9018681 | 8.683637e-01 | 0.061 | 0 | 0 |
| Formation of the active cofactor, UDP-glucuronate | R-HSA-173599 | 8.683637e-01 | 0.061 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 8.683637e-01 | 0.061 | 0 | 0 |
| Biosynthesis of E-series 18(R)-resolvins | R-HSA-9023661 | 8.683637e-01 | 0.061 | 0 | 0 |
| Acyl chain remodeling of CL | R-HSA-1482798 | 8.683637e-01 | 0.061 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 8.683637e-01 | 0.061 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 8.710177e-01 | 0.060 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 8.715965e-01 | 0.060 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 8.748407e-01 | 0.058 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 8.748407e-01 | 0.058 | 0 | 0 |
| Urea cycle | R-HSA-70635 | 8.748407e-01 | 0.058 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 8.783551e-01 | 0.056 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 8.794269e-01 | 0.056 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 8.794269e-01 | 0.056 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 8.811810e-01 | 0.055 | 0 | 0 |
| Signaling by Activin | R-HSA-1502540 | 8.823957e-01 | 0.054 | 0 | 0 |
| Transport and metabolism of PAPS | R-HSA-174362 | 8.823957e-01 | 0.054 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 8.823957e-01 | 0.054 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 8.823957e-01 | 0.054 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 8.854516e-01 | 0.053 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 8.899828e-01 | 0.051 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 8.899828e-01 | 0.051 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 8.919791e-01 | 0.050 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 8.920878e-01 | 0.050 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 8.949327e-01 | 0.048 | 0 | 0 |
| Phase 4 - resting membrane potential | R-HSA-5576886 | 8.949327e-01 | 0.048 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 8.949327e-01 | 0.048 | 0 | 0 |
| Activation of the phototransduction cascade | R-HSA-2485179 | 8.949327e-01 | 0.048 | 0 | 0 |
| Induction of Cell-Cell Fusion | R-HSA-9733458 | 8.949327e-01 | 0.048 | 0 | 0 |
| Fructose catabolism | R-HSA-70350 | 8.949327e-01 | 0.048 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 8.949327e-01 | 0.048 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 8.949327e-01 | 0.048 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 8.949327e-01 | 0.048 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 8.949327e-01 | 0.048 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 8.949327e-01 | 0.048 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 8.949327e-01 | 0.048 | 0 | 0 |
| Attachment and Entry | R-HSA-9678110 | 8.949327e-01 | 0.048 | 0 | 0 |
| Mitochondrial Uncoupling | R-HSA-166187 | 8.949327e-01 | 0.048 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 8.952234e-01 | 0.048 | 0 | 0 |
| Prednisone ADME | R-HSA-9757110 | 8.952234e-01 | 0.048 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 8.952234e-01 | 0.048 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 8.980238e-01 | 0.047 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.005600e-01 | 0.045 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 9.008628e-01 | 0.045 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 9.042143e-01 | 0.044 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 9.049692e-01 | 0.043 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 9.057141e-01 | 0.043 | 0 | 0 |
| Defective B3GALT6 causes EDSP2 and SEMDJL1 | R-HSA-4420332 | 9.061338e-01 | 0.043 | 0 | 0 |
| Defective B4GALT7 causes EDS, progeroid type | R-HSA-3560783 | 9.061338e-01 | 0.043 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 9.061338e-01 | 0.043 | 0 | 0 |
| Phase 2 - plateau phase | R-HSA-5576893 | 9.061338e-01 | 0.043 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 9.061338e-01 | 0.043 | 0 | 0 |
| Fibronectin matrix formation | R-HSA-1566977 | 9.061338e-01 | 0.043 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 9.061338e-01 | 0.043 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 9.061338e-01 | 0.043 | 0 | 0 |
| Galactose catabolism | R-HSA-70370 | 9.061338e-01 | 0.043 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 9.061338e-01 | 0.043 | 0 | 0 |
| Defects of contact activation system (CAS) and kallikrein/kinin system (KKS) | R-HSA-9651496 | 9.061338e-01 | 0.043 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.114921e-01 | 0.040 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 9.124799e-01 | 0.040 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 9.129837e-01 | 0.040 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 9.129837e-01 | 0.040 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.140389e-01 | 0.039 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 9.153561e-01 | 0.038 | 0 | 0 |
| Defective B3GAT3 causes JDSSDHD | R-HSA-3560801 | 9.161414e-01 | 0.038 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 9.161414e-01 | 0.038 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 9.161414e-01 | 0.038 | 0 | 0 |
| GDP-fucose biosynthesis | R-HSA-6787639 | 9.161414e-01 | 0.038 | 0 | 0 |
| Metabolism of ingested H2SeO4 and H2SeO3 into H2Se | R-HSA-2408550 | 9.161414e-01 | 0.038 | 0 | 0 |
| Biosynthesis of aspirin-triggered D-series resolvins | R-HSA-9020265 | 9.161414e-01 | 0.038 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 9.161414e-01 | 0.038 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 9.161414e-01 | 0.038 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 9.196201e-01 | 0.036 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 9.196201e-01 | 0.036 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.196201e-01 | 0.036 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 9.200724e-01 | 0.036 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.204629e-01 | 0.036 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.246272e-01 | 0.034 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 9.250826e-01 | 0.034 | 0 | 0 |
| FGFR1 ligand binding and activation | R-HSA-190242 | 9.250826e-01 | 0.034 | 0 | 0 |
| Organic anion transport by SLC5/17/25 transporters | R-HSA-428643 | 9.250826e-01 | 0.034 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 9.250826e-01 | 0.034 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 9.270414e-01 | 0.033 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 9.275884e-01 | 0.033 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 9.330709e-01 | 0.030 | 0 | 0 |
| mRNA decay by 3' to 5' exoribonuclease | R-HSA-429958 | 9.330709e-01 | 0.030 | 0 | 0 |
| Diseases of hemostasis | R-HSA-9671793 | 9.330709e-01 | 0.030 | 0 | 0 |
| Strand-asynchronous mitochondrial DNA replication | R-HSA-9913635 | 9.330709e-01 | 0.030 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 9.330709e-01 | 0.030 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 9.384745e-01 | 0.028 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 9.384745e-01 | 0.028 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 9.392926e-01 | 0.027 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 9.392926e-01 | 0.027 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 9.402078e-01 | 0.027 | 0 | 0 |
| Mitochondrial iron-sulfur cluster biogenesis | R-HSA-1362409 | 9.402078e-01 | 0.027 | 0 | 0 |
| Acyl chain remodelling of PI | R-HSA-1482922 | 9.402078e-01 | 0.027 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 9.402078e-01 | 0.027 | 0 | 0 |
| Pregnenolone biosynthesis | R-HSA-196108 | 9.402078e-01 | 0.027 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 9.428777e-01 | 0.026 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 9.446595e-01 | 0.025 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 9.446595e-01 | 0.025 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 9.446595e-01 | 0.025 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 9.446595e-01 | 0.025 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 9.463630e-01 | 0.024 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.465099e-01 | 0.024 | 0 | 0 |
| Matriglycan biosynthesis on DAG1 | R-HSA-9939291 | 9.465841e-01 | 0.024 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 9.465841e-01 | 0.024 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 9.465841e-01 | 0.024 | 0 | 0 |
| Synthesis, secretion, and deacylation of Ghrelin | R-HSA-422085 | 9.465841e-01 | 0.024 | 0 | 0 |
| Biosynthesis of E-series 18(S)-resolvins | R-HSA-9018896 | 9.465841e-01 | 0.024 | 0 | 0 |
| Vitamin C (ascorbate) metabolism | R-HSA-196836 | 9.465841e-01 | 0.024 | 0 | 0 |
| Acyl chain remodelling of PG | R-HSA-1482925 | 9.465841e-01 | 0.024 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.467469e-01 | 0.024 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.467469e-01 | 0.024 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.489957e-01 | 0.023 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.495725e-01 | 0.022 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.514523e-01 | 0.022 | 0 | 0 |
| Serine metabolism | R-HSA-977347 | 9.522807e-01 | 0.021 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 9.540675e-01 | 0.020 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 9.540675e-01 | 0.020 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 9.540675e-01 | 0.020 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 9.544151e-01 | 0.020 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.545305e-01 | 0.020 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 9.559949e-01 | 0.020 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 9.573701e-01 | 0.019 | 0 | 0 |
| Neurotoxicity of clostridium toxins | R-HSA-168799 | 9.573701e-01 | 0.019 | 0 | 0 |
| Biosynthesis of D-series resolvins | R-HSA-9018676 | 9.573701e-01 | 0.019 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 9.573701e-01 | 0.019 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 9.573701e-01 | 0.019 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 9.581776e-01 | 0.019 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 9.619170e-01 | 0.017 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 9.619170e-01 | 0.017 | 0 | 0 |
| Synthesis of UDP-N-acetyl-glucosamine | R-HSA-446210 | 9.619170e-01 | 0.017 | 0 | 0 |
| Purine salvage | R-HSA-74217 | 9.619338e-01 | 0.017 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 9.619338e-01 | 0.017 | 0 | 0 |
| CYP2E1 reactions | R-HSA-211999 | 9.659791e-01 | 0.015 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 9.659791e-01 | 0.015 | 0 | 0 |
| TNFs bind their physiological receptors | R-HSA-5669034 | 9.659791e-01 | 0.015 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.660197e-01 | 0.015 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.672461e-01 | 0.014 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 9.684973e-01 | 0.014 | 0 | 0 |
| Maturation of TCA enzymes and regulation of TCA cycle | R-HSA-9854311 | 9.684973e-01 | 0.014 | 0 | 0 |
| Metabolism of steroid hormones | R-HSA-196071 | 9.689785e-01 | 0.014 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 9.696082e-01 | 0.013 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 9.696082e-01 | 0.013 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 9.696082e-01 | 0.013 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.698851e-01 | 0.013 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 9.699922e-01 | 0.013 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.713126e-01 | 0.013 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.713558e-01 | 0.013 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 9.718674e-01 | 0.012 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.725825e-01 | 0.012 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 9.728504e-01 | 0.012 | 0 | 0 |
| Abacavir ADME | R-HSA-2161522 | 9.728504e-01 | 0.012 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 9.728504e-01 | 0.012 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.730001e-01 | 0.012 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 9.739632e-01 | 0.011 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 9.739632e-01 | 0.011 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 9.739632e-01 | 0.011 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 9.748341e-01 | 0.011 | 0 | 0 |
| Triglyceride biosynthesis | R-HSA-75109 | 9.757468e-01 | 0.011 | 0 | 0 |
| Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane | R-HSA-83936 | 9.757468e-01 | 0.011 | 0 | 0 |
| Synthesis of bile acids and bile salts via 27-hydroxycholesterol | R-HSA-193807 | 9.757468e-01 | 0.011 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 9.757468e-01 | 0.011 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 9.758217e-01 | 0.011 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 9.763405e-01 | 0.010 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.767836e-01 | 0.010 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.769092e-01 | 0.010 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.769092e-01 | 0.010 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 9.783344e-01 | 0.010 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 9.783344e-01 | 0.010 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 9.783344e-01 | 0.010 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 9.785071e-01 | 0.009 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 9.804808e-01 | 0.009 | 0 | 0 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | R-HSA-196741 | 9.804808e-01 | 0.009 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 9.804808e-01 | 0.009 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.805378e-01 | 0.009 | 0 | 0 |
| Regulation of pyruvate dehydrogenase (PDH) complex | R-HSA-204174 | 9.806460e-01 | 0.008 | 0 | 0 |
| Biosynthesis of EPA-derived SPMs | R-HSA-9018679 | 9.806460e-01 | 0.008 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 9.817212e-01 | 0.008 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.817212e-01 | 0.008 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 9.822008e-01 | 0.008 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 9.822782e-01 | 0.008 | 0 | 0 |
| Diseases associated with glycosaminoglycan metabolism | R-HSA-3560782 | 9.822782e-01 | 0.008 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 9.827112e-01 | 0.008 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 9.827112e-01 | 0.008 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 9.827112e-01 | 0.008 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 9.831294e-01 | 0.007 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.835830e-01 | 0.007 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.842777e-01 | 0.007 | 0 | 0 |
| Aspartate and asparagine metabolism | R-HSA-8963693 | 9.845561e-01 | 0.007 | 0 | 0 |
| DAG1 glycosylations | R-HSA-8931838 | 9.862042e-01 | 0.006 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 9.862042e-01 | 0.006 | 0 | 0 |
| HS-GAG degradation | R-HSA-2024096 | 9.862042e-01 | 0.006 | 0 | 0 |
| Defective B3GALTL causes PpS | R-HSA-5083635 | 9.876765e-01 | 0.005 | 0 | 0 |
| Recycling of bile acids and salts | R-HSA-159418 | 9.876765e-01 | 0.005 | 0 | 0 |
| Diseases associated with glycosylation precursor biosynthesis | R-HSA-5609975 | 9.876765e-01 | 0.005 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 9.889918e-01 | 0.005 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.901268e-01 | 0.004 | 0 | 0 |
| Glycosaminoglycan-protein linkage region biosynthesis | R-HSA-1971475 | 9.901667e-01 | 0.004 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 9.901667e-01 | 0.004 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 9.918911e-01 | 0.004 | 0 | 0 |
| HS-GAG biosynthesis | R-HSA-2022928 | 9.921540e-01 | 0.003 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 9.921540e-01 | 0.003 | 0 | 0 |
| O-glycosylation of TSR domain-containing proteins | R-HSA-5173214 | 9.929916e-01 | 0.003 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 9.929916e-01 | 0.003 | 0 | 0 |
| NCAM1 interactions | R-HSA-419037 | 9.929916e-01 | 0.003 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 9.929916e-01 | 0.003 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.938890e-01 | 0.003 | 0 | 0 |
| Aflatoxin activation and detoxification | R-HSA-5423646 | 9.955385e-01 | 0.002 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 9.955922e-01 | 0.002 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 9.959546e-01 | 0.002 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.959546e-01 | 0.002 | 0 | 0 |
| Glutathione conjugation | R-HSA-156590 | 9.959546e-01 | 0.002 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 9.960150e-01 | 0.002 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 9.963399e-01 | 0.002 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.964702e-01 | 0.002 | 0 | 0 |
| Defensins | R-HSA-1461973 | 9.968207e-01 | 0.001 | 0 | 0 |
| Synthesis of very long-chain fatty acyl-CoAs | R-HSA-75876 | 9.968207e-01 | 0.001 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 9.968816e-01 | 0.001 | 0 | 0 |
| Methylation | R-HSA-156581 | 9.971602e-01 | 0.001 | 0 | 0 |
| Xenobiotics | R-HSA-211981 | 9.972920e-01 | 0.001 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 9.972920e-01 | 0.001 | 0 | 0 |
| Biosynthesis of DHA-derived SPMs | R-HSA-9018677 | 9.973256e-01 | 0.001 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 9.979993e-01 | 0.001 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.980368e-01 | 0.001 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.982065e-01 | 0.001 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.985238e-01 | 0.001 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.986665e-01 | 0.001 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 9.986665e-01 | 0.001 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.986665e-01 | 0.001 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.986665e-01 | 0.001 | 0 | 0 |
| Aspirin ADME | R-HSA-9749641 | 9.989122e-01 | 0.000 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.989991e-01 | 0.000 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.990177e-01 | 0.000 | 0 | 0 |
| Glucuronidation | R-HSA-156588 | 9.990825e-01 | 0.000 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.993477e-01 | 0.000 | 0 | 0 |
| Heparan sulfate/heparin (HS-GAG) metabolism | R-HSA-1638091 | 9.994787e-01 | 0.000 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.994787e-01 | 0.000 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 9.995208e-01 | 0.000 | 0 | 0 |
| Endogenous sterols | R-HSA-211976 | 9.995842e-01 | 0.000 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.995842e-01 | 0.000 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.997500e-01 | 0.000 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.997638e-01 | 0.000 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.997890e-01 | 0.000 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.997890e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | R-HSA-193368 | 9.997890e-01 | 0.000 | 0 | 0 |
| Classical antibody-mediated complement activation | R-HSA-173623 | 9.997904e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.997998e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.998372e-01 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.998473e-01 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.998483e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid catabolism | R-HSA-9840310 | 9.998497e-01 | 0.000 | 0 | 0 |
| Transport of vitamins, nucleosides, and related molecules | R-HSA-425397 | 9.999044e-01 | 0.000 | 0 | 0 |
| Scavenging of heme from plasma | R-HSA-2168880 | 9.999179e-01 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.999238e-01 | 0.000 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.999392e-01 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.999393e-01 | 0.000 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.999457e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.999460e-01 | 0.000 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.999490e-01 | 0.000 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.999681e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.999735e-01 | 0.000 | 0 | 0 |
| Creation of C4 and C2 activators | R-HSA-166786 | 9.999767e-01 | 0.000 | 0 | 0 |
| Regulation of Complement cascade | R-HSA-977606 | 9.999789e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.999790e-01 | 0.000 | 0 | 0 |
| Class C/3 (Metabotropic glutamate/pheromone receptors) | R-HSA-420499 | 9.999825e-01 | 0.000 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.999847e-01 | 0.000 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.999861e-01 | 0.000 | 0 | 0 |
| Initial triggering of complement | R-HSA-166663 | 9.999910e-01 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 9.999928e-01 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.999957e-01 | 0.000 | 0 | 0 |
| Biosynthesis of specialized proresolving mediators (SPMs) | R-HSA-9018678 | 9.999977e-01 | 0.000 | 0 | 0 |
| Post-translational modification: synthesis of GPI-anchored proteins | R-HSA-163125 | 9.999980e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999981e-01 | 0.000 | 0 | 0 |
| Complement cascade | R-HSA-166658 | 9.999981e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.999985e-01 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.999985e-01 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 9.999986e-01 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.999989e-01 | 0.000 | 0 | 0 |
| Synthesis of substrates in N-glycan biosythesis | R-HSA-446219 | 9.999989e-01 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 9.999991e-01 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 9.999994e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 9.999995e-01 | 0.000 | 0 | 0 |
| Sensory perception of sweet, bitter, and umami (glutamate) taste | R-HSA-9717207 | 9.999998e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid metabolism | R-HSA-1660662 | 9.999998e-01 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 9.999999e-01 | 0.000 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 9.999999e-01 | 0.000 | 0 | 0 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | R-HSA-446193 | 9.999999e-01 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| Expression and translocation of olfactory receptors | R-HSA-9752946 | 1.000000e+00 | -0.000 | 0 | 0 |
| Olfactory Signaling Pathway | R-HSA-381753 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |